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Single Cell Molecular Heterogeneity In Musculoskeletal Differentiation
Abstract
Mesenchymal stem cells (MSCs) display substantial cell-to-cell variation that manifests across many
aspects of cell phenotype and complicates the use of MSCs in regenerative applications. However, most
conventional assays measure MSC properties in bulk and, as a consequence, mask this cell-to-cell
variation. To better understand MSC heterogeneity and its underlying mechanisms, we quantitatively
assessed MSC phenotype within the context of chondrogenesis, amongst clonal populations and single
cells. Clonal MSCs differed in their contractility, ability to transmit extracellular strain the nucleus, capacity
to form cartilage-like matrix, and transcriptomic signature. RNA FISH measurements of single cell gene
expression found that both primary chondrocytes and chondrogenically-induced MSCs showed
substantial mRNA expression heterogeneity. Surprisingly, variation in differentiation marker transcript
levels only weakly associated with cartilage-like matrix production at the single cell level. This finding
suggested that, although canonical markers have very clear functional roles in differentiation and matrix
formation, their instantaneous mRNA abundance is only tenuously linked to the chondrogenic phenotype
and matrix accumulation at the single cell level. One possible explanation for the apparent disconnect
between gene and protein expression is that mRNA and protein exhibit different temporal dynamics.
Using stochastic models of single cell behavior, we explored the impact of transcriptional stochasticity
and temporal matrix dynamics on the perceived relationship between single cell mRNA and protein
abundance. Simulations suggested that considering recent temporal fractions of protein (vs. total protein)
increased the correlation between mRNA and protein abundance, and illustrated that mRNA stability was
a crucial determinant of the timescale over which any such correlation persisted. Experimentally, noncanonical amino acid tagging was used to visualize and quantify temporal fractions of nascent
extracellular matrix with high fidelity. The organization and temporal dynamics of the proteinaceous
matrix depended on the biophysical features of the microenvironment, including the biomaterial scaffold
and the niche constructed by cells themselves. Both chondrocytes and MSCs demonstrated marked cellto-cell heterogeneity in nascent matrix production, consistent with model predictions. Ongoing work aims
to combine these experimental measurements of nascent protein expression with instantaneous
measures of mRNA abundance to better understand the mRNA-protein relationship, and to harness this
understanding to improve regenerative therapies.
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ABSTRACT	
  
SINGLE  CELL  MOLECULAR  HETEROGENEITY  IN  MUSCULOSKELETAL  DIFFERENTIATION  
Claire  M.  McLeod  
Robert  L.  Mauck  

Mesenchymal  stem  cells  (MSCs)  display  substantial  cell-to-cell  variation  that  manifests  
across  many  aspects  of  cell  phenotype  and  complicates  the  use  of  MSCs  in  
regenerative  applications.  However,  most  conventional  assays  measure  MSC  properties  
in  bulk  and,  as  a  consequence,  mask  this  cell-to-cell  variation.  To  better  understand  
MSC  heterogeneity  and  its  underlying  mechanisms,  we  quantitatively  assessed  MSC  
phenotype  within  the  context  of  chondrogenesis,  amongst  clonal  populations  and  single  
cells.  Clonal  MSCs  differed  in  their  contractility,  ability  to  transmit  extracellular  strain  the  
nucleus,  capacity  to  form  cartilage-like  matrix,  and  transcriptomic  signature.  RNA  FISH  
measurements  of  single  cell  gene  expression  found  that  both  primary  chondrocytes  and  
chondrogenically-induced  MSCs  showed  substantial  mRNA  expression  heterogeneity.  
Surprisingly,  variation  in  differentiation  marker  transcript  levels  only  weakly  associated  
with  cartilage-like  matrix  production  at  the  single  cell  level.  This  finding  suggested  that,  
although  canonical  markers  have  very  clear  functional  roles  in  differentiation  and  matrix  
formation,  their  instantaneous  mRNA  abundance  is  only  tenuously  linked  to  the  
chondrogenic  phenotype  and  matrix  accumulation  at  the  single  cell  level.  One  possible  
explanation  for  the  apparent  disconnect  between  gene  and  protein  expression  is  that  
mRNA  and  protein  exhibit  different  temporal  dynamics.    Using  stochastic  models  of  
single  cell  behavior,  we  explored  the  impact  of  transcriptional  stochasticity  and  temporal  
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matrix  dynamics  on  the  perceived  relationship  between  single  cell  mRNA  and  protein  
abundance.  Simulations  suggested  that  considering  recent  temporal  fractions  of  protein  
(vs.  total  protein)  increased  the  correlation  between  mRNA  and  protein  abundance,  and  
illustrated  that  mRNA  stability  was  a  crucial  determinant  of  the  timescale  over  which  any  
such  correlation  persisted.  Experimentally,  non-canonical  amino  acid  tagging  was  used  
to  visualize  and  quantify  temporal  fractions  of  nascent  extracellular  matrix  with  high  
fidelity.  The  organization  and  temporal  dynamics  of  the  proteinaceous  matrix  depended  
on  the  biophysical  features  of  the  microenvironment,  including  the  biomaterial  scaffold  
and  the  niche  constructed  by  cells  themselves.  Both  chondrocytes  and  MSCs  
demonstrated  marked  cell-to-cell  heterogeneity  in  nascent  matrix  production,  consistent  
with  model  predictions.  Ongoing  work  aims  to  combine  these  experimental  
measurements  of  nascent  protein  expression  with  instantaneous  measures  of  mRNA  
abundance  to  better  understand  the  mRNA-protein  relationship,  and  to  harness  this  
understanding  to  improve  regenerative  therapies.  
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  Introduction	
  	
  
Traumatic  injury  and  degenerative  processes  damage  articular  cartilage  and  
compromise  normal  joint  function.74,136  Cartilage  has  a  limited  intrinsic  healing  capacity,  
and  treatment  of  the  damaged  joint  surface  often  requires  its  replacement.  Tissue-
engineered  cartilage  replacements  utilize  cells  and  biomaterials  to  create  and  maintain  
constructs  that  mimic  the  structure  and  function  of  native  tissue.  95,136  While  
chondrocytes,  the  cells  native  to  cartilage,  can  be  used  to  create  robust  engineered  
cartilage,  their  availability  is  limited.  As  a  result,  many  approaches  now  rely  on  
mesenchymal  stem  cells  (MSCs),  multipotent  progenitor  cells  that  are  easily  expanded  
and  can  be  directed  to  undergo  chondrogenesis.    
While  MSC-based  approaches  can  yield  engineered  constructs  that  mimic  native  
cartilage,  the  clinical  use  of  MSC-based  therapies  is  complicated  by  the  extensive  
heterogeneity  that  typifies  this  cell  source.  Within  a  single  population,  MSCs  undergo  
chondrogenesis  to  varying  extents  and  over  different  timescales.  This  variability  offers  
potential  opportunities  to  identify  and  select  the  most  strongly  chondrogenic  
subpopulations  and  so  improve  the  performance  of  MSC-based  tissue  engineered  
constructs.  However,  while  there  is  growing  appreciation  of  the  inherent  cell-to-cell  
variation  amongst  MSCs,  the  metrics  most  indicative  of  differentiation  potential  remain  to  
be  identified.  Towards  this  end,  this  thesis  investigates  the  heterogeneity  of  MSCs  
between  single-cell  derived  clonal  populations  and  amongst  individual  MSCs,  with  
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particular  focus  on  the  ability  of  cells  to  produce  a  cartilage-like  extracellular  matrix.  In  
parallel,  MSC  variability  is  contrasted  with  the  relative  homogeneity  of  chondrocytes.    
The  scientific  context  of  this  work  is  established  in  Chapter  2,  which  reviews  the  current  
literature  surrounding  MSC  variability.  This  discussion  recognizes  three  types  of  
variation  that  exist  between  and  within  clonal  MSC  populations:  i)  variation  in  functional  
capacity  to  differentiate,  ii)  molecular  content  (e.g.  gene  and  protein  expression),  and  iii)  
cellular  biophysical  properties.  This  chapter  also  describes  important  features  of  
cartilage’s  extracellular  matrix,  and  provides  an  overview  of  techniques  used  to  monitor  
gene  and  protein  expression  at  the  single  cell  level.      
Chapter  3  identifies  cellular  mechanotransduction  as  a  new  dimension  of  clonal  
heterogeneity.  Specifically,  it  details  how  clonal  MSC  populations  differ  in  their  cellular  
contractility,  ability  to  transmit  strain  from  the  extracellular  environment  to  the  nucleus,  
and  their  ability  to  construct  mechanically  competent  cartilage-like  matrix.  In  Chapter  4,  
we  also  identify  transcriptomic  differences  between  clones,  and  relate  these  differences  
to  their  chondrogenic  functional  capacity.    
Chapter  4  further  extends  with  analysis  with  a  primary  focus  on  single  cell  differences  in  
gene  expression.  Interestingly,  there  is  high  transcriptional  variability  within  clonal  MSC  
populations,  and  cell-to-cell  variation  persists  throughout  the  course  of  differentiation.  
However,  we  show  that  this  transcriptional  variation  is  unable  to  explain  differences  in  
matrix  production  at  the  single  cell  level,  and  demonstrate  that  there  is  an  apparent  
disconnect  between  the  mRNA  and  protein  abundance  of  traditional  chondrogenic  
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markers.  Intriguingly,  despite  their  perceived  homogeneity,  chondrocytes  also  
demonstrate  cell-to-cell  variation  in  gene  expression.  This  lack  of  correlation  between  
gene  and  protein  expression  is  further  reinforced  by  the  finding  that  absolute  expression  
of  matrix  genes  increases  with  chondrocyte  dedifferentiation,  even  as  matrix  protein  
synthesis  decreases.  
One  potential  explanation  for  this  disconnect  between  gene  and  protein  expression  is  
that  is  that  these  molecules  differ  in  their  temporal  dynamics.  To  facilitate  an  improved  
understanding  of  matrix  synthesis  dynamics,  Chapter  5  presents  a  strategy  to  
metabolically  label  matrix  proteins  as  they  are  produced  (via  functional  non-canonical  
amino  acid  tagging).  This  approach  enables  detailed  visualization  of  matrix  organization  
and  can  distinguish  temporal  matrix  fractions.    We  develop  this  technique  for  3D  cultures  
of  chondrocytes  and  MSCs  and  use  it  to  examine  how  time,  phenotype,  and  cellular  
microenvironment  regulate  matrix  production  at  the  single  cell  level.  Cell-to-cell  
variability  is  apparent  in  these  data  as  well,  and  intriguingly,  nascent  extracellular  matrix  
appears  to  be  more  variable  than  total  matrix  protein  content.    
Building  on  this  observation,  Chapter  6  develops  and  applies  a  computational  model  to  
explore  the  impact  of  the  observational  window  in  our  single  cell  measures  on  the  
perceived  relationship  between  instantaneous  mRNA  expression,  nascent  protein  
expression,  and  total  extracellular  matrix  protein  deposition.  To  do  so,  the  transcriptional  
dynamics  of  five  matrix  genes  are  experimentally  quantified  and  used  to  parameterize  
stochastic  simulations  of  single  cell  gene  and  protein  expression.  These  simulations  of  
mRNA  and  protein  abundance  suggest  that  the  correlation  between  mRNA  and  protein  
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increases  as  the  observational  window  is  shortened.  Furthermore,  in  the  context  of  
matrix  genes  and  their  associated  proteins,  mRNA  half-life  appears  to  be  the  key  
determinant  of  the  mRNA-protein  correlation  in  this  3D  context.  
Finally,  Chapter  7  concludes  this  work  with  a  discussion  of  the  implications  of  MSC  
heterogeneity  on  cartilage  tissue  engineering  efforts  and  outlines  potential  future  work  
that  may  provide  additional  insight  into  the  relationship  between  mRNA  and  protein  
abundance  of  extracellular  matrix  genes  and  methods  to  improve  selection  of  superior  
cell  populations  for  tissue  engineering  and  repair  applications.    
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  Background	
  
Tissue	
  engineering	
  cartilage	
  to	
  recapitulate	
  the	
  extracellular	
  matrix	
  
Articular cartilage in health and disease
Articular  cartilage  covers  the  surfaces  of  articulating  joints  and  is  essential  to  healthy  
joint  function.  However,  injury  and  disease  often  compromise  the  ability  of  cartilage  to  
bear  load  and  facilitate  smooth  joint  movement.  Unfortunately,  the  intrinsic  healing  
capacity  of  cartilage  is  limited,  and  tissue  lesions  often  require  surgical  intervention.  
However,  these  procedures  have  substantial  limitations  and  there  is  considerable  
interest  in  the  development  of  tissue  engineered  cartilage  replacements.  Towards  this  
end,  researchers  aim  to  combine  cells,  biomaterial  scaffolds,  and  suitable  
biochemical/biophysical  cues  to  yield  engineered  constructs  that  mimic  the  structure  and  
function  of  healthy  native  tissue,  particularly  the  collagen  and  proteoglycan-rich  
extracellular  matrix  (ECM)  that  bears  and  distributes  load  in  the  healthy  joint.  

The extracellular matrix of native articular cartilage
Cartilage  ECM  is  primarily  comprised  of  collagens  and  proteoglycans,  which  respectively  
account  for  approximately  60%  and  30%  of  the  tissue’s  dry  weight.17  The  collagens  form  
a  fibrillar,  mesh-like  network  that  provides  tensile  strength  and  mechanically  constrains  
the  swelling  pressure  engendered  by  the  proteoglycans.  These  immobilized  
proteoglycans  concentrate  negative  charges  and  attract  soluble  cations,  creating  high  
osmotic  pressure  and  providing  cartilage  with  its  compressive  resistance.  
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The  collagen  network  primarily  consists  of  three  cartilage-specific  collagens:  collagen  II,  
collagen  IX,  and  collagen  XI.  Collagen  II  is  a  highly  abundant,  fibril-forming  collagen  that  
consists  of  three  identical  α1(II)  chains  and  comprises  80-90%  of  the  total  collagen  
content.59  Individual  collagen  II  molecules  organize  head-to-tail  to  form  a  staggered  
polymer,  and  bundle  into  microfibrils  and  fibrils  that  also  incorporate  additional  collagen  
IX  and  XI  molecules  (Figure  2-1).59  Collagen  IX  binds  to  the  surface  of  collagen  II  fibrils,  
and  and  consists  of  three  distinct  chains  [α1(IX),  α2(IX),  and  α3(IX)].  It  is  thought  to  
bridge  between  fibrils  and  covalently  anchor  other  matrix  molecules  to  the  collagen  
network.59  In  contrast,  collagen  XI  integrates  within  collagen  II  fibrils  and  displays  its  N-
terminal  domain  on  the  fibril  surface.59  The  protruding  N-terminal  domains  are  thought  to  
laterally  cross-link  fibrils  and  limit  fibril  diameter.    Collagen  XI  molecules  consist  of  two    
  

  
Figure  2-1:  The  cartilage  extracellular  matrix  is  primarily  comprised  of  collagens  and  proteoglycans.  
A)  Schematic  depicting  the  primary  molecular  constituents  of  articular  cartilage:  aggrecan  macromolecules  
and  collagen  fibrils.  Reprinted  from  Trends  in  Cell  Biology,  Vol  5,  Barbara  M.  Vertel,  The  Ins  and  Outs  of  
221
Aggrecan,  458-464,  1995,  with  permission  from  Elsevier.   B)  Structure  of  collagen  II  –  collagen  IX  –  
97
collagen  XI  fibrils.  Modified  from  Kadler  et  al.  under  a  Creative  Commons  Attribution  license  (CC  BY).   
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unique  alpha  chains  [α1(XI)  and  α2(XI)]  and  a  third,  post-translationally  modified  α1(II)  
chain.59  In  adult  cartilage,  an  α1(V)  chain  may  substitute  for  either  the  α1(XI)or  α2(XI)  
chain.59    
Other  collagens  found  in  cartilage  include  collagens  VI  and  X.  Collagen  VI  is  a  non-
fibrillar  molecule  that  is  found  immediately  adjacent  to  chondrocytes  and  is  thought  to  
facilitate  cell-matrix  attachment.26,131  Collagen  X  is  found  near  chondrocytes  in  calcifying  
tissue,  and  is  associated  with  cartilage  hypertrophy.131    
The  proteoglycan  fraction  of  cartilage  predominantly  consists  of  aggrecan  molecules,  
which  account  for  ~90%  of  proteoglycan  content  by  mass.17  Individual  aggrecan  
molecules  consist  of  a  core  protein  synthesized  from  the  aggrecan  gene  and  many  
attached  glycosaminoglycan  chains  (GAGs,  e.g.  chondroitin  sulfate  and  heparin  
sulfate).221  These  protein-GAG  complexes  associate  with  link  proteins  and  and  
hyaluronic  acid,  forming  larger  aggregates  which  become  ensnared  in  the  collagen  
network.  Each  sulfated  GAG  bears  negative  charges,  and  their  collective  aggregation  
yields  the  fixed  negative  charge  density  responsible  for  cartilage’s  compressive  
properties.  Other  proteoglycans  include  biglycan  and  decorin,  which  bind  to  collagens  
and  other  molecules,  including  chondrogenic  growth  factors.  Additional  minor  
proteoglycans  further  contribute  to  ECM  structure  and  cellular  function.184  

Tissue engineering cartilage to recapitulate the extracellular matrix
ECMs  are  created  and  maintained  by  cells,  and  the  choice  of  tissue  engineering  cell  
source  strongly  influences  engineered  cartilage  quality.  Chondrocytes,  the  cells  resident    
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Figure  2-2:  Bulk  observations  can  mask  heterogeneity,  including  i)  'tail'  observations,  ii)  small  
3
subpopulations,  and  iii)  bimodal  behavior.  Adapted  from  Altschuler  et  al. .  

  
in  native  cartilage,  excel  at  producing  robust  extracellular  matrices  in  vitro,  even  under  
nutrient  limiting  conditions.95,109  However,  due  to  the  difficulty  of  obtaining  chondrocytes  
in  sufficient  number,  chondrogenically  induced  stem  cells  are  often  used  instead.  
Mesenchymal  stem  cells  (MSCs)  are  readily  obtained  from  adult  tissue,  expand  well  in  
culture,  and  can  undergo  chondrogenic  differentiation.  However,  even  with  the  most  
effective  differentiation  protocols,  MSCs  fail  to  fully  match  the  performance  of  
chondrocytes.86,95  This  performance  gap  likely  exists  in  part  due  to  marked  variation  in  
the  ability  of  individual  MSCs  to  undergo  chondrogenesis:    while  some  MSCs  robustly  
undergo  chondrogenesis,  others  fail  to  do  so.86  These  underperforming,  alternatively  
performing  (e.g.  osteogenic),  or  non-responsive  subpopulations  hinder  the  maturation  of  
engineered  tissues,  but  their  poor  performance  is  often  masked  by  bulk  assays  that  pool  
signal  across  entire  cell  populations  (Figure  2-2).    Recently,  given  the  advent  of  single  
cell  methods  and  a  growing  appreciation  that  ensemble  measurements  can  mask  
important  variation,  new  findings  have  begun  to  delineate  MSC  heterogeneity.  In  the  
following  sections,  we  review  the  current  understanding  of  heterogeneity  between  and  
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within  MSC  populations,  and  discuss  how  single  cell  techniques  may  be  used  to  further  
parse  this  variability.    

Mesenchymal	
  stem	
  cell	
  heterogeneity	
  
The defining properties of mesenchymal stem cells
  

As  a  cell  type,  MSCs  are  defined  by  three  criteria. MSCs  must  1)  be  plastic  adherent;;  2)  
express  the  surface  markers  CD105,  CD73  and  CD90,  and  lack  expression  of  CD45,  
CD34,  CD14  or  CD11b,  CD79  or  CD19  and  HLA-DR;;  and  3)  be  capable  of  differentiating  
into  osteoblasts,  adipocytes,  and  chondroblasts.48  However,  this  operational  definition  
does  not  precisely  define  a  homogenous  population  of  multipotent  progenitors.  Instead,  
it  describes  a  heterogeneous  group  of  cells  that  demonstrate  variability  between  tissues  
of  origin,  between  individual  donors,  amongst  clonal  subpopulations,  and  at  the  single  
cell  level.  

MSCs exhibit heterogeneity on multiple levels
While  MSCs  were  first  isolated  from  bone  marrow,153,167  they  have  since  been  identified  
in  many  connective  tissues,  including  adipose  tissue,  the  umbilical  cord,  and  dental  
pulp.206  In  standard  isolation  techniques,  adipose  or  bone  marrow  aspirates  are  
progressively  centrifuged,  and  filtered  before  being  plated  into  culture.  A  small  fraction  of  
the  cells  (the  presumed  MSCs)  will  adhere  to  the  tissue  culture  plastic,  and  proliferate.  
Both  bone  marrow-  and  adipose-derived  MSCs  are  readily  available,58  yet  they  originate  
from  stem  cell  niches  that  provide  distinct  biological,  chemical,  and  mechanical  cues.  
Tissue-dependent  variation  in  differentiation  capacity,  surface  markers,  and  
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transcriptional  and  proteomic  profiles  has  been  widely  studied,  and  the  reader  is  referred  
to  recent  reviews  for  comparisons  of  MSCs  across  tissue  sources.102,143,206    
Even  when  derived  from  the  same  tissue  of  origin,  MSCs  demonstrate  tremendous  
donor-to-donor  variability.  Intuitively,  donor  health  may  influence  the  availability  and  
functional  potential  of  MSCs.113,224  Similarly,  as  donors  age,  MSC  availability,  self-
renewal  capacity,  and  differentiation  potential  have  been  reported  to  decline.39,100,204  
Surprisingly  however,  even  MSCs  isolated  from  young,  healthy  donors  exhibit  stark  
differences  in  proliferation  rate,  differentiation  capacity,  and  ultimate  clinical  utility.165  
This  functional  variation  extends  to  the  molecular  status  of  these  cells.148,149    For  
example,  mass  spectroscopy  of  MSCs  isolated  from  six  donors  revealed  that  only  62%  
of  all  identified  proteins  were  found  in  at  least  half  of  the  donors,  and  only  13%  of  
identified  proteins  were  found  in  cells  from  each  donor.148  Such  donor-to-donor  variation  
has  important  clinical  implications,  and  has  motivated  more  detailed  investigation  of  
MSC  variability.    
Further  study  has  revealed  that  donor-  and  tissue-dependent  differences  are  
superimposed  upon  cell-to-cell  variation  amongst  MSCs  within  a  single  population.  For  
example,  multiple  bone  marrow  aspirates  simultaneously  isolated  from  a  single  donor  
yield  MSC  cultures  that  proliferate  at  significantly  different  rates.  165  Even  within  a  single  
isolate,  cell-to-cell  variation  in  MSC  phenotype  becomes  evident  during  culture  
expansion  and  downstream  use.  This  variation  is  commonly  examined  by  comparing  
clonal  subpopulations  (groups  of  cells  that  are  not  only  genetically  identical,  but  also  
recently  derived  from  a  single  parent  cell).87    
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MSCs  readily  form  clones,  and  their  clonogenicity  can  be  observed  by  sparsely  plating  
an  initial  isolate  and  monitoring  colony  formation.  Populations  of  cells  from  the  same  
initial  colony  can  be  obtained  by  sub-culturing  these  colonies,  or  by  seeding  single  cells  
into  individual  culture  wells  via  limiting  dilution  or  flow  cytometry200.  Inter-clonal  
heterogeneity  (variation  between  clones)  most  obviously  manifests  as  morphological  and  
proliferative  diversity.  Clones  differ  in  morphological  phenotype,  ranging  from  elongated  
spindle-like  cells  to  large  flattened  cells  and  highly  protrusive  cells.34,153  Similarly,  
individual  clones  proliferate  both  more  quickly  and  more  slowly  than  their  corresponding  
polyclonal  parent  populations  and  differ  in  their  self-renewal  capacity,  with  select  clones  
reaching  early  senescence.185  Furthermore,  inter-clonal  variation  is  not  limited  to  these  
phenotypic  characteristics:  it  extends  to  include  functional  capacity,  molecular  signature,  
and  the  mechanical  state  of  the  cell.    

Inter-clonal functional variation
The  differentiation  capacity  of  clonal  MSCs  was  first  studied  to  prove  the  existence  of  
multipotent  cells  capable  of  committing  towards  adipogenic,  osteogenic,  and  
chondrogenic  fates.167    However,  in  parallel  with  the  discovery  of  these  tri-potential  cells,  
other  clonal  populations  were  identified  that  had  restricted  differentiation  potential  and  
only  differentiated  towards  a  subset  of  the  three  canonical  fates.153,167,186    The  relative  
frequency  of  clones  with  limited  differentiation  potential  was  donor  dependent,  with  
estimates  suggesting  that  ~50%  of  clones  are  tri-potential,  ~30%  are  bipotential  (either  
osteo-chondro  or  osteo-adipo),  and  ~10%  are  unipotential  osteoprogenitors.186  
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This  functional  heterogeneity  is  also  apparent  in  vivo,  and  influences  the  utility  of  MSCs  
in  multiple  regenerative  contexts.  For  example,  clonal  MSC  populations  implanted  
subcutaneously  in  mice  demonstrate  variable  osteogenic  capacity,  with  approximately  
half  of  clonal  implants  undergoing  some  degree  of  osteogenesis.114  Similarly,  clonal  
populations  screened  in  vitro  for  above-average  chondrogenic  capacity  result  in  repair  of  
cartilage  defects  more  robustly  than  unscreened  populations.93    Inter-clonal  functional  
heterogeneity  also  extends  to  include  commitment  towards  non-canonical  fates.  Stem  
cells  derived  from  dental  pulp  demonstrate  heterogeneous  myogenic  potential,  and  
clones  that  are  highly  myogenic  in  vitro  also  engraft  into  muscle  defects  more  
efficaciously  than  the  polyclonal  parent  populations.232  Such  functional  variability  
potentially  offers  the  opportunity  to  harness  clonal  identity  and  prospectively  identify  
MSC  subpopulations  best  suited  to  drive  the  functional  restoration  of  diverse  tissues.  
However,  the  challenge  of  performing  in  vitro  screening  of  clonal  functional  capacity  at  a  
clinically-useful  scale  has  motivated  ongoing  work  to  identify  molecular  or  biophysical  
markers  of  MSC  differentiation  potential.  

Inter-clonal molecular variation
Inter-clonal  functional  heterogeneity  must  derive  from  underlying  molecular  variation.    
While  proteomic  studies  comparing  individual  clonal  populations  are  challenging  due  to  
inherently  limited  cell  number,  comparisons  between  pooled  fast-  and  slow-growing  
clones  suggest  broad  trends.  Fast-growing  clones  were  more  likely  to  be  tri-potential  
than  slow-growing  clones,140,186  and  rapidly  self-renewing  MSCs  engrafted  into  tissues  
more  readily  than  slowly  renewing  MSCs.121  Indeed,  fast-  and  slow-growing  MSCs  
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differed  proteomically,  with  differential  expression  of  proteins  including  intermediate  
filaments  (e.g.  lamin  A/C),  calcium-binding  proteins  (e.g.  calmodulin),  and  glycolytic  
proteins  (e.g.  glyceraldehyde-3-phosphate  dehydrogenase).139    Furthermore,  surface  
marker  expression  across  clones  has  suggested  that  CD200  marks  osteogenic  
subpopulations,  while  SSEA4  and  CD140a  are  associated  with  adipogenic  
capacity.168,183  
Clonal  heterogeneity  also  extends  to  the  transcriptome.  Certainly,  there  is  great  
divergence  in  transcriptional  signature  between  high-  and  low-potential  clones  following  
exposure  to  differentiation  conditions.  There  is  also  now  evidence  for  clonal  variation  in  
basal  gene  expression  in  undifferentiated  cells.    Screens  comparing  stem  cell  gene  
expression  between  fast-  and  slow-growing  clones  have  identified  extensive  differences  
in  the  expression  of  genes  associated  with  the  cell  cycle  and  cellular  division.141,147  Fast-
growing  clones  also  expressed  select  growth  factors  (e.g.  BMP2,  FGF2,  IGF1),  lineage  
markers  (e.g.  aggrecan,  alkaline  phosphatase,  collagen  I,  collagen  II)  and  self-renewal  
markers  (e.g.  SOX2)  more  highly  than  slow-growing  clones.141  Conversely,  other  genes,  
including  CD44,  were  more  highly  expressed  in  slow-growing  clones.141    Separately,  
direct  comparisons  of  clonal  transcriptomes  indicated  that  clones  with  greater  functional  
potential  had  enriched  basal  expression  of  genes  implicated  in  skeletal  and  muscular  
development,  including  extracellular  matrix  components  and  MAP  kinase  signaling  
elements.54,117,210  Notably,  high  baseline  expression  of  calponin  negatively  correlated  
with  clonal  multipotency.210  Within  an  osteogenic  context,  high  potential  clones  also  
expressed  extracellular  matrix  genes  and  genes  regulated  by  osteogenic  transcription  
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factors  to  a  greater  extent  than  poorly  osteogenic  clones.117  Strikingly,  basal  expression  
of  four  genes,  including  decorin  and  lysyl  oxidase-like  4  was  more  predictive  of  clonal  
osteogenesis  than  the  expression  of  traditional  osteoblastic  markers  including  Runx2,  
collagen  type  I  and  osteopontin.117  Such  findings  suggest  that  transcriptome-wide  
analysis  of  undifferentiated  MSCs  may  be  key  to  identifying  prospective  markers  of  stem  
cell  fate;;  however,  these  predictors  must  also  be  validated  through  mechanistic  studies  
identifying  their  role  in  maintenance  of  multi-potency  and/or  lineage  specification.  
Transcriptional  activity  is  determined  not  only  by  the  presence  and  activity  of  
transcription  factors,  but  also  by  the  epigenetic  status  of  the  cell.  DNA  methylation,  one  
type  of  epigenetic  modification,  is  generally  associated  with  a  loss  of  gene  expression  
and  is  crucial  in  stem  cell  differentiation.  In  undifferentiated  adult  stem  cells,  lineage-
associated  promoters  are  often  hypomethylated.13    Investigation  of  clonal  MSC  
adipogenesis  has  found  that  while  adipogenesis-associated  promoters  were  
hypomethylated  in  MSC  clones,  the  specific  pattern  of  methylation  varied  between  clonal  
subpopulations.  However,  there  was  no  clear  relationship  between  a  clone’s  methylation  
status  and  its  gene  expression  pattern  or  ultimate  adipogenic  potential.156,157    

Biophysical variation amongst clones and individual cells
The  mechanical  state  of  the  cell  has  emerged  as  a  potential  biomarker  indicative  of  
cellular  phenotype.    Cellular  mechanical  properties  reflect  the  underlying  structure  of  the  
cell,  including  the  cytoskeleton  and  nucleus.  These  structures  change  with  
differentiation,  and  also  differ  between  committed  cell  types.  Interestingly,  increased  
nuclear  deformability  has  been  correlated  with  pluripotency.  With  differentiation,  
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chromatin  condenses  within  the  nucleus  and  the  nuclear  envelope  is  reinforced  by  
increasing  lamin  A/C  content.161  Embryonic  stem  cells  are  6-10  fold  softer  than  their  
differentiated  counterparts.  32,161      Mechanical  differences  of  similar  magnitude  have  
been  noted  between  individual,  undifferentiated  MSCs  isolated  and  passaged  
together.137  This  mechanical  variability  may  reflect  the  high  degree  of  functional  
heterogeneity  observed  when  these  individual  cells  are  tasked  with  a  specific  lineage  
transformation.    
Mechanical  differences  also  exist  between  clonal  MSC  populations.  A  study  monitoring  
32  MSC  clones  suggested  that  cellular  mechanics  can  be  prospectively  used  to  predict  
differentiation  capacity.73  The  functional  potential  of  clones  correlated  with  elastic  and  
viscoelastic  properties.73  Clones  with  the  highest  adipogenic  potential  were  were  
characterized  by  taller  cells  with  lower  elastic  moduli.73  Conversely,  osteogenic  capacity  
correlated  with  a  higher  elastic  modulus,  instantaneous  modulus  and  relaxed  modulus,  
while  chondrogenic  capacity  correlated  with  elastic  modulus  and  apparent  viscosity.73    
Separately,  efforts  to  biophysically  sort  MSCs  in  a  high-throughput  manner  suggest  that  
the  cells  of  tri-potential  MSC  subpopulations  are  smaller,  less  stiff,  and  exhibit  greater  
nuclear  membrane  fluctuations  than  cells  with  bi-potent  (osteo-chondro)  differentiation  
potential.122  
Cell  mechanics  not  only  indicate  cell  phenotype,  but  also  mediate  the  physical  
interaction  between  a  cell  and  its  environment.  Many  cell  types,  including  MSCs,  are  
able  to  sense  and  respond  to  mechanical  cues.  Biophysical  stimuli  including  the  
elasticity  of  the  microenvironment  and  exogenous  forces  have  been  widely  examined  as  
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determinants  of  stem  cell  fate.  These  cues  elicit  changes  in  biochemical  signaling,  gene  
expression,  and  ultimately  cell  phenotype  and  function.    
A  number  of  studies  have  begun  to  probe  how  individual  MSCs  response  to  biophysical  
cues.  Dual  adipogenic/osteogenic  media  causes  polyclonal  MSC  populations  to  undergo  
mixed  osteogenic  and  adipogenic  differentiation;;  the  relative  balance  between  these  two  
differentiated  states  is  regulated  by  the  physical  stiffness  of  the  cell  
microenvironment.66,77,103  Cell  response  is  most  uniform  in  extremely  soft  or  stiff  
environments,  which  favor  adipogenesis  and  osteogenesis  respectively.  However,  in  
environments  of  intermediate  stiffness,  commitment  is  variable:  subpopulations  of  cells  
will  differentiate  towards  each  fate.  Furthermore,  in  dynamic  systems  where  an  initially  
soft  substrate  can  be  stiffened,  the  ratio  of  adipogenic  to  osteogenic  commitment  is  
regulated  by  the  timing  of  the  soft-to-stiff  transition.77  Collectively,  these  findings  begin  to  
suggest  that  MSC  subpopulations  may  have  subtly  different  mechanical  setpoints  that  
govern  mechanically-regulated  fate  commitment.    
Any  such  setpoint  likely  relates  to  the  tension  sensed  and  contractility  generated  by  an  
individual  cell.  On  a  population  level,  osteogenesis  is  associated  with  the  ability  of  cells  
to  spread  and  generate  tension,  while  adipogenesis  is  promoted  by  conditions  that  
restrict  cell  spreading  and  contractility.    Interestingly,  the  traction  force  generated  by  an  
individual  cell  after  short-term  exposure  to  bipotential  media  serves  as  an  indicator  of  its  
ultimate  differentiation  propensity:  high  contractility  has  been  associated  with  osteogenic  
potential,  while  low  contractility  has  been  associated  with  adipogenic  capacity.66    Thus,  
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single  cell  or  clonal  heterogeneity  in  the  ability  of  cells  to  generate  traction  may  
correspond  to  the  functional  variability  observed.  
Variation  also  extends  to  cellular  activity  along  the  pathways  responsible  for  
mechanotransduction.  For  example,  calcium  signaling  is  highly  mechanosensitive,  and  
regulates  processes  including  differentiation  and  proliferation.142  Investigations  of  
baseline  calcium  signaling  in  MSCs  have  shown  that  some  cells  exhibit  spontaneous  
calcium  oscillations,  while  others  do  not.101,104,208  The  extent  of  variation  is  
microenvironment  dependent:  the  fraction  of  MSCs  experiencing  calcium  oscillations  
increases  with  substrate  stiffness,  with  59-98%  of  cells  oscillating  on  glass  culture  
surfaces.101,104,105,208  Furthermore,  this  variation  extends  to  the  cellular  response  to  active  
mechanical  stimulation.  Subpopulations  of  undifferentiated  MSCs  encapsulated  in  
hydrogels  differentially  respond  to  compression:  calcium  signaling  was  upregulated  in  
one  subset  of  cells,  while  it  was  downregulated  in  another.23  It  remains  to  be  seen  if  
similar  variation  extends  to  other  mechanosensitve  pathways,  including  MAPK  and  
RhoA/ROCK  signalling.  

Intra-clonal heterogeneity and cell-to-cell variation
Studies  investigating  inter-clonal  heterogeneity  often  imply  that  clonal  subpopulations  
are  relatively  homogeneous.  However,  there  is  growing  appreciation  that  even  within  a  
clone,  cellular  phenotype  can  be  highly  variable.180  Cells  within  a  clone  can  differ  in  their  
morphology  and  ability  to  differentiate.  When  intact  colonies  are  exposed  to  adipogenic  
or  osteogenic  differentiation  cues,  differentiation  initiates  in  the  dense,  inner  portion  of  
the  colony.233  Colony  microdissection  and  subsequent  analysis  reveal  spatial  differences  
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in  gene  and  protein  expression.  Cells  located  in  the  colony  interior  expressed  
extracellular  matrix  genes  to  a  greater  extent  than  cells  located  in  the  outer  periphery,  
while  ‘outer’  cells  expressed  higher  levels  of  genes  associated  with  cell  proliferation  and  
mitosis.233  Building  on  this  analysis,  technological  advances  have  enabled  the  
interrogation  of  single  cell  gene  expression  amongst  clonal  and  polyclonal  populations  (a  
major  focus  of  this  thesis).  In  parallel,  single  cell  RNA  sequencing  of  individual  MSCs  
has  shown  that  individual  MSCs  have  variable  basal  expression  of  both  early  and  late  
differentiation  markers,  and  that  markers  of  multiple  lineages  can  be  co-expressed  in  the  
same  cell.65  Furthermore,  DNA  methylation  patterns  are  mosaic  within  individual  clonal  
populations.156,157    Thus,  cell-to-cell  variation  exists  at  every  level  where  inter-clonal  
heterogeneity  has  been  noted.    

Potential origins & mechanisms of MSC heterogeneity
It  is  tempting  to  speculate  that  MSC  heterogeneity  mirrors  the  diversity  of  environments  
present  in  the  in  vivo  stem  cell  niche.  87    In  vivo,  MSCs  reside  in  niches  characterized  by  
diverse  cellular  communities  that  present  variable  chemical  and  mechanical  conditions.  
Indeed,  microanatomical  heterogeneity  within  the  bone  marrow  niche  has  been  shown  to  
dictate  cell-to-cell  variation  in  osteolineage  cells.198    Upon  isolation,  MSCs  from  these  
heterogeneous  environments  mix  together,  and  extant  in  vivo  variation  may  persist  into  
in  vitro  cultures.  Indeed,  there  is  mounting  evidence  that  cultured  cells  retain  ‘memory’  of  
their  previous  environments.124,230  Furthermore,  the  mechanical  properties  of  the  stem  
cell  microenvironment  influence  self-renewal  capacity  and  regenerative  potential.69  

18  
  

Perhaps  then,  the  mechanisms  responsible  for  in  vitro  cellular  memory  may  also  
facilitate  the  maintenance  of  heterogeneity  in  primary  cultures.    
In  addition  to  any  heterogeneity  derived  from  the  in  vivo  niche,  there  is  also  apparent  
plasticity  in  MSC  phenotype.  In  the  study  of  intra-clonal  spatial  variation  discussed  
above,  the  subculture  of  either  ‘inner’  or  ‘outer’  cells  yielded  new  colonies  with  their  own  
distinct  inner  and  outer  populations,  suggesting  that,  in  at  least  some  dimensions,  
cellular  variation  is  dynamic  and  reversible.233  Potential  dynamics  of  shifting  phenotypic  
variability  have  been  carefully  studied  in  the  context  of  hematopoietic  stem  cell  (HSC)  
lineage  commitment  towards  erythroid  and  myeloid  fates.  Clonal  HSC  populations  
heterogeneously  express  the  surface  protein  Sca-1,  a  marker  associated  with  the  
erythroid  transcriptional  signature.  Subcultures  of  cells  sorted  for  either  the  lowest  or  
highest  Sca-1  expression  shift  with  time  to  reconstitute  the  original  distribution  of  Sca-1  
expression.28  Similar  behavior  is  observed  in  MSCs,  which  express  Sca-1  
heterogeneously  between  and  within  clonal  populations.78  At  early  passage,  MSC  
fractions  with  either  low  or  high  Sca-1  expression  were  able  to  regenerate  the  
distribution  of  Sca-1  expression  in  the  parent  population.78  However,  after  extended  
passaging,  sorted  MSCs  were  less  able  to  reconstitute  the  full  range  of  Sca-1  
expression.78  Potential  explanations  of  this  behavior  include  spontaneous  transcriptional  
fluctuations  (of  either  transcriptome-wide  programs28  or  individual  regulators166)  and  
epigenetic  bistability78.  
Transcriptional  fluctuations  in  the  expression  of  individual  genes  might  arise  from  the  
stochasticity  inherent  to  many  biological  processes.  While  transcription  at  the  population  
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level  is  often  considered  a  process  that  proceeds  at  a  constant,  defined  rate,  
transcription  in  individual  cells  is  highly  stochastic.  Fundamentally,  transcription  requires  
the  chemical  interaction  of  RNA  polymerases  with  an  accessible  promoter  sequence  and  
any  requisite  transcription  factors.  Thus,  even  if  two  stem  cells  were  identical  in  every  
way,  the  transcriptional  processes  in  each  would  be  dictated  by  the  random  collisions  of  
molecules  within  the  nuclear  milieu.  The  importance  of  such  probabilistic  interactions  
was  elegantly  shown  in  a  now-classic  experiment  where  two  distinguishable  yet  near-
identical  genes  were  inserted  into  a  cell.53  Within  individual  cells,  the  expression  of  these  
two  genes  deviated,  suggesting  the  existence  of  “intrinsic”  random  noise  in  gene  
expression.  Notably,  this  intrinsic  noise  was  superimposed  upon  any  cell-to-cell  variation  
controlled  by  “extrinsic”  factors  (e.g.  epigenetic  differences  between  cells,  cell  size,  etc.  
–  many  of  the  types  of  variation  described  in  the  previous  sections).  Even  so,  intrinsic  
noise  can  give  rise  to  substantial  variation  in  copy  number,  and  may  drive  cellular  
decision-making  and  phenotypic  divergence.6,175    
Population  dynamics  also  likely  contribute  to  the  variation  that  emerges  as  the  stem  cells  
proliferate  in  culture.  Upon  cell  division,  a  single,  self-renewing  cell  splits  into  two  
daughter  cells  of  approximately  equal  size.  If  the  division  is  symmetrical,  both  daughter  
cells  will  possess  the  same  self-renewal  capacity:  they  will  either  both  divide,  or  not  
divide.  In  contrast,  asymmetric  cell  division  will  yield  one  self-renewing  cell,  and  one  that  
senesces  in  culture.  Such  dynamics  allow  an  initially  small  fraction  of  cells  to  give  rise  to  
the  majority  of  the  population  several  days  later.  For  example,  one  study  reported  that  
after  6  days  of  culture,  50%  of  progeny  cells  were  derived  from  9%  of  the  initial  
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population.226  Thus,  much  of  the  cell-to  variation  observed  in  polyclonal  populations  may  
actually  be  heterogeneity  within  a  single  dominant  clone.  Longer  term  tracking  of  MSC  
lineages  over  12  passages  confirms  this  notion  of  clonal  dominance.193  Interestingly,  
initially  dominant  clones  were  sometimes  overtaken  by  other  clonal  subpopulations.193    
This  delayed  dominance  may  be  related  to  variation  in  the  onset  of  senescence.  With  
extended  passage,  MSCs  suffer  from  decreased  multilineage  potential.  46,110,185,188  In  
parallel,  the  clonogeniticty  of  MSCs  decreases  and  proliferation  slows.46,188  Functional  
capacity  may  also  grow  increasingly  restricted  with  progressive  culture.  For  example,  the  
hierarchical  lineage  commitment  hypothesis  posits  that  through  divisions,  stem  cells  
progressively  lose  the  ability  to  commit  to  certain  lineages.  Alternatively,  MSC  functional  
heterogeneity  may  also  be  explained  in  part  trans-differentiation,  or  transitions  between  
partially  restricted  differentiation  capacties.164    The  existence,  structure,  and  governance  
of  any  such  hierarchy  or  trans-differentiation  processes  remain  to  be  elucidated.164        
Notably,  spontaneous  genetic  mutations  are  not  thought  to  be  the  source  of  cell-to-cell  
variation  amongst  MSCs.  Estimates  of  the  mutation  rate  that  would  be  required  to  give  
rise  to  the  observed  diversity  are  unfeasibly  high:  approximately  one  in  three  cells  would  
need  to  experience  a  phenotype-altering  mutation.180    While  such  rates  are  possible,  
they  are  improbable,  and  thus  genetic  mutation  is  unlikely  to  be  a  dominant  mechanism  
in  the  evolution  of  in  vitro  MSC  heterogeneity.  180  
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Measuring	
  cell-‐‑to-‐‑cell	
  molecular	
  variation	
  	
  
Studies  to  discern  the  underpinnings  of  stem  cell  heterogeneity  increasingly  rely  on  
methods  to  assay  the  molecular  content  of  individual  cells.  To  this  end,  adaptations  of  
traditional  methods  and  new  techniques  now  allow  one  to  assess  gene  and  protein  
expression  at  the  single  cell  level.  Broadly,  these  approaches  can  be  classified  on  the  
basis  of  their  timing  (continuous  observation  vs.  fixed  endpoint),  their  modality  (imaging  
based  vs.  lysate  based),  and  their  ability  to  support  multiplexed  observations  (high  vs.  
low).  In  this  section,  we  highlight  select  methods  that  may  be  of  particular  utility  for  
assessing  stem  cell  heterogeneity;;  a  summary  is  provided  in  Table  2-1.    
Table  2-1:  Single  cell  methods  to  assay  mRNA  and  protein  abundance.  
   Method  
Timing  
Modality  
Ability  to  multiplex  
mRNA  abundance  
   RNA  FISH  
Endpoint  
Image  based   Low  
   Single  cell  qPCR  
Endpoint  
Lysate  based   Intermediate  
   Single  cell  RNA  sequencing  
Endpoint  
Lysate  based   High  
   Molecular  beacons  
Continuous   Image  based   Low  
   Spherical  nucleic  acids  
Continuous   Image  based   Low  
   Transgenic  fluorescent  reporters   Continuous   Image  based   Low  
Protein  abundance  
   Immunostaining  
Endpoint  
Image  based   Low  
   Flow  cytometry  
Endpoint  
  
Intermediate  
   Mass  cytometry  
Endpoint  
  
Intermediate  
   Proximity  assays  
Endpoint  
Lysate  based   Low  
   Single  cell  western  blot  
Endpoint  
Lysate  based   Low  
   Single  cell  mass  spec  
Endpoint  
Lysate  based   High  
   Transgenic  fluorescent  reporters   Continuous   Image  based   Low  
  

Assaying gene expression in single cells
Single  molecule  RNA  fluorescent  in  situ  hybridization  (FISH)  is  an  imaging-based  
method  that  quantifies  the  absolute  numbers  of  mRNA  in  fixed  cells.  Sets  of  
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fluorescently  labeled  oligonucleotide  probes  tile  along  individual  mRNA  molecules  in  a  
sequence-specific  manner,  allowing  mRNA  molecules  to  be  visualized  as  diffraction-
limited  spots  (Figure  2-3A).62,174  In  standard  RNA  FISH,  the  number  of  genes  
simultaneously  assayed  is  restricted  by  the  availability  of  microscope  filter  sets  
(approximately  4  genes).  However,  recent  strategies  utilizing  combinatorial  and  
sequential  barcoding  have  substantially  increased  the  potential  number  of  genes  
measured.128,129    
Other  endpoint  methods  for  assaying  single  cell  gene  expression  include  single  cell  RT-
qPCR,  microarrays,  and  RNA-seq.187,203  Each  of  these  approaches  measures  the  
abundance  of  cDNA  amplified  from  mRNA  in  the  lysates  of  individual  cells.  The  ability  of  
single  cell  RNA-seq  to  report  transcriptome-wide  expression  holds  particular  promise  as  
the  field  develops  and  increased  understanding  of  the  many  dimensions  of  cell-to-cell  
variation.  However,  these  methods  also  require  normalization  (vs.  absolute  
quantification),  and  cannot  provide  information  about  the  spatial  distribution  of  individual  
mRNA  within  an  individual  cell.  
Alternative  techniques  allow  gene  expression  to  be  monitored  continuously  in  live  
cultures  through  imaging.  Strategies  such  as  molecular  beacons  and  spherical  nucleic  
acids  (e.g.  nanoflares)  rely  on  oligonucleotides,  fluorophores,  and  fluorescent  quenchers  
to  report  gene  expression  (Figure  2-3B,C).191,218  When  the  oligonucleotide  probe  binds  
to  a  target  mRNA,  the  quencher  separates  from  the  fluorophore  and  permits  fluorescent  
signal.  These  methods  have  been  used  to  monitor  gene  expression  in  live  MSCs  
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undergoing  osteogenesis,  and  can  be  combined  with  FACS  techniques  to  sort  individual  
cells  on  the  basis  of  their  gene  expression.123,138    
Other  efforts  to  monitor  gene  expression  in  real-time  rely  on  transgenic  methods.  
Expression  of  genes  modified  to  include  repetitive  stem-loop  motifs  can  be  monitored  
using  fluorescent  bacteriophage  proteins  that  bind  to  these  sequences  with  high  affinity  
(Figure  2-3D).67,197  Alternatively,  short-lived  fluorescent  reporter  proteins  have  been  
considered  as  proxies  for  the  expression  of  of  genes  the  control  of  the  same  promoter.209    

  
Figure  2-3:  Schematics  of  select  methods  to  measure  mRNA  in  single  cells.  A)  In  RNA  FISH,  
fluorescently  labeled  oligonucleotide  probes  tile  along  the  target  mRNA.  B)  Molecular  beacons  emit  
fluorescence  upon  binding  to  target  mRNA.  C)  Spherical  nucleic  acids  quench  fluorescence  until  target  
mRNA  binding  occurs.  D)  In  the  MS2  system,  fluorescently  tagged  proteins  bind  to  motifs  engineered  into  
the  mRNA  sequence.  Adapted  by  permission  from  Macmillan  Publishers  Ltd:  Nature  Cell  Biology,  Hoppe  et  
85
al.,   copyright  2014.  
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Assaying protein expression in single cells
In  addition  to  quantifying  mRNA  at  the  single  cell  level,  it  is  also  essential  to  map  and  
measure  the  protein  output  from  this  message  content  on  a  cell-by-cell  basis.    Single  cell  
measurements  of  protein  expression  are  possible  using  a  variety  of  techniques,  many  of  
which  rely  on  antibody-based  detection.  The  simplest  of  these  is  standard  
immunostaining,  imaged  at  high  magnification  and  quantified  on  a  per-cell  basis.  Flow  
cytometry  offers  high  throughput  measurements  of  fluorescent  antibody  signal,  and  can  
be  coupled  with  cell  sorting  and  multiplexed  to  accommodate  the  measurement  of  10-15  
proteins.202  Mass  cytometry  allows  further  multiplexing  by  leveraging  mass  spectroscopy  
to  detect  the  levels  of  metallically-conjugated  antibodies  bound  to  individual  cells.202  
Recently,  imaging  mass  spectrometry  has  further  extended  this  approach  to  enable  the  
measurement  of  protein  abundance  in  histological  sections  while  preserving  spatial  
information.29    
An  additional  category  of  assays  are  those  based  on  proximity,  including  proximity  
ligation  (PLA)  and  proximity  extension  (PEA).  In  these  approaches,  pairs  of  antibodies  
conjugated  to  oligonucleotides  are  used  to  probe  cell  lysates.75  When  an  antibody  pair  
binds  to  the  protein  of  interest,  the  two  oligos  are  brought  together  and  either  ligated  
(PLA)  or  hybridized  (PEA)  to  create  a  template  for  the  synthesis  of  reporter  DNA  that  is  
ultimately  detected  via  qPCR  or  sequencing.75  Interestingly,  this  method  is  compatible  
with  lysate-based  assays  of  single  cell  gene  expression,  and  has  recently  been  used  to  
simultaneously  examine  the  proteomic  and  transcriptomic  state  of  single  cells.44        
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Techniques  for  assaying  protein  expression  in  bulk  lysates  have  recently  been  adopted  
to  accommodate  single  cells.  Western  blots  can  be  performed  on  individual  cells  that  
have  settled  into  microwells  in  a  polyacrymaide  gel;;  the  cells  are  lysed  in  their  wells  
immediately  prior  to  in-gel  electrophoresis,  blotting  and  detection.88,98  There  is  also  
active  development  surrounding  single  cell  mass  spectrometry,  which  was  recently  used  
to  quantify  the  abundance  of  thousands  of  proteins  at  the  single  cell  level  during  
embryonic  stem  cell  differentiation.18      

	
  Conclusions	
  &	
  Outlook	
  
Mesenchymal  stem  cells  demonstrate  many  dimensions  of  heterogeneity:  they  differ  
between  donors,  as  well  as  between  and  within  clonal  populations.  Indeed,  cell-to-cell  
variation  seems  inherent  to  the  cell  type,  and  we  speculate  that  researchers  will  find  
heterogeneity  wherever  they  look  for  it.  The  emergence  of  genome-wide  single  cell  
techniques  holds  the  potential  to  identify  new  molecular  targets  that  vary  between  cells  
and  correspond  to  differences  in  functional  potential.  However,  as  our  technological  
ability  to  interrogate  biology  at  the  single  cell  level  grows,  we  will  need  to  distinguish  
biological  noise  from  variation  that  represents  actionable  signal.  Our  ability  to  discern  
such  signal  may  be  enhanced  by  the  choice  of  measurement  approach.  For  example,  
biological  noise  often  has  a  temporal  component  (e.g.  stochastic  gene  expression  
fluctuations).  In  these  situations,  endpoint  measurements  may  reveal  substantial  
variation,  even  if  time-averaged  behavior  is  similar  between  cells.  In  contrast,  continuous  
measurements  could  be  integrated  or  averaged  over  time  to  potentially  smooth  
stochastic  temporal  fluctuations  while  retaining  evidence  of  major  cell-to-cell  variation.  
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Regardless  of  measurement  technique,  the  further  study  of  MSC  variation  holds  the  
potential  to  clarify  the  mechanisms  and  implications  of  cell-to-cell  heterogeneity.  
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Introduction	
  

In  vivo  and  in  vitro,  MSC  fate  commitment  is  strongly  regulated  by  soluble  chemical  
stimuli.  Tissue  engineering  applications  have  leveraged  this  biochemical  responsivity  via  
the  application  of  exogenous  growth  factors  to  direct  MSC  differentiation.217  However,  
MSCs  are  notoriously  heterogeneous  and  only  a  fraction  of  a  given  MSC  population  will  
respond  to  differentiation  cues  as  intended.164  Such  functional  heterogeneity  complicates  
the  efficient  and  widespread  use  of  MSCs  in  clinical  therapies.86  Efforts  to  sort  MSC  
populations  via  surface  marker  expression  are  limited  by  low  yield  as  well  as  the  lack  of  
definitive  markers  that  identify  high-potency  cells.199  Recently,  efforts  to  sort  MSCs  
based  on  their  biophysical  properties  (such  as  size  and  stiffness)  have  shown  some  
promise  in  distinguishing  MSC  subpopulations  predisposed  towards  specific  
lineages,73,122  and  suggest  the  existence  of  biophysically  distinct  subpopulations  that  
may  differ  in  their  response  to  soluble  differentiation  cues.    
Recent  studies  have  also  highlighted  that  the  biophysical  relationships  between  a  cell  
and  its  microenvironment  can  influence  cell  fate.89  These  relationships  depend  not  only  
upon  the  physical  properties  of  the  microenvironment,  but  also  on  the  mechanical  state  
of  the  cell.  The  cytoskeletal  network  provides  a  physical  link  to  the  extracellular  
environment  and  enables  external  physical  cues  to  elicit  biological  responses.89  For  
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example,  mechanosensitive  signaling  cascades  are  initiated  by  force-induced  changes  
to  protein  conformation90,  and  extracellular  force  transmission  to  the  nucleus  modulates  
both  intracellular  signaling50  and  transcriptional  activity211.  Similarly,  cytoskeletal  
contractility  is  requisite  for  force-induced  changes  in  chromatin  condensation  in  the  
nucleus.82  Such  condensation  is  a  hallmark  of  gene  silencing,  and  is  typically  associated  
with  both  differentiation  and  nuclear  stiffening161.    However,  while  mechanotransduction  
can  influence  cell  fate,  changes  in  differentiation  status  also  modulate  the  
mechanoresponsivity  of  the  cell.  Thus,  the  biophysical  state  of  a  cell  is  simultaneously  a  
determinant  and  outcome  of  cellular  differentiation.    
Here,  we  build  on  the  previous  work  linking  biophysical  properties  of  cells  to  
differentiation  potential,  and  evaluate  mechanotransductive  heterogeneity  amongst  
clonal  MSC  subpopulations.  First,  we  consider  clone-to-clone  variation  in  cellular  
morphology  and  their  proliferative  potential.  Next,  we  examine  how  clonal  variation  
persists  in  the  context  of  expansion,  with  a  particular  focus  on  the  nucleus  
(heterochromatic  content  and  transmission  of  extracellular  strain  to  the  nucleus).  Finally,  
we  consider  differences  in  how  cells  of  differing  clonal  origins  respond  to  the  application  
of  TGF  to  alter  baseline  contractile  properties  of  the  cells  and  how  they  construct  a  
mechanically  competent  nascent  matrix  during  early  chondrogenesis  in  a  3D  
environment.    
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Results	
  

Clonal variations in MSC proliferation and morphology
Clonal  MSC  populations  were  both  morphologically  and  metabolically  distinct  from  one  
another.  Initial  colonies  differed  in  both  the  area  occupied  by  the  initial  colony  and  cell  
density  within  that  region  (Figure  3-1B).  Upon  isolation,  measurement  of  population  
doubling  time  showed  wide  variation  between  clones,  ranging  from  1.5  to  7  days  (Figure  
3-1C).  In  terms  of  morphology,  some  clones  exhibited  a  classic  spindle-like  morphology,  
while  others  had  multiple  protrusions  and  lacked  a  clear  polarization  (Figure  3-1D).  
While  cell  area  did  not  significantly  differ  between  clones  (Figure  3-1E),  quantification  of  
parameters  such  as  cell  aspect  ratio,  circularity,  and  solidity  (Figure  3-1F-H)  all  
supported  the  morphological  differences  we  observed.  

Clonal differences in nuclear morphology and heterochromatin content
In  addition  to  these  overall  cell  features,  other  intracellular  metrics  diverged  between  
clones  as  well.    For  instance,  DAPI  staining  showed  wide  variation  in  nuclear  shape  and  
morphology  between  clones.    Moreover,  for  some  clones,  these  nuclear  features  
changed  markedly  with  passage.    For  example,  nuclear  spread  area  increased  
dramatically  in  select  clones  (e.g.  Clone  C),  but  remained  near  constant  with  passage  in  
others  (e.g.  Clone  A,  F;;  Figure  3-2A,B).  Inside  the  nucleus,  distinct  morphological  
features  could  be  observed  as  well.    Staining  for  markers  of  heterochromatin  showed  
wide  variation  amongst  clones,  and  this  too  changed  with  passage  number.    For  
example,  at  passage  2,  two  of  five  clones  (A  and  F)  stained  strongly  for  heterochromatin    
30  
  

  

  
Figure  3-1:  Clonal  MSC  populations  differ  morphologically  and  in  their  proliferation  rates.  (A)  
Schematic  and  photographs  of  the  colony  isolation  process.  Colonies  formed  on  sparsely  seeded  plates,  
and  were  outlined  before  isolation.  Top  image  shows  microscopic  view  of  an  individual  colony,  lower  images  
shows  macroscopic  view  of  a  culture  dish  with  multiple  colonies  identified.  (B)  Cell  morphology  and  density  
in  the  initial  colonies  varied  between  clonal  populations  (each  image  taken  from  a  different  clonal  population  
in  the  same  plate).  (C)  Doubling  time  calculated  between  passages  1  and  2,  for  19  clonal  populations.  (D)  
Cell  silhouettes  obtained  from  phalloidin-stained,  passage  1  MSCs  seeded  on  glass  coverslips  (scale:  100  
μm).  (E  -  H)  Quantitative  cell  shape  metrics  of  the  four  clones  pictured  in  (D):  cell  spread  area,  cell  aspect  
ratio,  circularity  and  solidity  (n  =  30/condition;;  bars  indicate  p  <  0.05  when  compared  via  one-way  ANOVA  
with  Bonferroni  post  hoc  test).  For  circularity  and  solidity,  example  silhouettes  and  corresponding  
quantification  are  included  below  the  graphs.  
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(Figure  3-2A,C).  By  passage  4,  heterochromatin  staining  intensity  was  attenuated  
across  all  clones  and  was  more  spatially  uniform  within  individual  nuclei,  as  indicated  
both  visually  (Figure  3-2A)  and  by  the  decreased  variance  of  staining  within  individual  
cells  (Figure  3-2D).    

Clonal variation in cytoskeletal-to-nuclear strain transmission
Since  mechanotransduction  is  influenced  by  the  ability  of  a  cell  to  transmit  strain  to  the  
nucleus  and  the  mechanics  of  the  nucleus  itself,  inter-clonal  differences  in  these  nuclear  
metrics  might  also  indicate  the  existence  of  mechanobiological  heterogeneity  in  these  
cell  populations.  To  interrogate  clonal  differences  in  cytoskeletal-nuclear  strain  
transmission,  we  cultured  clonal  and  polyclonal  MSCs  on  nanofibrous  scaffolds  and  
monitored  the  deformation  of  the  nucleus  in  response  to  applied  strain.  Nuclear  
deformability  was  calculated  as  the  post-strain  nuclear  aspect  ratio,  normalized  to  the  
pre-strain  nuclear  aspect  ratio,  with  a  higher  value  indicating  greater  nuclear  deformation  
(Figure  3-3A).  At  passage  2,  nuclear  deformation  was  similar  between  clones  (Figure  
3-3B,  p  =  0.37).  By  passage  4,  however,  clones  differed  in  their  response  to  applied  
strain  (Figure  3-3B-D,  p  =  0.02).  Two  of  five  clonal  populations  remained  highly  
deformable  between  passage  2  and  passage  4  (Clones  A  and  B,  p  <  0.05).    In  contrast,  
nuclear  deformation  in  the  remaining  three  clones  was  significantly  attenuated  by  
passage  4  (p  ≥  0.42).  
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Figure  3-2:  Passage-dependent  clonal  differences  in  nuclear  morphology  and  chromatin  
organization.  (A)  Immunofluorescent  staining  for  tri-methyl  H3K27,  an  epigenetic  marker  of  
heterochromatin.  (B)  Projected  nuclear  area  of  polyclonal  and  clonal  MSCs  with  passage.  (C-D)  Mean  and  
standard  deviation  of  tri-methyl  H3K27  pixel  intensity,  calculated  on  a  per-cell  basis.  (n  =  21-60  
cells/condition.    Boxes  denote  the  first  and  third  quartiles.  Whiskers  extend  to  the  most  extreme  
observations  within  [1.5  *  interquartile  range]  of  the  box  hinges,  and  outlying  observations  are  represented  
as  individual  points.)  
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Figure  3-3:  Passage-dependent  clonal  differences  in  nuclear  deformability.  (A)  Schematic  illustrating  
nuclear  deformation  and  the  calculation  of  nuclear  aspect  ratio  (NAR).    (B)  Nuclear  deformability  in  response  
to  applied  strain,  measured  as  the  ratio  of  NAR  post-strain,  to  NAR  pre-strain  (n  =  38-65  cells/condition,  *  
indicates  p  <0.05  P2  vs.  P4  when  compared  via  t-test  with  Bonferroni  adjustment  for  multiple  comparisons).    

  

Cell-to-cell and clonal variation in contractility
Given  their  morphological  differences  at  the  cell  and  nuclear  level,  as  well  as  their  
differences  in  strain  transfer  to  the  nucleus,  we  next  hypothesized  that  clonal  populations  
would  differ  in  their  baseline  contractility  levels.    We  have  recently  reported  that  baseline  
contractility  in  mesenchymal  stem  cells  is  required  for  nuclear  deformation  and  ultimately  
regulation  of  chromatin  condensation.      
As  a  preliminary  assessment,  we  first  assessed  MSC  clonal  heterogeneity  in  contractility  
using  traction  force  microscopy.    In  this  assay,  the  deformation  of  a  hydrogel  substrate  is  
measured  in  the  context  of  a  cell  before  and  after  lysis  in  order  to  determine  the  cellular  
forces  exerted  on  the  substrate  at  a  given  point  in  time  (Figure  3-4A).  Consistent  with  
our  findings  on  glass,  donor-matched  clonal  and  polyclonal  populations  had  similar  
spread  areas  on  these  hydrogels  (polyclonal:  821  ±  121  μm2,  clone  1:    1226  ±  225  μm2,  

34  
  

clone  2:  946  ±  96  μm2;;  mean  ±  SEM,  p  =  0.17).  Despite  these  comparable  cell  areas,  
however,  clone  2  had  an  average  traction  stress  that  was  1.6x  greater  than  that  of  clone  
1  and  the  polyclonal  population  (Figure  3-4B;;  polyclonal:  274  ±  34  Pa,  clone  1:  265  ±  37    
Pa,  clone    2:  451  ±  58  Pa,  p  <  0.05).    This  suggests  that  clonal  subpopulations  establish  
different  levels  of  baseline  contractility,  and  that  these  differences  are  maintained  
through  at  least  two  passages.          
Given  that  our  previous  work  had  shown  contractility  was  in  part  established  through  
TGF/BMP  basal  signaling  (in  the  absence  of  ligand),81  we  were  curious  as  to  whether  
the  addition  of  these  factors  would  increase  traction  levels  to  a  maximum  level  that  
would  be  the  same  across  clones.    To  test  this,  traction  forces  generated  in  a  polyclonal  
MSC  population  were  assessed  using  a  higher  throughput  micropost  array  detector  
system  (µPADS),  with  cells  analyzed  both  before  and  with  time  after  exposure  to  TGFβ  
(Figure  3-4C).80  Prior  to  the  addition  of  TGFβ  (t  ≤  0,  Figure  3-4C),  the  baseline  strain  
energy  of  individual  cells  varied  between  55  and  540  mJ  (168.5  ±  128.9,  mean  ±  s.d.,  n  
=  15),  consistent  with  our  previous  observations  of  marked  heterogeneity  across  clonal  
populations  using  gel-based  TFM  measures.  Upon  addition  of  TGFβ,  the  average  
contractility  of  the  population  increased  (Figure  3-4C,  black  line  profile).  Quite  
interestingly,  we  observed  that  the  contractile  response  induced  by  TGFβ    was  
heterogeneous  at  the  single  cell  level.    That  is,  some  cells  became  more  contractile,  
while  others  failed  to  respond  at  all  (red  and  green  profiles,  respectively).    This  response  
(or  lack  thereof)  did  not  seem  depend  on  the  initial  contractile  state  of  the  cells.    Taken  
together,  these  data  suggest  that  individual  MSCs  and  clonal  populations  differ  in  how  
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Figure  3-4:  Traction  force  exerted  by  cells  differs  between  individual  cells  and  amongst  clonal  
populations.  (A)  Traction  force  map  of  an  individual  MSC  cultured  on  a  polyacrylamide  gel.  (B)  Mean  
traction  stress  per  cell,  for  donor-matched  polyclonal  and  clonal  populations  (n  =  12-28  cells/condition,  mean  
±  SEM,  bars  indicate  p  <  0.05  when  compared  via  Mann-Whitney-U  tests  across  groups).  (C)  Contractility  of  
individual  polyclonal  MSCS,  assessed  on  microposts  before  and  after  addition  of  TGFβ  at  t=0.  Mean  
population  response  shown  in  black,  with  dashed  lines  indicating  ±  SEM.  Individual  cell  traces  are  shown  in  
grey,  red,  and  teal.  

  
they  establish  their  baseline  cellular  traction  stress  generation  as  well  as  how  their  
contractile  state  changes  in  response  to  agonists  of  contractility  (including  chondrogenic  
factors).  
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Micromechanics of the cell and nascent pericellular matrix
The  combined  effects  of  clonal  heterogeneity  are  likely  to  culminate  in  clonal  differences  
in  functional  capacity.  Within  a  chondrogenic  context,  functionality  is  defined  by  the  
ability  of  cells  to  produce  a  robust  extracellular  matrix  capable  of  resisting  mechanical  
compression.    Here,  we  evaluated  this  capacity  by  monitoring  how  cells  encapsulated  in  
agarose  deform  in  response  to  30%  compression  of  the  gel,  and  how  this  response  
changed  with  culture  duration  (Figure  3-5A,B).  As  a  control  we  examined  native  
chondrocytes,  which  demonstrated  mean  deformability  ratios  of  1.47  and  1.14,  after  1  
and  8  days  of  culture  respectively.  The  effect  of  culture  time  was  slightly  attenuated  in  
polyclonal  MSCs,  which  demonstrated  mean  deformability  ratios  of  1.39  and  1.25  at  
days  1  and  8  respectively,  as  well  as  a  donor-dependent  effect  (Figure  3-5C).  Within  the  
nine  clonal  populations  examined,  Day  8  deformability  ratios  reflected  wide  clonal  
variation  and  ranged  from  1.17  to  1.40.  Despite  the  stark  differences  in  mean  
deformability,  the  variation  around  the  mean  was  similar  across  populations.  The  
evolution  of  pericellular  mechanics  between  Day  1  and  Day  8  also  differed  between  
clones  (Figure  3-5D).  Notably,  select  MSC  clones  and  the  donor-matched  (Donor  B)  
polyclonal  populations  did  not  show  a  significant  change  in  deformability  with  time  in  
culture  (p  >  0.05).  In  contrast,  many  individual  clonal  subpopulations  showed  significant  
decreases  in  this  metric  (p  <  0.05),  reflecting  the  progressive  development  of  
mechanically  robust  matrix.  Corresponding  Alcian  blue  staining  showed  that  populations  
with  lower  deformation  had  greater  pericellular  accumulation  of  sulfated  proteoglycans  
(Figure  3-5E).        
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Figure  3-5:  Chondrogenically-induced  clonal  populations  differ  in  their  response  to  compression.  (A-
B)  Schematics  illustrating  microcompression  to  assess  nascent  extracellular  matrix  mechanics.  (A)  
Illustration  of  gel  orientation  during  compression.  (B)  Cell  response  to  compression,  measured  by  cell  aspect  
ratio,  serves  as  a  proxy  for  the  mechanics  of  the  newly  formed  pericellular  matrix.  (C)  Cellular  deformability  
of  donor-matched  chondrocytes,  polyclonal  MSCs,  and  clonal  MSCs  after  8  days  of  culture,  represented  as  
post-compression  cell  aspect  ratio  normalized  to  pre-compression  cell  aspect  ratio.  (n  =  3  fields  of  
view/condition.)  (D)  Corresponding  change  in  post-compression  cell  aspect  ratio,  between  days  1  and  7.  
(same  populations  as  C,  *  indicates  p<0.05  day  1  vs  day  8  when  cellular  deformability  is  compared  via  two-
way  ANOVA.)  (E)  Representative  staining  with  Alcian  blue,  showing  heterogeneous  pericellular  staining  in  
polyclonal  and  clonal  MSC  populations.    
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Discussion	
  

Polyclonal  MSC  populations  isolated  using  standard  techniques  display  heterogeneous  
chondrogenic  potential.167  Individual  clonal  populations  differ  in  their  ability  to  
differentiate,  their  molecular  fingerprint,  and  their  mechanical  properties.43,122,164  To  
further  delineate  the  variation  present  amongst  clonal  MSC  populations,  this  work  
entailed  a  series  of  experiments  targeted  towards  understanding  the  mechanobiologic  
facets  of  MSC  heterogeneity.    Specifically,  our  data  show  marked  clone  dependent  
variation  in  cell  and  nuclear  morphology,  nuclear  chromatin  condensation,  nuclear  
deformability,  contractility,  response  to  contractile  agonists,  and  establishment  of  a  
mechanical  microenvironment.    
We  found  that  clonal  MSC  populations  differed  in  their  cellular  morphology  and  ability  to  
proliferate,  corroborating  previous  reports.153  Morphological  diversity  extended  to  the  
nucleus,  with  clonal  populations  also  differing  in  their  sub-nuclear  organization.  These  
differences  in  chromatin  condensation  support  findings  of  epigenetic  differences  
between  clones.156,157  Intriguingly,  this  heterogeneity  attenuated  with  passage.  Namely,  
staining  to  mark  chromatin  condensation  revealed  differences  between  clones  at  
passage  2.  However,  with  passage,  clonal  populations  with  high  heterochromatin  
staining  appeared  to  lose  or  reorganize  H3K27me3  marks,  and  by  passage  4,  
H3K27me3  patterns  were  similar  between  the  five  clones  we  examined.  This  finding  
builds  on  a  previous  report  that  H3K27  tri-methylation  is  stable  with  passage,78  and  
newly  identifies  the  clonal  dependence  of  this  behavior.    
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Measurements  of  nuclear  deformation  in  response  to  applied  strain  exhibited  similar  
passage  and  subpopulation  dependence.  Such  attenuation  of  nuclear  deformability  
could  reflect  either  a  change  in  nuclear  mechanics  or  in  the  transmission  of  strain  to  the  
nuclear  envelope.  While  we  did  not  measure  nuclear  mechanics  directly,  we  considered  
heterochromatin  organization  as  a  proxy  for  nuclear  stiffness.40  There  was  no  consistent  
relationship  between  chromatin  condensation  status  and  nuclear  deformability,  
suggesting  that  either  changes  in  nuclear  deformability  are  driven  by  altered  strain  
transmission  (i.e.,  nuclear  connectivity),  or  that  the  mechanisms  underlying  decreased  
strain  transmission  are  also  clone  dependent  (e.g.  select  clones  have  altered  nuclear  
mechanics,  while  others  have  altered  strain  transmission).  Indeed,  a  challenging  aspect  
of  studying  variation  amongst  clones  is  that  a  single  outcome  may  have  multiple  
potential  causes,  and  different  causes  could  drive  phenotype  in  individual  clonal  
populations.  
The  passage-dependent  effects  observed  in  nuclear  morphology  and  deformability  also  
highlighted  that  not  all  differences  are  preserved  with  expansion.  This  may  reflect  
increasing  intra-clonal  diversity  as  the  the  cells  in  a  clonal  population  reconstitute  the  
heterogeneity  of  the  parent  polyclonal  population  (similar  to  how  heterogeneity  has  been  
observed  to  reemerge  in  sorted  polyclonal  populations28,78).  Alternatively,  mechanisms  
such  as  mechanical  memory  may  drive  the  apparent  homogenization.  For  example,  
extended  culture  on  stiff  surfaces  may  override  initial  differences  in  clonal  
mechanobiological  phenotype,  and  force  clones  towards  to  exhibit  similar  behavior  with  
extended  exposure  to  this  modifier  of  their  baseline  mechanobiology.  
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Inter-clonal  variation  also  extended  to  the  clonal  response  to  soluble  factors.  Cellular  
contractility  differed  between  clones,  potentially  contributing  to  variation  in  nuclear  pre-
stress  (and  hence  the  observed  differences  in  nuclear  area  and  deformability).  
Furthermore,  clonal  populations  exposed  to  TGFβ  constructed  extracellular  
microenvironments  with  variable  mechanical  properties.  This  finding  provides  a  
mechanical  perspective  on  functional  variation  amongst  clones.  In  cartilage,  matrix  
quality  is  a  key  measure  of  differentiated  phenotype:    chondrocytes  surround  themselves  
with  a  pericellular  matrix,  which  not  only  allows  the  tissue  to  bear  compressive  load  but  
also  mediates  mechanical  strain  transfer  from  the  tissue  to  the  cell76.  Previous  studies  
have  noted  that  within  sparsely  seeded  agarose  hydrogels  similar  to  those  used  here,  
both  chondrocytes107  and  polyclonal  MSCs222  develop  pericellular  matrices.  In  this  study,  
we  employed  similar  micromechanical  techniques  to  identify  clonal  variation  in  
pericellular  matrix  production  and  mechanics.  In  parallel,  proteoglycan  staining  revealed  
intense  staining  localized  in  a  compact  manner  around  some  clonal  populations,  but  a  
lighter,  more  diffuse  pericellular  staining  in  others,  indicating  they  had  produced  less  
matrix  or  ECM  molecules  of  different  molecular  weights,  sulfation  levels  (charges),  and  
diffusivity.  These  observations  further  underscore  the  notion  that  clones  differ  in  their  
ability  to  differentiate,  and  also  establish  that  cells  from  different  clones  become  situated  
in  very  different  microenvironments  with  different  mechanical  properties.  Any  such  
micromechanical  variation  may  feed  back  to  the  cells  through  mechanotransductive  
mechanisms  and  further  drive  divergence  of  phenotype.    
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Collectively,  these  findings  add  to  the  growing  appreciation  of  clonal  MSC  heterogeneity.  
While  it  would  be  ideal  to  ultimately  identify  parameters  that  could  be  used  to  
prospectively  isolate  the  cells  most  capable  of  undergoing  differentiation,  any  such  effort  
may  be  complicated  by  the  passage  dependent  changes  described  here.  An  alternative  
strategy  may  be  the  mitigation  of  heterogeneity  –  for  example,  can  the  combination  of  
multiple  orthogonal  stimuli  increase  the  percentage  of  MSCs  exhibiting  a  desired  
response?  By  more  fully  understanding  how  clones  respond  to  a  variety  of  stimuli  (e.g.  
active  mechanical  stimulation,  mechanotransductive  alteration,  other  growth  factors),  it  
may  be  possible  to  optimize  the  potential  of  polyclonal  populations.    

Methods	
  

Cell isolation & culture
Cells  were  isolated  from  juvenile  bovine  tissue  (Research  87,  Boylston,  MA).  
Chondrocytes  were  isolated  from  tibial  plateau  cartilage  via  a  series  of  pronase  and  
collagenase  digestions.  MSCs  were  isolated  from  femoral  and  tibial  bone  marrow.    
Marrow  from  matched  tibia/femur  pairs  was  plated  over  four  dishes  measuring  592  cm2  
in  combined  area,  and  cultured  in  basal  media  consisting  of  high  glucose  DMEM  with  
10%  FBS  and  1x  antibiotic-antimycotic.  MSC  cultures  were  monitored  for  the  formation  
of  clearly  demarcated  cell  colonies,  which  were  isolated  and  sub-cultured  10-14  days  
after  marrow  isolation.    

42  
  

Colonies  were  considered  as  single-cell  derived  clonal  populations,  and  were  isolated  
via  the  trypsin  drop  method  modified  from  Bartov  et  al.  (Figure  3-1A).8  Individual  
colonies  were  identified  via  bright  field  observation  at  4x  magnification,  and  a  7.5  mm  
diameter  circle  surrounding  their  location  was  marked  on  the  outside  of  the  culture  plate  
using  adhesive  rings  or  permanent  marker.    The  plate  was  then  washed  with  phosphate  
buffered  saline  (PBS)  and  a  cell  scraper  was  used  to  remove  cells  outside  of  the  
identified  colonies.  Following  PBS  aspiration,  a  surgical  spear  was  used  to  dry  the  plate  
surrounding  each  colony.  A  droplet  of  trypsin  was  added  to  each  colony  and  held  in  
place  by  surface  tension.  Colonies  were  incubated  at  37°C  for  2-5  min,  gently  agitated  
with  a  pipette,  and  transferred  to  either  6-well  or  24-well  culture  plates,  depending  on  
colony  size.  In  parallel,  donor-matched  polyclonal  populations  were  obtained  by  
trypsinizing  cells  from  an  entire  plate  using  standard  techniques.    Following  this  initial  
passage  (passage  1),  both  clonal  and  polyclonal  populations  were  passaged  when  they  
reached  ~80%  confluence;;  cells  were  counted  at  each  passage.  At  each  replating,  cells  
were  reseeded  at  5,000  cells/cm2  in  basal  media  for  continued  proliferation.  Population  
growth  rates  were  estimated  from  the  cell  counts  taken  at  passages  2  and  3.  
Subsequent  experiments  utilized  chemically  defined  media,  consisting  high-glucose  
DMEM  supplemented  with  1  ×  antibiotic–antimycotic,  40  ng  ml−1  dexamethasone,  
50  μg  ml−1  ascorbate  2-phosphate,  40  μg  ml−1  L-proline,  100  μg  ml−1  sodium  pyruvate,  
1.25  mg  ml−1  bovine  serum  albumin,  5.35  μg  ml−1  linoleic  acid  and  1  ×  insulin–transferrin–
selenous  acid  premix  (Corning  CB-40350),  either  with  or  without  10  ng  ml−1  TGFβ3  (R&D  
Systems,  CM+  and  CM-  respectively).  
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Fluorescent imaging and quantification
At  each  passage,  cells  were  seeded  on  collagen  I-coated  glass  coverslips  at  a  density  of  
3000  cells/cm2  in  CM+  and  fixed  with  4%  paraformaldehyde  after  one  day.  To  assess  
cell  morphology,  cells  were  stained  with  Alexa  Fluor  488  phalloidin  (Invitrogen,  #A12379)  
and  4',6-diamidino-2-phenylindole  (DAPI,  ProLong  Gold  Reagent,  ThermoFisher,  
#P36931).  Five  20x  fields  of  view  were  selected  randomly  and  imaged  using  a  
fluorescent  microscope  (Nikon  T30).  Cells  were  manually  segmented  and  morphology  
was  quantified  using  ImageJ  (n=30  cells/condition).  Cell  solidity  was  calculated  as  the  
ratio  of  cell  spread  area  to  convex  hull  area.  Nuclear  morphology  and  heterochromatin  
organization  were  assessed  with  DAPI  and  staining  for  histone  H3  tri-methylation  at  K27  
(1°:  mouse  monoclonal  H3K27  trimethyl,  Abcam  ab6002;;  2°:  anti  mouse  IgG-TRITC  
(T2402,  Sigma).  Images  focused  around  the  nucleus  mid-plane  were  taken  using  a  
fluorescent  microscope  (Zeiss  Axioplan-2),  and  a  custom  Matlab  script  was  used  to  
segment  individual  nuclei  using  the  DAPI  signal  and  measure  the  corresponding  
intensity  of  H3K27  tri-methyl  staining  (n  =  21  -  36  cells/condition).    

Micropost and traction force microscopy measures of contractility
Traction  force  microscopy  was  performed  as  previously  described.50  Briefly,  
polyacrylamide  hydrogels  (5  kPa,  ν=0.45)  containing  0.2  μm  fluorescent  microspheres  
(Invitrogen  F8810)  were  prepared,5  treated  with  2  mg/mL  sulfo-SANPAH  (Pierce  22589),  
coated  with  fibronectin  (20  μg/mL),  and  UV  sterilized.  Passage  1  MSCs  were  seeded  
onto  the  gels  in  basal  media  at  a  density  of  3000  cells/cm2  and  allowed  to  attach  for  20  
hours.  Phase  contrast  and  fluorescent  images  of  live  cells  and  beads  were  acquired  
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before  and  after  cell  lysis  with  SDS  buffer  using  a  microscope  equipped  with  live  cell  
imaging  chamber  (DeltaVision  Deconvolution).  Image  analysis  was  performed  using  the  
freely  available  plugin  suite  for  ImageJ  (n  =  12-  25  cells/condition).216    
The  cellular  contractile  response  to  the  addition  of  TGFβ  was  assessed  using  a  custom  
micro-post  array  detector  (mPAD).66,231  MSCs  were  cultured  on  electrospun  scaffolds  for  
7  days,  re-seeded  on  the  micropillars  (spring  constant:  18.19  nN/mm,  post  tips  labeled  
wih  DiI),  and  cultured  for  1  day  prior  to  observation.  Micropillar  deflection  was  then  
monitored  using  a  fluorescence  microscope  equipped  with  a  live-cell  imaging  chamber.  
Using  measured  post  deflection,  strain  energy  per  cell  was  calculated  as  a  function  of  
time.231  

Tensile stretch to assess nuclear deformation
At  passage  2  and  passage  4,  polyclonal  and  clonal  MSC  populations  were  seeded  onto  
aligned  electrospun  poly(ε-caprolactone)  scaffolds,  and  cultured  in  CM-  for  one  day.    
Next,    live  cells  were  stained  with  Hoechst  (Sigma  33342)  for  20  minutes  at  37°C,  and  
scaffolds  were  mounted  into  a  custom  stretching  apparatus  on  a  fluorescent  microscope  
(Nikon  T30).50  Scaffolds  were  stetched  from  0%  to  15%  grip-to-grip  strain,  in  increments  
of  3%.    Images  of  cell  nuclei  were  collected  at  0  and  15%  strain  (n  =  20  -  43  
cells/condition).    Nuclei  were  automatically  segmented  using  a  custom  MATLAB  script  
and  individual  cells  were  tracked  through  each  strain  level.  Nuclear  aspect  ratio  (NAR,  
equal  to  the  ratio  of  principle  lengths)  was  calculated  as  the  ratio  of  the  long  and  short  
axes  of  each  nucleus  at  each  strain  increment.    
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Compression to assess matrix micromechanics
Clonal  and  passage  2  MSCs  were  encapsulated  in  2%  agarose  hydrogels.  3x106  
cells/mL  were  suspended  in  an  agarose  solution,  and  cast  into  cylindrical  constructs  
measuring  4  mm  in  diameter  and  2.25  mm  in  thickness.  Hydrogels  were  cultured  for  1  
day  in  CM−  or  8  days  in  CM+.  On  days  1  and  8,  constructs  were  halved,  and  one  half  
was  stained  with  4  μM  calcein-AM  in  PBS  for  30  min  and  tested  using  a  custom  
microscope-mounted  microcompression  device.107  The  remaining  half  was  fixed  in  4%  
paraformaldehyde,  paraffin  embedded,  sectioned  to  8  μm,  and  stained  with  Alcian  blue  
(pH  1.0)  to  histologically  assess  matrix  accumulation.    
Micromechanical  testing  was  conducted  using  a  custom  unconfined  compression  testing  
device  consisting  of  micrometer-controlled  platens  inside  a  glass-bottomed,  PBS-filled  
well.60,146  Constructs  were  placed  in  the  PBS  bath  with  the  mid-sagittal  plane  downward  
and  imaged  at  0%  and  30%  compressive  grip-to-grip  stain  using  a  inverted  confocal  
microscope  (Olympus  Fluoview  FV1000,  20X  UPlanFL  objective).  Images  were  acquired  
through  approximately  60  μm  of  the  construct  depth  with  a  step  interval  of  2.34  μm  per  
slice.  Z-stack  maximum  intensity  projections  were  binarized  in  MATLAB,  and  bounding  
boxes  were  computationally  constructed  around  individual  cells.  Bounding  box  aspect  
ratio  was  calculated  as  the  ratio  of  bounding  box  dimensions  (Y/X).  Parameters,  
including  mean  and  standard  deviation,  were  calculated  for  each  image  stack  to  
measure  the  behavior  of  cells  in  each  field  of  view  (n=3  gels/condition).    These  
parameters  were  then  aggregated  over  each  condition,  and  are  presented  as  the  
condition  mean  ±  standard  deviation.    
46  
  

Statistics
Metrics  describing  cell  morphology  were  compared  between  clones  using  one-way  
ANOVAs  with  Bonferroni  post  hoc  tests.  Average  traction  stress  was  compared  between  
clones  using  Mann-Whitney  U  tests  adjusted  for  multiple  comparisons.  Nuclear  
deformability  was  compared  across  clones  and  passage  using  a  two-way  ANOVA  with  
Bonferroni  post  hoc  tests  for  planned  comparisons.  Cellular  deformability  was  compared  
across  time  (Day  1  vs  Day  8)  and  clone  using  a  two-way  ANOVA  with  Bonferroni  post  
hoc  tests  for  planned  comparisons.    
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Introduction	
  
Despite  the  phenotypic  heterogeneity  in  MSC  populations,  most  studies  that  explore  the  
molecular  underpinnings  of  phenotype  monitor  differentiation  via  bulk  assays  of  
transcriptional  state  and  protein  synthesis  averaged  over  an  entire  cell  population.  These  
ensemble  measurements,  by  definition,  mask  population  heterogeneity  3,155.  The  advent  
of  single  cell  methods  allows  for  the  measurement  of  cell-to-cell  variation  and  the  ability  
to  quantify  absolute  gene  expression  in  a  single  cell,37,91,96  revealing,  for  example,  
marked  transcriptional  heterogeneity.  Real-time  fluorescent  monitoring  of  changes  in  
transcript  levels  in  individual  cells  has  also  shown  that  individual  MSCs  differ  in  the  
timing  and  extent  to  which  they  upregulate  an  early  osteogenic  marker138.  These  findings  
underscore  the  limitations  of  coarse  ensemble  approaches  and  highlight  the  need  for  
single-cell  molecular  profiling  of  these  differentiation  events.  Although  it  is  reasonable  to  
speculate  that  the  subpopulation  of  cells  expressing  high  levels  of  marker  genes  would  
ultimately  be  the  most  chondrogenic,  this  hypothesis  remains  untested.  
Given  that  individual  MSCs  are  highly  variable  in  their  capacity  to  undergo  
chondrogenesis  and  accumulate  cartilage-like  matrix86,  we  postulated  that  one  could  use  
single  cell  marker  gene  transcript  levels  as  a  means  to  enrich  for  MSC  subpopulations  
most  suited  for  therapeutic  application.  Here,  we  define  this  relationship  by  developing  
probe  sets  for  RNA  fluorescence  in  situ  hybridization  directed  against  transcripts  of  
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markers  of  cartilage,  bone,  and  fat,  and  use  single-cell  analysis  to  delineate  the  
relationships  between  absolute  transcript  level  and  differentiated  cell  function.  
Specifically,  we  hypothesized  that  cells  that  robustly  accumulate  an  aggrecan-rich,  
cartilage-like  matrix  would  also  express  high  levels  of  aggrecan  mRNA,  while  at  the  
same  time  suppressing  markers  of  other  lineages.  
We  find  surprising  levels  of  variability  in  the  expression  of  aggrecan  and  other  marker  
genes  between  individual  MSCs  both  before  and  after  differentiation.  However,  when  we  
compare  expression  with  functional  capacity  (defined  by  actual  matrix  deposition)  on  a  
single  cell  basis,  we  find  a  weak  correlation  between  transcript  abundance  and  protein  
expression.  Transcriptome-wide  analysis  via  RNA  sequencing  further  suggests  that  
neither  an  expanded  set  of  marker  genes,  nor  the  principal  components  of  global  gene  
expression  variation,  correlate  strongly  with  functional  capacity.  Indeed,  even  in  fully  
differentiated  chondrocytes  derived  from  native  tissue,  absolute  aggrecan  mRNA  
expression  is  decoupled  from  cartilage-like  matrix  accumulation.  Collectively,  these  
findings  suggest  that  sorting  based  solely  on  a  small  set  of  differentiation  markers  will  
not  improve  chondrogenic  outcomes,  and  challenge  the  traditional  notion  that  marker  
gene  expression  defines  or  is  even  strongly  associated  with  phenotype.    

Results	
  
Single cells express differentiation markers heterogeneously
To  quantify  absolute  gene  expression  of  marker  genes  on  a  single  cell  basis  during  MSC  
differentiation  and  chondrocyte  de-/re-differentiation,  we  paired  classic  cartilage  tissue  
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engineering  and  cartilage  biology  experiments  with  single  molecule  RNA  FISH62,174.  
Specifically,  we  monitored  the  simultaneous  expression  of  aggrecan  as  a  marker  of  
chondrogenic  differentiation,  GAPDH  as  a  reference  gene,  and  osteopontin  and  
lipoprotein  lipase  (LPL)  as  markers  of  alternate  fates  (osteogenesis  and  adipogenesis,  
respectively)64,163,192.  For  each  gene,  we  designed  fluorescently-labeled  sequence-
specific  oligonucleotide  probes  to  visualize  individual  mRNA  molecules  in  intact  fixed  
cells.  Individual  mRNA  appeared  as  bright  diffraction  limited  spots  (Figure  4-1a-b)  and  
subsequent  spot  counting  yielded  absolute  copy  number  at  the  single  cell  level.  
To  show  that  our  measurements  corresponded  well  with  existing  measurements  of  these  
systems,  we  first  determined  how  absolute  gene  expression  changed  as  MSCs  
underwent  chondrogenic  differentiation.  To  do  so,  we  formed  engineered  constructs  and  
used  RNA  FISH  to  quantify  gene  expression  over  three  weeks  in  chemically  defined  
media  with  or  without  TGFβ  (chondrogenic  induction  media  and  control  media  
respectively,  Figure  4-1c).  As  expected,  chondrogenic  induction  promoted  proteoglycan  
synthesis  and  matrix  accumulation  (Figure  4-1d)  and  increased  aggrecan  copy  number  
in  comparison  to  control  media  (Figure  4-1e).  Though  there  was  considerable  donor-to-
donor  variability  in  mean  aggrecan  levels  and  matrix  deposition,  the  trends  were  similar  
between  donors,  with  mean  aggrecan  copy  number  generally  increasing  over  the  first  7  
days,  before  decreasing  at  later  time  points  (Figure  4-1e,  Figure  4-2a,  Appendix  2  
Supplementary  Table  1).  Mean  GAPDH  copy  number  increased  with  exposure  to  
induction  media  (Figure  4-2b).  Thus,  in  aggregate,  this  RNA  FISH  analysis  aligned  with  
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the  canonical  understanding  of  gene  expression  changes  during  chondrogenic  
differentiation170.  
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Figure  4-1  (previous  page):  RNA  FISH  reveals  heterogeneity  in  lineage  marker  expression  in  
mesenchymal  stem  cells  and  chondrocytes.  a-b)  Representative  images  (a)  and  schematic  (b)  of  single  
molecule  RNA  FISH,  in  which  fluorescently  labelled  DNA  oligonucleotides  enable  quantification  of  absolute  
expression  of  multiple  genes  in  the  same  cell.  c)  Chondrogenic  induction  scheme,  involving  cell  
encapsulation  in  3D  agarose  constructs  and  exposure  to  TGFβ.  d)  Alcian  blue  staining  for  sulfated  
proteoglycans;;  Donor  B  shown.  e)  Mean  aggrecan  RNA  counts  in  MSCs  cultured  in  3D  for  up  to  21  days.  
Narrow  bars  represent  the  mean  within  an  individual  donor;;  overlaid  bars  represent  the  mean  across  donors.  
Error  bars  indicate  standard  error  (n  =  24-128  cells  per  donor  and  condition),  **  indicates  p<0.01  vs.  –TGFβ  
conditions,  and  between  +TGFβ  time  points.  See  Appendix  2  Supplementary  Table  4  for  all  statistical  
comparisons.  f-g)  Distributions  of  single  cell  aggrecan  expression  for  chondrocytes  and  MSCs  plated  on  
glass  in  basal  media  (f,  n  =  56  chondrocytes,  49  MSCs)  and  3D  encapsulated  MSCs  exposed  to  TGFβ  for  1  
and  21  days  (g,  n  =  105  cells  for  day  1,  79  cells  for  day  21;;  Donor  A  shown.)  h)  Single  cell  aggrecan  
expression  for  each  donor  after  7  days  of  3D  culture  with  TGFβ  relative  to  the  median  aggrecan  expression  
in  freshly  isolated  chondrocytes  (dashed  line;;  n  =  103  cells  for  Donor  A,  54  cells  for  Donor  B,  65  cells  for  
Donor  C).  i)  Simultaneous  expression  of  aggrecan,  osteopontin,  LPL,  and  GAPDH  on  day  1  and  day  21;;  
Donor  A  shown  (n  =  105  cells  for  day  1,  79  cells  for  day  21).    

While  these  ensemble  measures  corresponded  with  previous  findings,  they  did  not  
provide  information  on  cell-to-cell  variability  in  expression  of  these  lineage  markers.  
Thus,  we  measured  mRNA  copy  number  on  a  cell-by-cell  basis  under  baseline  
conditions  and  with  differentiation.  We  assayed  four  conditions:  naive  MSCs  in  
expansion  culture,  MSCs  differentiating  in  engineered  constructs  after  1  and  21  days  in  
induction  media,  and  as  a  positive  control,  fully  differentiated  primary  chondrocytes  
(Figure  4-1f-g).  For  each  of  these  groups,  single-cell  analysis  showed  striking  
heterogeneity  in  expression,  with  aggrecan  mRNA  copy  number  per  cell  spanning  three  
orders  of  magnitude  (100  -  102).  Consistent  with  the  notion  that  stem  cells  exhibit  greater  
variability  than  differentiated  cells,  naive  MSCs  showed  the  greatest  heterogeneity  in  
aggrecan  expression  (as  measured  by  the  coefficient  of  variation,  Table  4-1),  and  the  
coefficient  of  variation  decreased  with  exposure  to  induction  media.  However,  the  
variability  remained  high  even  after  long  periods  of  time  in  differentiation  culture  (Figure  
4-1g).  Fully  differentiated  chondrocytes  had  the  most  homogeneous  aggrecan  
expression  of  all  the  cell  types  and  conditions  we  examined,  though  their  mean  
aggrecan  copy  number  was  slightly  lower  than  that  of  differentiated  MSCs.  These  data    
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Figure  4-2:  Matrix  production,  GAPDH  copy  number,  and  viability  of  MSCs  in  3D  culture.  a)  Alcian  
blue  staining  for  sulfated  proteoglycans  for  MSCs  in  3D  culture,  for  all  donors  and  time  points,  with  and  
without  TGFβ  induction  of  chondrogenesis.  Donor  B  is  also  shown  in  Figure  1.  Scale  bar  =  5  mm.  b)  Mean  
GAPDH  RNA  counts  and  c)  cell  viability  over  21  days  in  3D  culture.  Narrow  bars  represent  the  mean  within  
an  individual  donor;;  overlaid  bars  represent  the  mean  across  donors.  Error  bars  indicate  standard  error  (n  =  
24-128  cells  per  donor  and  condition).  RNA  count  means  compared  by  t-tests  with  Satterthwaite  
approximation  and  simulated  adjustment  for  multiple  comparisons.  See  Appendix  2  Supplementary  Table  1  
for  all  statistical  comparisons.  d)  Simultaneous  RNA  FISH  and  fixable  dead  staining  established  a  threshold  
of  GAPDH>10  to  differentiate  live  cells  from  dead  cells  for  further  analysis.  n  =  85  cells  for  TGFβ-,  75  cells  
for  TGFβ+.  

  
show  that  MSCs  exhibit  substantial  cell-to-cell  expression  heterogeneity  and  that,  while  
chondrogenic  culture  promotes  a  chondrocyte-like  gene  expression  pattern,  copy  
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number  remains  highly  variable  between  cells.  Indeed,  this  variability  within  a  population  
of  differentiated  MSCs  overshadowed  differences  in  mean  expression  between  donors  
(3-4  orders  of  magnitude  vs.  a  maximum  ~2-fold  difference,  Figure  4-1h).    

Table  4-1:  Mean  and  Coefficient  of  Variation  Associated  with  Aggrecan  RNA  
Count  in  Undifferentiated  and  Differentiated  Cells  
Mean  Aggrecan

Aggrecan  CV

Naive  MSCs

69

1.60

Day  1  MSCs  in  gels

247

0.69

Day  21  MSCs  in  gels

334

0.72

Chondrocytes

225

0.57

  
This  heterogeneity  may  either  reflect  different  subpopulations  that  have  adopted  distinct  
fates  or  appear  in  cells  that  remain  uncommitted.  In  the  former  scenario,  if  differentiated  
MSCs  can  express  markers  for  only  one  fate  at  a  time,  then  alternate  lineage  
commitment  should  manifest  as  an  anti-correlation  between  aggrecan  and  other  lineage  
markers  at  the  single  cell  level.  To  determine  if  this  was  the  case,  we  performed  RNA  
FISH  for  aggrecan,  osteopontin  and  LPL  in  the  same  cells,  with  the  latter  two  markers  
indicating  an  osteogenic  and  adipogenic  lineage,  respectively.  Rather  than  identifying  
subpopulations  that  were  distinctly  chondrogenic  or  osteogenic,  we  instead  observed  a  
slight  positive  correlation  between  aggrecan  and  osteopontin  (Figure  4-1i,  Day  1  
ρ=0.49,  p<  0.001;;  Day  21  ρ=  0.34,  p<0.005).  Conversely,  LPL  expression  was  minimal,  
and  did  not  correlate  with  either  aggrecan  or  osteopontin  expression  (Appendix  2  
Supplementary  Table  2).  These  data  suggested  that  heterogeneity  in  marker  
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expression  after  differentiation  is  not  due  to  alternate  lineage  commitment,  but  rather  
highlights  the  fact  that  even  differentiated  MSCs  can  express  high  levels  of  markers  for  
inappropriate  lineages.  

RNA levels poorly predict single-cell functional potential
Based  on  this  tremendous  cell-to-cell  heterogeneity  in  chondrogenic  gene  expression,  
we  next  asked  if  aggrecan,  Sox9,  or  collagen  oligomeric  matrix  protein  might  serve  as  a  
means  for  separating  robustly  chondrogenic  cells  from  the  less  chondrogenic  ones  in  the  
initial  heterogeneous  population.  For  this  to  be  possible,  mRNA  levels  would  need  to  
correlate  with  chondrogenic  capacity,  indicated  by  the  accumulation  of  a  proteoglycan-
rich  extracellular  matrix.  To  determine  if  such  a  connection  existed,  we  seeded  MSCs  in  
3D  culture  and  induced  chondrogenesis  for  7  days,  the  point  at  which  mean  aggrecan  
expression  peaked.  We  then  performed  immunofluorescent  staining  for  aggrecan  core  
protein  (a  central  component  of  the  cartilage-like  extracellular  matrix)  simultaneously  
with  RNA  FISH  using  one  of  two  probe  sets:  probes  for  markers  of  multiple  fates  
(aggrecan,  osteopontin,  LPL,  and  GAPDH;;  Batch  1  samples)  or  probes  for  chondrogenic  
markers  (Sox9,  cartilage  oligomeric  matrix  protein  (COMP),  and  GAPDH;;  Batch  2  
samples).  We  designated  cells  with  evidence  of  extracellular  staining  for  aggrecan  core  
protein  as  ‘high-performing’  (comprising  12-62%  of  the  population,  depending  on  donor),  
and  cells  lacking  extracellular  staining  as  ‘low-performing’  (Figure  4-3a-b).  Surprisingly,  
aggrecan  expression  did  not  strongly  predict  aggrecan  core  protein  accumulation.  
Indeed,  even  within  a  single  donor,  the  distribution  of  aggrecan  mRNA  abundance  in  
high-  and  low-  performing  cells  overlapped  substantially  (Figure  4-3c).  The  mRNA/cell  
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distributions  of  other  chondrogenic  markers  (COMP,  Sox9),  markers  of  alternative  fates  
(osteopontin,  LPL)  and  the  housekeeping  gene  GAPDH  (Figure  4-4a)  also  
demonstrated  similar  overlap.  While  in  aggregate  the  high-performing  cells  had  a  greater  
mean  expression  of  aggrecan,  COMP,  and  Sox9  and  lower  mean  expression  of  
osteopontin  than  low-performing  cells,  the  magnitude  of  these  differences  was  small  and  
similar  to  the  shift  seen  in  GAPDH  expression  (Figure  4-4a,  aggrecan:  1.35  fold  
increase,  COMP:  1.14  fold  increase,  Sox9:  1.33  fold  increase,  GAPDH:  1.17  fold  
increase,  osteopontin:  -1.22  fold  decrease).  We  also  determined  the  expression  ratios  
relative  to  commonly  used  normalization  genes  (i.e.  aggrecan/GAPDH)  or  to  genes  
indicating  alternate  lineage  specification  (i.e.  aggrecan/osteopontin).  These  metrics  also  
showed  substantial  overlap  and  small  effect  size  (Figure  4-4a).  Thus  on  this  qualitative  
basis,  neither  absolute  nor  normalized  single  cell  expression  of  marker  genes  was  highly  
predictive  of  chondrogenic  capacity  at  the  single  cell  level.  
To  quantify  the  ability  of  transcript  abundance  to  predict  the  extent  of  a  cell’s  matrix  
accumulation,  and  thus  sort  high-  from  low-performing  cells,  we  constructed  receiver  
operating  characteristic  curves  to  determine  the  ‘true  positive’  (sensitivity)  and  ‘true  
negative’  (specificity)  rates  associated  with  potential  mRNA  thresholds.  We  pooled  data  
across  donors  assayed  using  the  same  probes  (batches  1  and  2).  Within  each  batch,  we  
assessed  the  high/low  classification  performance  of  individual  genes,  gene  expression  
ratios  and  linear  combinations  of  gene  expression  levels  (Figure  4-3d-f,  Figure  4-4b).    
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Figure  4-3  (previous  page):  Marker  gene  expression  is  a  poor  predictor  cartilage-like  matrix  
production  in  individual  MSCs.  a)  Aggrecan  core  protein  identified  by  immunostaining  of  MSCs  showing  
high  or  low  cartilage-like  matrix  formation  after  7  days  of  3D  culture  with  TGFβ.  b)  Fraction  of  cells  classified  
as  high-  or  low-performing  based  on  aggrecan  protein  staining  (cells/donor:  D:  78,  E:  89,  F:  51,  X:  62,  Y:  43,  
Z:  47).  c)  Distribution  of  aggrecan  copy  number  in  high-  and  low-performing  MSC  populations;;  probability  
density  curve  for  Donor  E  shown  (n  =  153  cells).  d-e)  Receiver  operating  characteristic  curves  using  
individual  gene  expression  and  regression  analysis  on  combinations  of  genes  from  batch  1  (d)  and  individual  
gene  expression  from  batch  2  genes  (e)  to  distinguish  between  high-  and  low-performing  MSCs  (cells/donor:  
D:  132,  E:  153,  F:  122,  X:  57,  Y:  42,  Z:  47).  f)  Summary  graph  of  area  under  the  curve  of  receiver  operating  
characteristic  curves  for  individual  gene  expression,  gene  expression  ratios,  and  regression  analysis  of  
combinations  of  gene.  g-h)  Simulated  sorting  of  MSCs  into  anticipated  high-  and  low-performing  cells,  using  
the  optimized  threshold  of  405  aggrecan  mRNA  copies  (g)  and  the  optimized  threshold  from  the  
ACAN+OPN  regression  (h).    

  
While  each  metric  discriminated  between  high-  and  low-performing  cells  better  than  
random  chance  (represented  by  the  diagonal  line  on  the  ROC  plots,  and  an  area  under  
the  curve  =  0.5),  the  improvements  in  selection  specificity  were  relatively  small.  Of  the  
individual  RNA  types  indicative  of  the  chondrogenic  lineage,  aggrecan  and  Sox9  were  
best  able  to  discriminate  between  high  and  low  performing  cells.  For  example,  consider  
the  optimized  threshold  of  405  aggrecan  mRNA,  which  maximizes  the  Youden  J  statistic  
(sensitivity  +  specificity  −  1).  Conceptually,  we  can  designate  all  cells  with  >405  
aggrecan  RNA  as  anticipated  high  performers,  and  others  as  anticipated  low  performers.  
For  the  donors  studied,  this  unsorted  population  was  34%  high-  and  66%  low-performing  
cells.  Sorting  based  on  this  optimized  aggrecan  threshold  misclassified  37%  of  all  cells  
(i.e.  percent  of  high  cells  predicted  to  be  low,  or  low  cells  predicted  to  be  high).  50%  of  
high-performing  cells  were  lost  due  to  incorrect  classification  as  ‘anticipated-low’  cells,  
and  the  fraction  of  high-performing  cells  in  the  ‘anticipated-high’  population  was  enriched  
only  35%  over  the  unsorted  population  (Figure  4-3g).  A  logistic  regression  model  
combining  aggrecan  and  osteopontin  expression  improved  on  this  performance  only  
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Figure  4-4  (previous  page):  Matrix  staining  intensity  versus  mRNA  copy  number  and  ROC  curves  for  
individual  donors,  markers,  and  marker  ratios.  a)  Distribution  of  aggrecan,  GAPDH,  osteopontin,  
aggrecan/GAPDH,  and  aggrecan/osteopontin  gene  expression  within  high-  and  low-performing  MSC  
populations;;  separated  by  donor.  Dashed  lines  represent  the  mean  for  each  condition.  For  
aggrecan/osteopontin,  only  cells  that  had  at  least  one  osteopontin  (>95%  of  cells  per  donor)  mRNA  were  
included  in  the  graph  and  mean  statistics  calculation.  b)  Receiver  operating  characteristic  curves  using  
individual  gene  expression  and  gene  expression  ratios  to  distinguish  between  high-  and  low-performing  
MSCs,  separated  by  donor.  Cells/donor:  D:  132,  E:  153,  F:  122,  X:  57,  Y:  42,  Z:  47.    

  
slightly,  where  its  optimized  threshold  yielded  a  33%  misclassification  rate,  and  enriched  
the  fraction  of  high  cells  by  37%  (Figure  4-3h,  vs  35%  for  aggrecan  alone).  Of  the  gene  
expression  ratios,  aggrecan/osteopontin  was  a  better  discriminator  than  
aggrecan/GAPDH,  though  its  selection  performance  did  not  surpass  that  of  aggrecan  
alone.  Sorting  on  a  donor-by-donor  basis  was  similarly  ineffective  (Figure  4-4b).  Thus,  
sorting  cells  based  on  expression  of  aggrecan,  other  common  differentiation  markers,  
and  linear  combinations  thereof  would  result  in  only  marginal  enrichment  of  the  
population,  while  substantially  reducing  available  cell  number.  

Transcriptomics does not identify better marker sets
Based  on  the  inability  of  aggrecan  and  other  lineage  specific  markers  to  robustly  predict  
matrix  accumulation  at  the  single  cell  level,  we  next  utilized  high  throughput  RNA  
sequencing  to  determine  if  other  features  of  the  transcriptome,  and  specifically  factors  
present  in  the  undifferentiated  population,  might  prospectively  identify  MSCs  with  high  
differentiation  potential.  We  expanded  single  cell-derived  MSC  colonies  in  monolayer,  
and  collected  a  fraction  of  the  cells  for  RNA  sequencing  and  subsequent  transcriptome  
analysis.  The  remaining  fraction  was  expanded  through  an  additional  passage,  formed  
into  pellets,  and  cultured  in  the  presence  of  TGFβ  for  21  days  to  assay  chondrogenic    
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Figure  4-5:  Genome-wide  transcriptome  profiling  does  not  predict  MSC  functional  potential.  a)  
Schematic  for  RNA  sequencing  and  testing  of  functional  capacity  of  single  cell  derived  clones.  b)  Unbiased  
clustering  of  clones  (or  heterogeneous  population)  based  on  fragments  per  kilobase  of  transcript  per  million  
reads  (FPKM)  of  RNA  sequencing  results  (subsetted  for  genes  where  at  least  one  sample  had  FPKM  >  1).  
c)  Glycosaminoglycan  deposition  per  DNA  in  micropellets  derived  from  clonal  or  heterogeneous  populations  
(from  part  b)  cultured  for  21  days  in  chondrogenic  (TGFβ+)  culture  media.  d)  Principal  component  analysis  
of  same  RNA  sequencing  results  as  in  part  b,  colored  by  GAG/DNA  for  each  clone.  e)  log2  transformed  
FPKM  of  selected  genes  from  RNA  sequencing  results  as  a  function  of  GAG/DNA  for  each  clone.    
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potential  (Figure  4-5a).  This  evaluation  of  baseline  MSC  gene  expression  in  clonal  
populations  derived  from  single  cells  had  the  potential  to  identify  markers  that  could  be  
used  to  sort  freshly  isolated  MSCs  based  on  their  gene  expression  signatures.    
  

An  initial  comparison  of  differential  expression  between  clones  (Figure  4-5b),  as  
compared  to  the  deposition  of  extracellular  matrix  components  of  each  clone  (Figure  
4-5c),  revealed  no  striking  patterns  of  gene  expression  that  correlated  with  subsequent  
matrix  deposition.  We  also  used  principal  component  analysis  to  determine  if  the  
variation  between  the  gene  expression  of  each  clone  could  be  used  to  predict  functional  
capacity,  but  there  was  no  relationship  between  clustering  in  either  of  the  first  two  
principal  components  and  matrix  deposition  (Figure  4-5d).  
Given  that  the  full  transcriptome  lacked  global  predictive  capacity,  we  next  sought  to  
broaden  our  conclusions  from  the  FISH  experiments  by  examining  the  sequencing  data  
associated  with  individual  genes.  We  selected  a  small  subset  of  genes  that  
corresponded  to  four  categories  of  markers  identified  in  previous  studies:  chondrogenic  
markers,  stemness  markers,  cell-cycle  associated  genes,  and  housekeeping  genes27.  
Consistent  with  our  single-cell  analysis  results,  none  of  these  genes  correlated  strongly  
with  functional  potential  on  a  clonal  basis  (Figure  4-5e).  Even  the  most  predictive  genes,  
MMP13  and  aggrecan,  correlated  only  weakly  (r2=  0.3,  p  =  <  .05  and  r2=0.23,  p  =  0.062,  
respectively).  Together,  this  transcriptomic  analysis  suggests  that  there  is  no  expression  
signature  at  the  RNA  level  that  could  pre-identify  specific  clones  with  high  chondrogenic  
potential.  
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Marker heterogeneity emerges rapidly after cell division
Based  on  the  inability  of  transcript  levels  to  robustly  predict  matrix  forming  potential,  we  
next  asked  whether  it  was  propagated  through  cell  division;;  that  is,  whether  cells  with  a  
higher  expression  level  would  transmit  this  feature  to  their  daughter  cells.  As  an  initial  
assay,  we  measured  aggrecan  copy  number  in  every  cell  located  within  a  series  of  small  
MSC  colonies  stimulated  with  TGFβ  (where  each  individual  colony  likely  arose  from  a  
single  cell,  Figure  4-6b).  Results  from  this  analysis  showed  that  aggrecan  copy  number  
varied  more  within  a  single  colony  than  it  did  between  colonies  (Figure  4-6b).  This  result  
suggests  that  with  just  a  few  cell  divisions,  aggrecan  levels  rapidly  devolved  to  
recapitulate  the  heterogeneity  present  in  the  bulk  population.  In  contrast,  GAPDH  was  
less  variable  than  aggrecan  within  each  colony  (lower  coefficient  of  variation,  Appendix  
2  Supplementary  Table  3),  but  showed  greater  differences  in  mean  level  between  
colonies  (Figure  4-6c).  Thus,  not  every  gene  demonstrated  the  high  intra-colony  
variability  observed  in  aggrecan  expression,  and  some  genes  were  differentially  
expressed  between  colonies.  However,  without  live-cell  time-lapse  measurements  of  the  
cellular  lineage,  it  was  difficult  to  directly  show  that  variability  in  aggrecan  mRNA  levels  
arose  through  randomization  rather  than  heritable  differences.    
To  overcome  this  limitation,  we  next  continuously  tracked  MSCs  as  they  migrated  and  
divided  in  induction  media  by  live  cell  microscopy  for  three  days,  and  correlated  terminal  
aggrecan  expression  between  sister  cells  with  respect  to  the  time  since  their  last  division  
(Figure  4-6d).  Shortly  after  division  (<12  hours),  sister  cells  had  comparable  aggrecan  
and  GAPDH  levels  (Figure  4-6e-f,  Figure  4-7a-b),  suggesting  symmetric  partitioning  of  
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Figure  4-6:  Marker  expression  heterogeneity  emerges  shortly  after  cell  division.a-c)  Gene  expression  
in  small  MSC  colonies.  a)  Colony  formation  scheme.  b-c)  Aggrecan  and  GAPDH  expression  in  four  colonies  
established  from  a  single  donor  (n  =  75  cells  in  colony  A,  7  cells  in  colony  B,  6  cells  in  colony  C,  8  cells  in  
colony  D).  d)  Live-cell  tracking  scheme  to  identify  sister  cell  pairs  at  various  times  post-cell  division.  e-f)  
Divergence  in  aggrecan  gene  expression  between  sister  cells  as  a  function  of  time  since  last  division  (n  =  81  
sister  cell  pairs,  ***  indicates  p<0.001,  see  Appendix  2  Supplementary  Table  5  for  all  comparisons).  
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RNA.  However,  after  more  than  ~12  hours  since  division,  sister  cells  showed  
increasingly  divergent  levels  of  aggrecan  and  GAPDH  expression  (Figure  4-6e-f,  Figure  
4-7a-b,  Appendix  2  Supplementary  Table  6).  Within  cell  pairs,  aggrecan  and  GAPDH  
divergence  only  weakly  correlated,  suggesting  that  the  relative  difference  between  sister  
cells  was  not  globally  regulated,  underscoring  the  fact  that  aggrecan  and  GAPDH  do  not  
necessarily  change  together  (Figure  4-7c-d).  These  findings  may  reflect  a  difference  in  
cell  function  as  a  consequence  of  asymmetric  cell  division  (i.e.  sister  cells  have  different  
target  expression  levels)  or  could  simply  identify  how  asynchronous  dynamic  fluctuations  
lead  to  temporal  differences  in  expression  level.  In  either  case,  these  differences  
suggest  that  a  sorted  population  of  high  aggrecan  cells  would  not  remain  so  for  more  
than  a  couple  days,  and  may  explain  why,  at  the  single  cell  level,  cells  with  high  
aggrecan  RNA  expression  are  not  necessarily  the  cells  with  the  greatest  amount  of  
matrix  deposition.  

Marker genes do not identify a chondrocyte phenotype
While  aggrecan  gene  expression  did  not  correlate  with  matrix  deposition  in  MSCs,  it  is  a  
canonical  feature  of  the  differentiated  chondrocyte  ‘phenotype’  and  is  widely  considered  
to  be  a  leading  indicator  of  cartilage-specific  extracellular  matrix  deposition  (e.g.  
aggrecan  core  protein)  7,134,221.  It  is  also  well  accepted  that,  upon  serial  passaging  and  
expansion  in  monolayer,  chondrocyte  matrix  production  decreases  along  with  a  multi-
fold  decrease  in  the  aggrecan/GAPDH  ratio  (Figure  4-8a)30,42,52,126,132.  This  change  in  
expression  is  associated  with  increases  in  cell  size  and  proliferation  rate  71,111,189.  To  
reconcile  our  finding  of  discordant  aggrecan  expression  and  matrix  deposition  in  MSCs  
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with  these  classical  experiments  that  define  the  chondrocyte  ‘phenotype’,  we  performed  
RNA  FISH  on  chondrocytes  that  were  serially  passaged  in  monolayer  to  induce  “de-
differentiation”  and  after  they  were  “re-differentiated”  in  3D  culture  (where  one  would  
expect  a  resumption  of  the  cartilage  phenotype)12,15.  

  
Figure  4-7:  Heritability  of  marker  copy  number  through  cell  division.  a-b)  Divergence  in  gene  
expression  between  sister  cells  as  a  function  of  time  since  their  last  division.  c)  Divergence  in  GAPDH  vs  
aggrecan  and  d)  osteopontin  vs  aggrecan  between  sister  cells  as  a  function  of  time  since  their  last  division.  
Box  hinges  denote  the  first  and  third  quartiles.  Whiskers  extend  from  the  hinges  to  the  most  extreme  data  
points  within  (1.5  *  interquartile  range)  of  the  hinges.    Means  compared  by  t-tests  with  Satterthwaite  
approximation  and  simulated  adjustment  for  multiple  comparisons,  ***  indicates  p<0.001,*  p<0.05.  See  
Appendix  2  Supplementary  Table  6  for  all  statistical  comparisons.  n  =  81  sister  cell  pairs.  
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Figure  4-8  (previous  page):  Chondrocyte  de-differentiation  and  re-differentiation  are  not  driven  by  
altered  absolute  aggrecan  expression. a)  Chondrocyte  de-differentiation  and  re-differentiation  scheme.  b-
f)  Analysis  of  chondrocytes  de-differentiating  with  passage  in  monolayer  culture.  b)  RNA  FISH  counts  of  
aggrecan  pooled  over  the  population  and  normalized  to  GAPDH  expression.  c)  Absolute  aggrecan  
expression  with  passage  number.  d)  Absolute  GAPDH  expression  with  passage  number  (n  =  39-113  cells  
per  donor  per  passage).  e-f)  Chondrocyte  suspended  cell  volume  (e)  and  morphology  (f)  with  passage  (n  =  
274-543  cells  per  donor  per  passage).  g-j)  Analyses  of  early  passage  (P0)  and  late  passage  (P5)  
chondrocytes  re-differentiating  in  3D  culture.  g)  Alcian  blue  staining  after  1  and  14  days  of  3D  culture.  h)  
Absolute  aggrecan  expression.  i)  Absolute  GAPDH  expression.  j)  Single  cell  aggrecan  expression  
normalized  to  GAPDH  expression.  (n  =  46-65  cells  per  donor  per  condition).  Narrow  bars  represent  the  
mean  within  an  individual  donor;;  overlaid  bars  represent  the  mean  across  donors.  Error  bars  indicate  
standard  error;;  *  indicates  p<0.05,  **  indicates  p<0.01  and  ***  indicates  p<0.001,  see  Appendix  2  
Supplementary  Table  7  and  Supplementary  Table  8  for  all  comparisons).    
  

For  dedifferentiation  studies,  we  serially  passaged  chondrocytes  nine  times  in  monolayer  
with  analysis  at  every  other  passage  via  RNA  FISH.  Consistent  with  classical  findings  
12,205

,  the  normalized  ratio  of  aggrecan  to  GAPDH  expression  level  decreased  with  

passage  number  (Figure  4-8b).  However,  and  quite  surprisingly,  this  change  was  not  
due  to  a  decrease  in  absolute  aggrecan  copy  number  (Figure  4-8c).  Rather,  aggrecan  
copy  number  showed  a  small  but  significant  increase  from  passage  0  (initial  plating)  to  
passage  1,  before  returning  to  passage  0  mean  copy  number  at  later  passages.  In  
contrast,  there  was  a  rapid  increase  in  mean  GAPDH  copy  number  over  the  first  
passage  (increasing  ~4  fold)  that  remained  at  these  elevated  levels  through  additional  
passages  (Figure  4-8d).  Previous  studies  from  our  group  have  shown  that  global  
transcription  (including  expression  of  GAPDH  and  many  other  abundant  “house-keeping”  
genes)  correlates  with  and  can  be  dictated  by  cell  size  38.  We  also  found  that  
chondrocyte  spread  cell  area  generally  increased  with  passage  number  (Figure  4-8f,  
Figure  4-9)  and  that  the  mean  volume  of  suspended  cells  increased  by  ~3-fold  between  
primary  isolation  (passage  0)  and  passage  5  (Figure  4-8e).  Taken  together,  these  
findings  suggest  that  aggrecan  expression  does  not  decrease  with  chondrocyte  de-  
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Figure  4-9:  Chondrocyte  morphology  with  passage  number.  Chondrocyte  spread  area  with  increasing  
passage  number  during  de-differentiation  (n  =  25-27  cells  per  donor  per  condition).  Narrow  bars  represent  
the  mean  within  an  individual  donor;;  overlaid  bars  represent  the  mean  across  donors.  Error  bars  indicate  
standard  error.  Compared  via  one-way  ANOVA  with  Tukey  post-hoc  test,  ***  indicates  p<0.01.  

  
differentiation  and  does  not  correlate  with  chondrocyte  functional  potential  at  the  
population  level.  Instead,  normalization  to  housekeeping  genes  obscures  relatively  minor  
changes  in  aggrecan  gene  expression  that  occurs  during  chondrocyte  “de-
differentiation”.  These  single  cell  data  suggest  that  canonical  markers  of  the  chondrocyte  
phenotype  do  not  accurately  describe  the  molecular  profile  of  de-differentiation.      
To  further  explore  how  normalization  may  confound  our  interpretation  of  gene  
expression  changes,  we  forced  the  re-differentiation  of  culture-expanded  chondrocytes  
that  had  lost  their  ‘phenotype’.  To  do  so,  we  encapsulated  chondrocytes  at  early  and  late  
passage  (passage  0  and  5,  respectively)  in  3D  agarose  hydrogels,  and  monitored  matrix  
synthesis  and  gene  expression  over  two  weeks  via  Alcian  blue  staining  and  RNA  FISH  
(Figure  4-8a).  Consistent  with  classical  studies  12,15,  early  passage  chondrocytes  
produced  matrix  robustly  upon  encapsulation,  while  late  passage  (de-differentiated)  
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chondrocytes  showed  a  significant  attenuation  in  matrix  deposition  (Figure  4-8g).  RNA  
FISH  showed  that  after  1  day  of  agarose  culture,  late  passage  chondrocytes  expressed  
more  aggrecan  and  more  GAPDH  than  early  passage  chondrocytes  (Figure  4-8h-i).  
Over  14  days,  mean  aggrecan  levels  were  maintained  in  early  passage  cells,  but  
decreased  in  late  passage  cells.  In  keeping  with  our  findings  in  monolayer,  the  
aggrecan/GAPDH  ratio  was  strongly  influenced  by  changes  in  GAPDH  (Figure  4-8j).  
These  data  further  support  the  finding  that  absolute  changes  in  aggrecan  expression  
levels  are  not  responsible  for  the  loss  of  phenotype  observed  in  serially  passaged  
chondrocytes.  

Discussion	
  
In  this  work,  quantitative  single  cell  analysis  of  gene  expression  provided  evidence  that  
the  abundance  of  mRNA  markers  is  only  weakly  linked  to  the  chondrogenic  phenotype  
of  cartilage  and  progenitor  cells.  Specifically,  we  found  that  both  MSCs  and  
chondrocytes  exhibited  rampant  transcriptional  heterogeneity.  This  observation  was  not  
altogether  surprising  for  MSCs,  given  that  a  single  MSC  population  is  comprised  of  a  
heterogeneous  pool  of  related  but  distinct  clonal  populations.  However,  the  
transcriptional  heterogeneity  within  individual  MSC  colonies  suggested  that  this  overall  
population  heterogeneity  is  not  entirely  due  to  the  mixing  of  clonal  populations  of  varying  
potency,  but  instead  likely  arose  from  random  transcriptional  processes.  While  such  
heterogeneity  may  confound  the  interpretation  of  ensemble  measurements,  if  this  
variation  reflected  intrinsic  differences  in  differentiation  capacity  or  differentiated  state,  
then  it  might  be  harnessed  toward  a  productive  end.  That  is,  cell  sorting  based  on  this  
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variability  could  enable  selection  of  ‘superior’  sub-populations  for  therapeutic  
applications.  For  example,  the  expression  of  ‘stemness  markers’  such  as  SOX2118,  
OCT4106  and  NANOG116  can  distinguish  pluripotent  cells  from  larger  heterogeneous  
populations,  and  the  expression  of  an  early  osteogenic  marker  enables  enrichment  of  
the  stromal  vascular  fraction  for  osteogenic  cells138.    
However,  our  data  show  that  for  naive  MSCs,  neither  genome-wide  transcriptional  
metrics  nor  the  transcriptional  abundance  of  MSC  stemness  and  chondrogenic  markers  
correlate  with  the  ultimate  functional  capacity.  Strikingly,  the  most  predictive  genes  
(aggrecan  and  MMP13)  were  negatively  associated  with  chondrogenic  capacity,  
potentially  suggesting  that  high  transcriptional  promiscuity  in  naive  MSCs  reflects  an  
inability  to  undergo  robust  lineage  commitment.  Furthermore,  our  single  cell  studies  
showed  that  while  naïve  MSCs  and  chondrocytes  represent  opposite  ends  of  the  
differentiation  spectrum,  their  absolute  expression  of  canonical  differentiation  markers  
largely  overlapped.  When  we  monitored  gene  expression  and  cartilage-like  matrix  
accumulation  simultaneously  on  a  cell-by-cell  basis,  marker  expression  taken  at  a  single  
time  point  only  weakly  associated  with  cell  output  of  extracellular  matrix.  Thus,  we  
conclude  that  marker  expression  would  only  enable  a  slight  enrichment  of  the  population  
(~35%  increase  in  high  performing  cells  over  the  unsorted  population)  while  drastically  
restricting  available  cell  number  for  therapeutic  application.  
One  possible  explanation  of  the  disconnect  between  an  individual  cell’s  transcript  
abundance  and  differentiated  state  is  that,  for  many  genes,  transcription  is  a  stochastic  
process  comprised  of  long  ‘silent’  periods  punctuated  by  short  transcriptional  
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bursts33,72,176,177,209,236.  Bursting  kinetics  are  strongly  dependent  on  both  the  gene  in  
question  and  the  stimulus  that  is  applied  41,159,177,209,  along  with  position  in  cell  cycle  and  
cell  volume  160,237.  For  instance,  stimulation  (e.g.  TGFβ)  can  induce  a  synchronized  initial  
burst  of  target  gene  expression,  but  subsequent  bursts  are  typically  asynchronous  
20,68,150,195

.  Thus,  two  cells  with  fluctuating  but  equivalent  gene  expression  over  time  may  

exhibit  different  copy  number  when  sampled  at  a  single  time  point.  As  recently  reported  
112,150

,  the  rate  of  fluctuation  (slow  vs.  fast)  of  a  single  gene  manifests  in  the  

heterogeneity  observed  between  and  within  small  clonal  clusters.  Our  findings  of  high  
intra-colony  variability  and  sister  cell  divergence  in  MSCs  suggest  that  marker  copy  
number  fluctuates  rapidly  over  a  short  timescale.  As  a  result,  absolute  marker  gene  
expression  is  not  strongly  heritable  in  MSCs,  and  we  speculate  that  cells  sorted  on  the  
basis  of  such  expression  will  undergo  transcriptional  shifts  over  time  and  with  further  
population  expansion.  In  other  systems,  such  stochastic  variation  in  gene  expression  not  
only  marks  but  can  also  determine  cell  fate  31,51,133,175,178,207,225.  Here,  it  is  surprising  that  
for  aggrecan,  a  gene  whose  product  plays  such  a  critical  role  in  the  extracellular  matrix,  
such  emergent  heterogeneity  in  transcript  abundance  does  not  appear  to  reflect  true  
variation  in  potency.  
The  disconnect  between  expression  and  functional  capacity  (matrix  accumulation)  may  
also  reflect  the  time  history  of  the  system  and  the  influence  of  other  regulatory  
mechanisms.  Aggrecan  core  protein  undergoes  co-  and  post-translational  modifications,  
and  may  be  subject  to  processing  or  secretory  errors  130,221.  It  may  be  that  not  every  cell  
that  produces  core  protein  can  appropriately  modify  the  core  and  secrete  it  into  the  
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extracellular  space.  Further,  integration  and  retention  of  aggrecan  core  protein  within  the  
extracellular  matrix  relies  on  association  with  the  hyaluronic  acid  and  collagen  network  
and  other  molecules  108,221,  and  even  aggrecan  that  has  been  integrated  into  the  
established  matrix  may  ultimately  be  degraded  by  aggrecanases  produced  locally  25.  
Deficiencies  in  any  of  these  steps  could  decouple  even  temporally-constant  aggrecan  
mRNA  expression  from  aggrecan  core  protein  accumulation  in  the  pericellular  space.  
However,  our  transcriptome-wide  data  suggest  that  there  is  not  a  transcript  level  
correlation  between  functional  capacity  and  any  of  the  genes  involved  in  these  
processing  steps.  
Collectively,  our  findings  in  MSCs  show  that  instantaneous  aggrecan  expression  is  only  
tenuously  connected  to  matrix  deposition.  Moreover,  differentiation  of  these  cells  fails  to  
recapitulate  the  potential  of  native  chondrocytes  and  does  not  prevent  the  expression  of  
markers  of  alternate  lineages  even  at  the  single  cell  level.  Our  finding  that  chondrocyte  
expression  of  aggrecan  does  not  decrease  with  dedifferentiation  also  supports  this  weak  
connection,  and  raises  questions  as  to  the  role  of  marker  gene  expression  in  defining  
phenotype.  While  aggrecan  is  one  of  the  most  conventional  markers  for  the  cartilage  
phenotype,  its  absolute  expression  did  not  correlate  with  cartilage-like  matrix  production  
and  did  not  change  as  cells  ‘de-differentiated’.  If  aggrecan  expression  does  not  change,  
other  elements  of  the  cell  must  be  responsible  for  shifting  cell  fate  and  altering  the  
transcriptional  ‘focus’  of  the  cell.  Here,  our  finding  of  major  shifts  in  GAPDH  with  minor  
changes  in  aggrecan  during  de-differentiation  suggest  that  de-differentiation  may  be  
better  characterized  as  a  shift  in  cell  focus  rather  than  a  loss  in  specific  programmatic  
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expression  of  marker  genes.  While  it  is  not  yet  clear  what  cell-wide  changes  drive  this  
process,  future  work  utilizing  transcriptomics  may  identify  a  more  comprehensive  set  of  
markers  that  are  predictive  of  differentiated  cell  function.  Until  phenotype  and  its  basis  in  
gene  expression  are  more  precisely  defined,  our  results  suggest  that  it  may  be  
ineffective  to  design  therapies  that  seek  to  bolster  phenotype  by  increasing  expression  
of  individual  genes  or  regulating  transcriptional  control  of  individual  promoter  regions,  
even  for  those  genes  whose  products  are  directly  related  to  functional  matrix  assembly.  
Simply  increasing  the  raw  RNA  signal  available  to  the  cell  may  be  insufficient,  and  it  may  
also  be  necessary  to  alter  the  transcriptional  context  in  which  this  occurs.  These  findings  
challenge  the  traditional  notion  that  marker  gene  expression  defines  or  is  even  strongly  
associated  with  the  chondrocyte  phenotype,  and  identify  new  directions  in  progenitor  cell  
biology  to  establish,  enforce,  and  select  subpopulations  for  therapeutic  application.  

Methods	
  
Cell Isolation and Expansion
MSCs  were  isolated  from  the  tibial  and  femoral  bone  marrow  of  juvenile  bovine  cows  (3–
6-months,  Research  87,  Boylston,  MA)  and  expanded  in  a  basal  media  consisting  of  
high  glucose  DMEM  with  10%  FBS  and  1x  antibiotic-antimycotic.  After  the  initial  plating  
reached  ~80%  confluence,  cells  were  passaged  at  a  ratio  1:3  before  use  in  experiments.  
For  single  cell  derived  colonies,  bovine  MSCs  were  isolated  as  described  above  and  
seeded  sparsely  onto  glass  coverslips.  Individual  colonies  were  allowed  to  expand  for  3  
days  in  basal  media,  followed  by  4  days  in  chondrogenic  induction  media  prior  to  
fixation.  All  cells  in  each  colony  were  manually  located  and  imaged  as  described  below.  
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Chondrocytes  were  isolated  from  articular  cartilage  from  the  trochlear  groove  of  juvenile  
bovine  knees.  Cartilage  was  digested  in  basal  media  supplemented  with  type  II  
collagenase  (0.5  mg/mL,  Sigma-Aldrich)  for  up  to  18h.  Isolated  cells  were  filtered,  
washed,  and  plated  in  basal  media.  To  improve  cell  yield  for  chondrocyte  re-
differentiation  studies,  cartilage  was  also  digested  in  basal  media  with  pronase  (2.5  
mg/mL,  Calbiochem)  for  1h  prior  to  collagenase  digestion.  For  all  studies,  chondrocytes  
were  expanded  in  basal  media  and  passaged  1:10  when  plates  reached  ~80%  
confluence.  

Cell Encapsulation
For  3D  culture,  MSCs  (passage  2)  or  chondrocytes  (passage  0  and  passage  5)  were  
encapsulated  in  2%  agarose  micro-gels  at  a  density  of  2  million  cells/mL.  Molten  4%  w/v  
agarose  (type  VII,  Sigma,  44  °C)  was  mixed  1:1  with  cells  suspended  in  media  and  
pipetted  into  small  drops  in  a  well  plate.  Round  coverslips  were  placed  on  top  of  the  
molten  drops  to  spread  the  mixture  before  the  gel  solidified,  resulting  in  the  formation  of  
uniform  micro-gels  that  were  10-12  mm  in  diameter  (depending  on  coverslip  diameter)  
and  ~400  μm  thick.  Coverslips  were  removed  from  the  micro-gels  prior  to  culture.  Micro-
gels  were  supplied  with  fresh  medium  every  three  days  and  24  hours  before  collection.  
MSC  micro-gels  were  maintained  in  a  chemically  defined  media  consisting  of  high  
glucose  DMEM  supplemented  with  1x  antibiotic-antimycotic,  40  ng/mL  dexamethasone,  
50  μg/mL  ascorbate  2-phosphate,  40  μg/mL  L-proline,  100  μg/mL  sodium  pyruvate,  1.25  
mg/mL  bovine  serum  albumin,  5.35  μg/mL  linoleic  acid  and  1×  insulin–transferrin–
selenous  acid  premix  (Corning  CB-40350),  either  with  or  without  10  ng/mL  TGFβ3  (R&D  
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Systems)144.  Chondrocyte  micro-gels  were  cultured  in  basal  media  (high  glucose  DMEM  
+  10%  FBS  +  1x  antibiotic-antimycotic)  supplemented  with  50  μg/mL  ascorbate  2-
phosphate.  At  defined  time  points,  gels  were  fixed  for  30  minutes  in  paraformaldehyde  
(PFA)  and  stored  in  70%  ethanol  at  4°C.  
Cell  viability  in  gels  was  assessed  using  the  LIVE/DEAD  Cell  Viability  Assay  Kit  
(Molecular  Probes  L-3224).  A  custom  Matlab  script  quantified  the  number  of  live  
(calcein-AM  positive)  and  dead  (ethidium-homodiner-1  positive)  cells  in  three  4X  fields  of  
view  per  micro-gel.  To  assess  viability  in  conjunction  with  RNA  FISH,  a  fixable,  amine-
binding  green  fluorescent  dead  cell  stain  (Molecular  Probes  L-23101)  was  employed.  
For  fixable  dead  staining,  micro-gels  were  washed  with  PBS,  stained  for  30  minutes  in  a  
1:5000  dilution  in  PBS,  washed  with  PBS  again,  and  then  fixed  in  PFA  prior  to  RNA  
FISH  analysis,  as  described  below.  

Chondrogenic Pellet Culture and Biochemical Content
Clonally  derived  passage  2  MSCs  were  formed  into  cell-rich  pellets  via  centrifugation  
(200,000  cells/pellet)  and  cultured  in  chondrogenic  induction  media  with  TGFβ  for  21  
days61.  Pellets  were  papain-digested  and  biochemically  assayed  for  glycosaminoglycan  
(GAG)  and  DNA  content  using  via  the1,9-dimethylmethylene  blue  and  Picogreen  
(Molecular  Probes,  Eugene,  OR)  assays,  respectively61.  

Live Cell Imaging and Tracking
To  investigate  mRNA  levels  as  a  function  of  the  time  history  of  division,  passage  2  
MSCs  were  seeded  into  two-well  LabTek  chambered  coverglass  dishes  (Fisher  
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Scientific)  and  cultured  in  chondrogenic  induction  media  with  TGFβ  for  4  days.  Seeded  
cells  were  supplied  with  fresh  medium  every  3  days  and  24  hours  before  fixation.  Over  
the  last  3  days  of  culture,  live  cells  were  imaged  using  a  Nikon  Ti-E  microscope  with  a  
custom  environmental  chamber.  Transmitted  light  images  were  automatically  acquired  
every  30  minutes  over  a  period  of  70  hours  using  a  10X  air  objective  over  a  289-image  
grid  in  each  well  of  the  two-well  coverglass.  Cell  division  was  tracked  manually  using  
ImageJ,  and  matched  to  the  corresponding  RNA  FISH  quantification  that  followed.    

RNA Fluorescence In-Situ Hybridization and Imaging
Single  molecule  RNA  FISH  was  performed  on  samples174.  Micro-gels  and  monolayer  
cells  were  fixed  in  PFA  and  permeabilized  with  70%  ethanol  before  in  situ  hybridization  
was  performed  using  the  specified  pools  of  oligonucleotides.    Monolayer  and  micro-gel  
samples  were  simultaneously  co-stained  with  oligonucleotide  probes  for  osteopontin  
labeled  with  Cy3,  lipoprotein  lipase  labeled  with  Alexa  594,  aggrecan  labeled  with  Atto  
647N,  and  GAPDH  labeled  with  Atto700  (Stellaris  oligonucleotides,  Biosearch  
Technologies).  See  Appendix  3  for  a  complete  list  of  sequences  of  oligonucleotide  
probes  used  in  this  study.  Subsequently,  samples  were  washed  with  2x  saline  sodium  
citrate  buffer  (SSC)  with  10%  formamide  (Ambion),  and  then  2x  SSC  supplemented  with  
DAPI  (Molecular  Probes  D3571)  to  stain  the  cell  nuclei.  Monolayer  cells  cultured  in  
coverglass  chambers  were  submerged  in  2x  SSC  for  imaging.  Micro-gels  were  mounted  
in  2x  SSC  and  compressed  between  a  coverglass  and  slide  for  imaging.  Cells  in  the  
micro-gel  and  small  colonies  were  imaged  using  a  Leica  DMI600B  automated  widefield  
fluorescence  microscope  equipped  with  a  100x  Plan  Apo  objective,  a  Pixis  1024BR  
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cooled  charge-coupled  device  (CCD)  camera,  a  Prior  Lumen  220  light  source,  and  filter  
sets  specific  for  each  fluorophore.  Images  in  each  fluorescence  channel  were  taken  as  a  
series  of  optical  z-sections  (0.5-0.7  microns  per  section)  spanning  the  vertical  extent  of  
each  cell.  To  prevent  differences  in  viability  between  conditions  from  confounding  
interpretation  of  single-cell  gene  expression,  the  fixable  dead  cell  stain  was  used  to  
establish  a  GAPDH  copy  number  of  >  10  mRNA  as  a  threshold  to  identify  live  cells  for  
inclusion  in  further  analysis  (Figure  4-2d).  When  this  FISH  analysis  was  applied  to  live-
imaged  cells,  single  plane  scans  were  performed  using  a  Nikon  Ti-E  microscope  with  a  
63x  Plan  Apo  objective.    

Quantification of Copy Number from RNA FISH Images
Upon  collecting  images  of  RNA  FISH  samples,  cell  boundaries  were  manually  identified  
and  RNA  spots  were  counted  and  localized  using  custom  software  written  in  MATLAB174.  
For  spot  counting  in  FISH  images  from  live  cell  tracking,  each  cell  was  tracked  through  
the  acquired  time  series,  and  sister  cells  manually  matched,  with  care  taken  to  note  the  
time  since  last  division.    

Quantification of Extracellular Matrix Deposition
Extracellular  aggrecan  protein  content  was  quantified  by  immunostaining.  Briefly,  after  
the  final  wash  stages  of  the  FISH  protocol,  samples  were  incubated  with  primary  
antibody  (Abcam  ab3778,  1:50  in  PBS)  at  4oC  overnight,  washed  for  30  minutes  in  PBS,  
incubated  with  Alexa  488  secondary  antibody  (Invitrogen,  1:200  in  PBS)  at  room  
temperature  for  1  hour,  washed  with  PBS  for  30  minutes,  and  then  mounted  for  imaging.  
For  immunofluorescence  images,  a  scorer  blinded  to  the  RNA  FISH  images  examined  
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the  DAPI,  GFP  (aggrecan  core  protein),  and  transmitted  light  images  to  classify  cells  
with  and  without  extracellular  aggrecan  core  protein  staining.    
Receiver  operating  characteristic  curves  were  constructed  and  analyzed  using  the  
pROC  package  in  R181.  Matrix  deposition  (high  vs.  low)  was  used  as  the  binary  outcome,  
and  sensitivity  and  specificity  were  calculated  for  possible  thresholds  of  RNA  copy  
number,  a  linear  combination  of  RNA  counts,  and  RNA  ratios.  To  construct  the  linear  
combination,  the  data  sets  corresponding  to  each  batch  (Batch  1:  Donors  D-F,  assayed  
for  aggrecan,  osteopontin,  LPL,  GAPDH;;  Batch  2:  Donors  X-Z,  assayed  for  COMP,  
Sox9,  and  GAPDH)  were  randomly  split  in  half  to  create  training  and  test  data  sets,  to  be  
used  for  model  construction  and  evaluation  respectively.  Logistic  regression  was  
performed  using  glm  in  R,  and  non-significant  terms  were  dropped.  For  batch  1,  the  final  
model  was  established  as  (Equation  1):  

ln

𝜋$
= 𝛽)*)+ 𝑎𝑔𝑔𝑟𝑒𝑐𝑎𝑛2 − 	
   𝛽45+ 𝑜𝑠𝑡𝑒𝑜𝑝𝑜𝑛𝑡𝑖𝑛2 − 1.52	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  (1)	
    
1 − 𝜋$

where  𝜋$ ,  the  estimated  probability  of  the  i-th  cell  having  high  matrix  staining,  was  a  
function  of  the  cell’s  aggrecan  and  osteopontin  expression.  Aggrecan  associated  
positively  (βACAN  =  0.003,  p<0.001),  while  osteopontin  associated  negatively  (βOPN  =  -
0.001,  p=0.05);;  other  markers  were  not  significantly  associated  with  matrix  deposition.  
For  batch  2,  the  intercept  was  the  only  significant  term  and  the  model  was  not  further  
analyzed.  Having  established  this  model  on  the  training  data  set,  its  predictive  
performance  was  evaluated  by  constructing  an  ROC  curve  of  the  model  applied  to  the  
test  data  set.    
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RNA sequencing
Poly-adenylated  RNA  from  passage  1  clonal  MSCs  populations  were  isolated  from  
monolayer  culture  in  basal  media.  The  Qiagen  miRNeasy  kit  was  used  for  RNA  isolation,  
the  NEBNext  Poly(A)  mRNA  Magnetic  Isolation  Module  was  used  for  selection  of  poly-
adenylated  transcripts,  and  NEB  Next  Ultra  Library  Preparation  Kit  for  Illumina  was  used  
for  library  preparation.  Each  sample  was  sequenced  with  50  bp  single-end  reads  on  an  
Illumina  HiSeq  and  to  a  depth  of  15–25M  reads.  Reads  were  aligned  to  bosTau7  using  
STAR47.  Reads  per  gene  were  quantified  using  HTSeq  and  a  RefSeq  bosTau7  from  
annotation  release  103  4.  FPKM  (fragments  per  kilobase  of  transcript  per  million  mapped  
reads)  for  each  gene  was  calculated  using  R.    

Cell Volume and Area Measurements
Chondrocyte  area  was  measured  in  ImageJ  by  manually  tracing  images  of  phalloidin-
stained  cells  sparsely  plated  onto  glass  coverslips.  Chondrocyte  suspended  cell  volumes  
were  computed  from  the  cell  radii  measured  by  an  automatic  cell  counter  (Nexcelom  
Cellometer)  for  chondrocytes  in  solution  during  passaging  (immediately  following  
trypsinization).  

Alcian Blue Staining
Micro-gels  were  removed  from  70%  ethanol  and  equilibrated  in  3%  acetic  acid  for  30  
minutes  at  room  temperature.  Gels  were  then  transferred  to  Alcian  blue  solution  (pH  1.0,  
Rowley  Biochemical)  for  30  minutes,  washed  three  times  in  acid  alcohol  (1%  
hydrochloric  acid  in  70%  ethanol)  for  30  minutes,  and  then  washed  in  PBS  for  30  
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minutes  before  imaging.  For  macroscopic  images,  gels  were  photographed  using  a  
Ricoh  photocopier  and  digital  camera.  For  microscopic  images,  micro-gels  were  
mounted  in  PBS  and  compressed  between  a  coverglass  and  slide.  Images  were  taken  at  
10x  using  a  Nikon  Eclipse  Ni-E  motorized  upright  microscope.    

Statistical Comparisons
To  compare  mean  single  cell  RNA  counts,  a  generalized  linear  mixed  model  with  a  log-
link  function  and  by-donor  random  intercepts  was  constructed.  For  MSC  RNA  counts,  
media  condition,  and  culture  duration  (with  interaction  term)  were  considered  fixed  
effects,  and  an  additional  by-donor  random  slope  effect  was  associated  with  media  (-
TGFβ  vs  +  TGFβ).  For  MSC  RNA  divergence,  time-since-division  was  considered  a  fixed  
effect.  For  chondrocyte  RNA  counts  during  dedifferentiation  in  monolayer,  passage  was  
considered  a  fixed  effect  and  was  also  associated  with  a  by-donor  random  slope.  For  
chondrocyte  RNA  counts  during  re-differentiation,  passage  and  culture  duration  (with  
interaction  term)  were  considered  fixed  effects,  and  an  additional  by-donor  random  slope  
effect  was  associated  with  passage.  In  each  model,  estimated  means  were  compared  
using  Satterthwaite-based  t-distributions  with  simulated  adjustment  for  multiple  
comparisons  (SAS  Studio  3.3).  Pooled  chondrocyte  aggrecan/GAPDH  expression  data  
were  compared  using  a  one-way  ANOVA  with  Tukey’s  post-hoc  test.  Chondrocyte  area  
and  volume  data  were  pooled  across  donors  and  compared  using  a  one-way  ANOVA  
with  Tukey  post-hoc  tests.  Sample  size  was  chosen  based  on  previous  experience  with  
these  assays.  Details  of  all  statistical  comparisons  are  provided  in  the  supplementary  
tables  included  in  Appendix  2.  
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Introduction	
  
In  tissues  throughout  the  body,  the  extracellular  matrix  (ECM)  guides  cell  phenotype  and  
imparts  mechanical  resilience  over  a  lifetime  of  load-bearing  use.  These  extracellular  
matrices  are  highly  dynamic,  and  change  in  both  structure  and  molecular  composition  as  
development  progresses,  and  with  aging  and  disease  processes.  In  articular  cartilage,  
the  ECM  transitions  from  a  fibronectin-rich  environment  in  early  development,  to  one  
dominated  by  aggrecan  and  collagen  II  at  tissue  maturity173.  Notably,  in  both  developing  
and  mature  cartilage,  matrix  synthesis  and  turnover  occur  continuously,  and  are  
requisite  for  tissue  homeostasis  152.  Unfortunately,  this  homeostasis  is  often  disturbed  by  
injury-  and  degeneration-induced  damage  to  the  cartilage  matrix  and  its  resident  cells.  
Such  damage  fails  to  intrinsically  heal,  and  has  prompted  the  development  of  
engineered  cartilage  replacements.    
In  the  context  of  cartilage  tissue  engineering,  chondrocytes  and  progenitor  cells  must  not  
only  create  matrix,  but  also  retain  and  assemble  it  in  the  pericellular  space.  The  rates  of  
ECM  production,  retention,  and  degradation  define  how  rapidly  an  engineered  construct  
can  mature.  Thus,  the  manner  in  which  the  matrices  produced  by  individual  cells  interact  
and  integrate  with  one  another  ultimately  defines  the  functional  properties  of  the  tissue  
that  forms  57,194.  Moreover,  just  as  the  in  vivo  ECM  influences  cell  phenotype  in  native  
tissue,  the  structure  and  composition  of  the  matrix  in  these  in  vitro  constructs  regulates  
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the  extent  and  progression  of  chondrogenesis  21.    Thus,  heightened  understanding  of  
matrix  protein  synthesis  and  remodeling  is  relevant  to  contexts  spanning  development,  
disease,  and  tissue  engineering.    
Towards  the  quantification  matrix  dynamics,  ECM  formation  can  be  monitored  via  bulk  
biochemical  measures  across  time  and  disease  state.    However,  such  ensemble  
approaches  mask  cell-to-cell  variation  and  do  not  provide  information  regarding  the  
spatial  organization  of  the  matrix.  Alternatively,  autoradiography  with  radiolabeled  sulfate  
and  proline  can  provide  insight  into  the  localization  of  proteoglycans  and  collagens  
around  individual  cells,  and  has  demonstrated  temporal  changes  in  the  rate  and  spatial  
distribution  of  secreted  matrix  19,171,172.  However,  this  approach  is  inherently  complicated  
by  its  use  of  radioisotopes.  Moreover,  the  punctate  pattern  of  autoradiographic  grains  
offers  limited  information  regarding  the  structure  and  organization  of  this  nascent  
extracellular  matrix.    
To  overcome  these  limitations,  we  introduce  the  use  of  a  metabolic  labeling  approach,  
functional  noncanonical  amino  acid  tagging  (FUNCAT),  to  enable  high  fidelity  fluorescent  
observation  of  nascent  extracellular  matrix  protein  accumulation  and  assembly.  
Previously,  FUNCAT  has  been  used  to  visualize  protein  synthesis  and  intracellular  
trafficking  in  cell  monolayers  10,45,215,234  ,  bacteria  135,  larval  zebrafish  83,  and  drosophila  
55

.  FUNCAT  relies  on  “residue-specific”  incorporation  of  non-canonical  amino  acids  

(ncAA)  into  proteins  as  they  are  synthesized  94.  While  many  ncAAs  exist  and  collectively  
offer  a  diverse  suite  of  functions,  the  ncAAs  utilized  in  FUNCAT  are  restricted  to  those  
that  contain  bio-orthogonal  functional  groups  that  can  be  detected  by  highly  selective  
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fluorescent  tags  following  ncAA  incorporation.  Operationally,  FUNCAT  ncAA  
incorporation  resembles  pulse  labeling:  a  canonical  amino  acid  (cAA)  is  removed  from  
the  environment,  and  is  replaced  with  a  corresponding  ncAA  10,94.  In  the  absence  of  the  
cAA,  the  endogenous  translation  machinery  of  the  cell  incorporates  the  ncAA  into  
proteins  during  synthesis,  yielding  global  incorporation  of  the  ncAA  across  the  nascent  
proteome  94.  This  strategy  contrasts  with  “site-specific”  ncAA  incorporation,  which  utilizes  
genetic  manipulation  to  substitute  ncAAs  in  targeted  locations,  and  more  advanced  
residue-specific  strategies  that  rely  on  engineered  biosynthetic  machinery  to  incorporate  
ncAA  94.    
In  this  study,  we  adapt  the  FUNCAT  technique  to  enable  the  fluorescent  visualization  of  
extracellular  matrix  proteins  in  both  native  cartilage  and  in  3D  engineered  constructs.  
Our  results  demonstrate  that  the  FUNCAT  method  enables  high  fidelity  labeling  of  
extracellular  matrix  proteins  throughout  the  time  course  of  matrix  formation  and  
homeostasis.    We  use  this  labeling  approach  to  query  cell-to-cell  heterogeneity  in  matrix  
formation  and  to  determine  how  the  density  of  the  microenvironment,  crosslinking  of  
nascent  ECM  proteins,  and  the  pre-established  ECM  influence  matrix  protein  distribution  
and  assembly  on  a  single  cell  basis  using  both  primary  chondrocytes  and  mesenchymal  
stem  cells  undergoing  chondrogenic  differentiation.      
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Results	
  
Methionine analogs enable the fluorescent labeling of extracellular matrix
proteins.
Current  implementations  of  FUNCAT  rely  on  the  substitution  of  the  cAA  methionine,  an  
amino  acid  that  comprises  between  0-6%  of  the  residues  in  ECM  proteins  (Figure  5-1a,  
Appendix  3).  For  example,  methionine  constitutes  1.1%  of  fibronectin  and  1.8%  of  
collagen  IV,  an  ECM  protein  found  primarily  in  basal  lamina.  For  articular  cartilage,  our  
tissue  of  interest,  methionine  represents  ~1%  of  the  amino  acid  content  16,99,  with  similar  
relative  abundance  amongst  the  major  cartilage  ECM  constituents  collagen  II  (1.08%)  
and  aggrecan  core  protein  (0.54%).  In  the  present  work,  we  separately  considered  
labeling  with  two  bio-orthogonal  methionine  analogs:  homopropargylglycine  (HPG)  and  
azidohomoalanine  (AHA)45.  These  analogs  are  structurally  and  functionally  similar  to  
native  methionine,  but  include  an  alkyne  and  azide  side  chain  respectively.  
To  assess  the  ability  of  HPG  and  AHA  to  identify  nascent  ECM  proteins,  we  first  cultured  
chondrocytes  in  thin  (~400  µm  thickness)  2%  agarose  gels  for  9  days  in  the  absence  of  
native  methionine  and  the  continuous  presence  of  either  HPG  or  AHA.    Following  HPG  
or  AHA  culture  and  sample  fixation,  we  identified  incorporated  HPG  and  AHA  by  
labelling  alkyne  or  azide  residues  with  fluorescent  azide  or  alkyne  tags,  respectively,  via  
a  copper-catalyzed  azide-alkyne  cycloaddition  (“click”)  reaction.  This  staining  procedure  
fluorescently  and  covalently  labeled  proteins  synthesized  in  the  presence  of  each  ncAA,  
and  was  combined  with  additional  fluorescent  staining  to  identify  the  cell  nuclei  as  well  
as  the  cell  membrane  (to  distinguish  intracellular  proteins  from  extracellular  matrix    
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Figure  5-1  (previous  page):  HPG  labeling  enables  high  fidelity  visualization  of  the  extracellular  
matrix.  (a)  Percentage  methionine  content  of  361  extracellular  matrix  proteins,  ordered  by  relative  
methionine  abundance.  (b,  c)  Confocal  cross  section  of  a  chondrocyte  cultured  in  agarose  and  continuously  
labeled  with  HPG  for  9  days.  (d,  e)  3D  reconstruction  of  5  µm  confocal  stacks  taken  near  the  cell  midplane  
(d)  and  below  the  cell  (e)  of  day  9  chondrocytes.  Color  indicates  vertical  position  in  the  stack.  (f)  Alcian  blue  
staining  of  constructs  cultured  in  control  media  with  native  methionine  and  labeling  media  containing  HPG.  
(g)  Schematic  illustrating  microcompression  to  assess  extracellular  matrix  mechanics.  (h)  Percent  increase  
in  cellular  aspect  ratio  following  compression.  Bars  represent  mean  ±  SEM  (n=40  cells/group,  compared  via  
ANOVA  with  Tukey’s  post  hoc  test).  i)  Schematic  illustrating  radial  profile  quantification  of  extracellular  HPG  
labeling.  (j,  k)  Images  and  radial  profile  quantification  of  simultaneous  collagen  II  immunostaining  and  HPG  
labeling.    (l,  m)  Images  and  radial  profile  quantification  of  simultaneous  aggrecan  immunostaining  and  HPG  
th
th
labeling.    For  (k)  and  (m),  lines  represent  median  intensity  profile,  shaded  areas  represent  25   to  75   
percentiles  (n  =  20  cells/group).  

  
components).  Stained  gels  were  whole-mounted  and  imaged  via  confocal  microscopy  at  
high  magnification  (40-100X).    Scans  across  the  surface  and  through  the  depth  
suggested  that  labeling  intensity  was  uniform  throughout  the  gel  (Figure  5-2).  Individual  
cells  exhibited  extensive  extracellular  staining  that  had  a  clear  fibrous  structure  (Figure  
5-1b-e).  Near  the  cell  midplane  (Figure  5-1b-d),  densely  packed  HPG-tagged  proteins  
extended  outward  from  the  cell  body,  forming  a  mesh-like  structure.  Labeled  proteins  
often  undulated  through  multiple  z-planes,  emphasizing  the  3D  nature  of  forming  ECM.  
Below  the  cell  (Figure  5-1e),  protein  was  more  loosely  organized  and  fibrous  structures  
were  vertically  oriented  towards  the  cell  body.  The  labeling  patterns  of  HPG  and  AHA  
were  similar  (Figure  5-3),  and  so  HPG  was  utilized  for  the  remainder  of  the  studies.  
Control  samples  cultured  with  native  methionine  instead  of  HPG  showed  minimal  click  
reaction  staining,  confirming  that  the  labeling  is  highly  specific,  with  minimal  off-target  
binding  or  labeling  (Figure  5-4).  
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Figure  5-2:  Large  area  scans  confirm  uniform  labeling  across  gel.  Chondrocytes  in  agarose,  cultured  in  
HPG  labeling  media  for  9  days.  Scan  taken  at  40X,  ~  50  μm  into  the  gel.  
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Figure  5-3:  Matrix  labeling  with  azidohomoalanine  (AHA).  Mid-plane  confocal  cross-section  of  a  
chondrocyte  cultured  in  AHA  labeling  media  for  7  days  and  tagged  with  Alexa  Fluor  594-alkyne.  

  
Figure  5-4:  Fluorescent  tagging  of  HPG  is  highly  specific.  Mid-plane  confocal  cross-sections  of  two  
chondrocytes,  cultured  in  either  labeling  media  (with  HPG,  left)  or  control  methionine  media  (no  HPG,  right)  
for  9  days,  and  fluorescently  tagged  with  488-azide.  
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To  confirm  that  the  substitution  of  methionine  with  HPG  did  not  impact  matrix  
accumulation,  we  compared  gels  cultured  for  9  days  in  either  labeling  media  (with  HPG)  
or  control  media  (with  native  methionine).  Matrix  accumulation,  marked  by  Alcian  blue  
staining  of  histological  sections,  was  similar  between  the  labeling  and  control  groups  
(Figure  5-1f).  Furthermore,  HPG  incorporation  did  not  alter  the  mechanical  function  of  
the  formed  matrix.  We  performed  microcompression  testing  to  monitor  matrix  stress  
shielding  and  infer  the  mechanical  properties  of  the  nascent  ECM  107.  In  this  assay,  cells  
with  little  or  weak  ECM  deform  readily  with  bulk  compression  of  the  gel,  while  cells  with  
robust  pericellular  matrix  accumulation  deform  much  less  (Figure  5-1g).  At  day  2,  cells  
deformed  readily  in  response  to  applied  strain  (18.6%  ±  5.6%).  By  day  9,  cell  
deformation  was  attenuated  (4.1%  ±  2.9%,  p  =  0.01  vs  Day  2),  and  the  extent  of  this  
attenuation  was  nearly  identical  between  control  and  labeled  groups  (labeled:  2.9%  ±  
1.5%  ,  p  =  0.97  vs  Day  9  Methionine,  Figure  5-1h).  Thus,  the  matrix  produced  in  the  
presence  of  HPG  was  similar  in  both  its  distribution  and  mechanical  function  compared  
to  matrix  formed  in  standard  culture  conditions.    
Because  HPG  should  label  all  methionine-containing  proteins,  we  next  asked  how  the  
spatial  pattern  of  HPG  labeling  compared  with  that  of  specific  extracellular  matrix  
proteins.  For  this  and  all  subsequent  studies,  individual  cells  were  identified  via  nuclear  
staining  and  imaged  through  the  midplane  of  the  cell  body  (Figure  5-1i).  Simultaneous  
staining  for  HPG  and  either  aggrecan  core  protein  (Figure  5-1j,k)  or  collagen  II  (Figure  
5-1l,m)  emphasized  the  high  degree  of  structural  detail  revealed  by  FUNCAT  in  
comparison  with  traditional  staining  methods.  Aggrecan  core  protein  was  restricted  to  
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the  pericellular  space,  an  area  where  HPG  labeling  was  often  most  intense  (Figure  
5-1j,k).  In  contrast,  collagen  II  co-localized  with  the  outer  reaches  of  HPG  labeling,  both  
qualitatively  (Figure  5-1l,m)  and  as  quantified  by  average  intensity  profiles  directed  
radially  from  the  cell  surface  and  extending  into  the  gel  (Figure  5-1k,m).  Pre-treatment  
of  fixed  samples  with  hyaluronidase  revealed  additional  collagen  II  staining  closer  to  the  
cell,  but  did  not  influence  the  outer  radius  of  staining,  nor  did  it  alter  the  co-localization  
between  collagen  II  and  HPG  at  the  matrix  boundary  (Figure  5-5).  Collectively,  the  tight  
co-localization  of  HPG  signal  with  prevalent  matrix  proteins  was  consistent  with  the  
expectation  that  HPG  would  incorporate  into,  and  label,  the  proteinaceous  components  
of  the  extracellular  matrix.    

  
Figure  5-5:  Hyaluronidase  digestion  of  fixed  samples  increases  collagen  II  detection  by  
immunofluorescence,  but  does  not  alter  HPG  labeling.  Radial  intensity  profiles  for  chondrocytes  cultured  
in  agarose  and  labeled  with  HPG  for  9  days.  Following  fixation,  samples  were  incubated  in  either  PBS  
(control)  or  hyaluronidase  before  immunostaining  and  HPG  tagging.    Lines  represent  median  intensity  
th
th
profile,  shaded  areas  represent  25   to  75   percentiles  (n  =  9-11  cells/group).  
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Metabolic labeling tags pericellular collagenous network.
To  better  understand  the  identity  and  relative  organization  of  the  extracellular  proteins  
labeled  with  HPG,  we  enzymatically  digested  chondrocyte-generated  ECM  prior  to  
sample  fixation  on  day  9.  Alcian  blue  staining  confirmed  the  efficacy  of  digestion  with  
collagenase,  hyaluronidase,  and  chondroitinase  ABC  (Figure  5-6a).  Collagenase  
digestion  of  the  fibrous  collagen  network  completely  removed  HPG-labeled  proteins  
accumulated  near  the  cell,  and  yielded  short  fibrous  protein  fragments  that  were  
distributed  throughout  the  gel  (Figure  5-6b,c).  In  contrast,  digestion  with  either  
hyaluronidase  or  chondroitinase  ABC  had  only  subtle  effects  on  the  pattern  of  HPG  
labeling  (Figure  5-6b,c).  Because  hyaluronan  and  chondroitin  sulfate  are  not  proteins,  
they  are  not  tagged  directly  by  HPG  labeling.  Instead,  hyaluronan  digestion  would  be  
expected  to  disrupt  pericellular  proteoglycan  aggregates,  while  chondroitinase  ABC  
would  be  expected  to  remove  the  fixed  negative  charge  density  and  cause  a  loss  of  
charge-bound  proteins  in  the  pericellular  space  229.  Thus,  these  results  suggest  that,  at  
this  time  point,  the  majority  of  extracellular  proteins  labeled  by  HPG  are  collagens,  or  
proteins  that  rely  on  collagens  to  be  retained  in  the  pericellular  space.    

Biophysical features of the cellular microenvironment influence matrix
organization.
To  assess  the  ability  of  HPG  labeling  to  identify  differences  in  matrix  catabolism  and  
organization,  we  next  used  continuous  HPG  exposure  to  monitor  the  time  course  of  
matrix  accumulation  by  chondrocytes.  With  time,  extracellular  proteins  progressively  
extended  from  the  cell  (Figure  5-7).  Matrix  distributed  symmetrically  around  individual  
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Figure  5-6:  Enzymatic  digestion  differentially  effects  HPG-labeled  matrix.  (a)  Alcian  blue  staining  of  
chondrocyte/agarose  constructs  cultured  and  labeled  with  HPG  for  9  days  followed  by  enzymatic  digestion  
prior  to  fixation.  (b)  Corresponding  visualization  of  HPG-labeled  matrix  in  digested  samples.  (c)  Radial  profile  
quantification  of  HPG  intensity  following  digestion,  compared  to  constructs  incubated  in  PBS.  Lines  
th
th
represent  median  intensity  profile,  shaded  areas  represent  25   to  75   percentiles  (n  =  20  cells/group).    

  
chondrocytes  (Figure  5-11),  and  overall  labeling  intensity  increased  with  time  in  culture  
(Figure  5-7).  By  day  7,  HPG  labeling  in  chondrocytes  often  exhibited  a  low-intensity  
band  adjacent  to  the  cell  surface,  potentially  reflecting  the  formation  of  a  pericellular  
matrix  rich  in  proteoglycans.    

93  
  

  
Figure  5-7:  HPG  labeling  captures  nascent  matrix  deposition.  Images  (a)  and  radial  profile  quantification  
(b)  of  chondrocytes  cultured  in  2%  agarose  and  continuously  labeled  with  HPG  for  up  to  9  days.  Colormap  
and  scale  bar  are  consistent  across  all  images.  Lines  represent  median  intensity  profile,  shaded  areas  
th
th
represent  25   to  75   percentiles  (n  =  20  cells/group).  

  
The  structure  of  this  accumulating  matrix  was  modulated  by  the  cellular  
microenvironment,  including  the  choice  of  the  biomaterial  scaffold  and  its  physical  
properties.  We  have  previously  demonstrated  that  increasing  hydrogel  density  promotes  
matrix  formation,  but  prevents  matrix  distribution  throughout  the  material  32.  To  examine  
this  behavior  at  the  single  cell  level,  we  cultured  chondrocytes  in  2%  agarose  gels  (the  
standard  condition),  as  well  as  1%  and  3%  agarose  gels,  for  9  days.  Extracellular  
proteins  distributed  readily  throughout  the  1%  gel,  resulting  in  a  disperse  protein  network  
that  extended  between  neighboring  cells  (Figure  5-8).  Conversely,  in  denser  2%  and  3%    
94  
  

  
Figure  5-8:  Density  of  the  cellular  microenvironment  impacts  organization  of  nascent  matrix.  (a)  
Images  of  HPG-labeled  chondrocytes  cultured  in  agarose  of  varying  densities.  (b)  Radial  profile  
quantification  of  HPG  intensity  in  1%,  2%,  and  3%  agarose  hydrogels.  

  
gels,  individual  cells  retained  discrete  extracellular  protein;;  accumulated  protein  was  
most  compact  in  3%  agarose  (Figure  5-8).  Thus,  as  the  microenvironment  became  
increasingly  dense  and  less  permissive,  matrix  proteins  were  spatially  restricted  to  their  
point  of  origin.  
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Nascent matrix intersperses with pre-existing matrix in developing (but not
developed) microenvironments.
Next,  we  asked  how  proteinaceous  matrix  forms  and  is  organized  within  the  context  of  
an  existing  extracellular  matrix.    That  is,  do  matrix  proteins  accumulate  in  concentric  
rings  (like  growing  trees),  or  does  new  matrix  interdigitate  with  the  pre-existing  structure?  
To  answer  this  question,  gels  were  cultured  in  control  media  for  2,  7,  19,  and  40  days  
and  switched  to  HPG  labeling  media  for  the  two  final  days  of  culture.  Only  proteins  
synthesized  during  the  final  two  days  would  be  labeled  with  HPG,  while  pre-existing  
protein  would  be  unlabeled.  Results  from  this  study  showed  that,  between  2  and  4  days,  
nascently  produced  fibrous  proteins  accumulated  in  the  pericellular  space  (Figure  5-9).  
Fibrous  structures  also  formed  between  days  7  and  9,  and  were  distributed  within  the  
pre-existing  matrix  (Figure  5-9a).  Between  19-21  days  and  40-42  days,  however,  
nascent  proteins  were  primarily  restricted  to  the  immediate  pericellular  space  and  lacked  
a  fibrous  structure  (Figure  5-9b).    This  likely  reflects  an  increasingly  dense  
microenvironment  and  a  potential  shift  in  the  molecular  composition  of  the  nascent  
matrix.  Cartilage  explants  cultured  for  3  days  in  labeling  media  showed  little  evidence  of  
nascent  proteins  in  the  extracellular  space  (Figure  5-9c),  suggesting  that  matrix  turnover  
in  mature  tissue  occurs  on  a  timescale  longer  than  the  labeling  period.  Collectively,  
these  results  are  consistent  with  the  notion  that  the  permissivity  of  the  existing  matrix  
dictates  nascent  matrix  elaboration  and  organization.  At  early  time  points  in  culture,  cells  
form  matrix  rapidly  and  incorporate  this  newly  formed  material  within  the  existing  matrix.  
As  the  existing  matrix  matures,  increased  matrix  density  restricts  nascent  proteins  to  the  
more  immediate  pericellular  space.  
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Figure  5-9:  Extent  and  organization  of  nascent  matrix  assembly  depend  on  construct  maturity  and  
collagen  cross-linking.  (a,b)  Images  (a)  and  radial  profile  quantification  (b)  of  chondrocytes  cultured  in  
agarose  for  4  and  9  days  that  were  pulse-labeled  with  HPG  for  the  final  2  days  of  culture.  (c)  Chondrocytes  
cultured  in  agarose  for  21  and  42  days,  and  pulse  labeled  for  the  final  2  days  of  culture.  (d)  Pulse-labeled  
chondrocyte  in  a  cartilage  explant,  cultured  for  3  days.  (e)  Pulse-labeled  (final  2  days  of  culture)  
chondrocytes  cultured  in  the  presence  or  absence  of  BAPN,  a  collagen  cross-linking  enzyme  inhibitor.  
BAPN  was  administered  either  continuously  or  over  the  final  2  days  of  culture.  (f)  Radial  intensity  profiles  of  
day  7-9  pulse  labeled  chondrocytes  in  the  presence  and  absence  of  BAPN.    Colormaps  are  consistent  within  
subfigures.  Lines  represent  median  intensity  profile,  shaded  areas  represent  25th  to  75th  percentiles  (n  =  20  
cells/group).  

  
Because  matrix  formation  and  accumulation  are  highly  regulated  processes,  we  also  
asked  how  perturbation  of  normal  matrix  assembly  might  alter  nascent  matrix  protein  
synthesis  and  organization.  To  do  so,  we  used  β-aminopropionitrile  (BAPN)  to  inhibit  the  
collagen  crosslinking  enzyme,  lysyl  oxidase.  Here,  continuous  exposure  to  BAPN  for  9  
days  dramatically  altered  matrix  organization,  but  did  so  in  a  non-intuitive  manner.  In  the  
context  of  BAPN,  continuous  labeling  revealed  dense  and  intensely  labeled  proteins  
adjacent  to  the  cell  (Figure  5-12).  The  extent  of  extracellular  protein  deposition  was  
sharply  truncated  at  7.9  ±  0.5  µm  from  the  cell,  suggesting  that  matrix  proteins  were  
unable  to  extend  into  the  hydrogel  as  they  had  in  control  samples.  Pulse  labeling  with  
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HPG  from  7-9  days  showed  that  continuous  BAPN  treatment  (from  day  0)  influenced  not  
only  the  spatial  organization  of  matrix  proteins,  but  also  their  synthesis  dynamics.  In  
pulse-labeled  control  groups,  matrix  protein  labeling  was  of  low  intensity  and  
interspersed  within  the  pre-existing  matrix  (Figure  5-9d,e;;  Figure  5-12).  Strikingly,  
BAPN  treatment  increased  the  amount  of  nascent  extracellular  proteins  produced,  and  
restricted  these  proteins  to  the  immediate  pericellular  space.  Intriguingly,  these  results  
suggest  that  collagen  crosslinking  is  necessary  for  the  cell  to  project  collagen  outward  
into  the  microenvironment,  and  for  cells  to  achieve  matrix  homeostasis.  

Patterns of matrix deposition identify phenotypic differences between cell
types.
Having  shown  that  chemical  manipulation  of  matrix  crosslinking  fundamentally  altered  
the  distribution  of  extracellular  matrix  proteins,  we  next  wondered  if  FUNCAT  labeling  
could  also  detect  phenotypic  differences  between  cell  types  that  would  be  reflected  in  
their  nascent  matrix  production  and  assembly.  For  example,  using  standard  histological  
techniques  and  biochemical  assays,  we  have  previously  shown  that  chondrocytes  and  
mesenchymal  stem  cells  (MSCs)  differentially  produce  and  organize  their  ECM  56.  To  
examine  this  phenomenon  with  higher  fidelity  and  with  single  cell  resolution,  we  next  
cultured  MSCs  and  chondrocytes  in  the  presence  of  HPG.  Continuous  labeling  between  
days  0-9  showed  that  matrix  protein  accumulation  by  MSCs  lagged  behind  that  of  
chondrocytes,  and  differed  in  its  spatial  organization.  Notably,  there  was  high  MSC-to-
MSC  variation  in  the  labeled  extracellular  protein  present  (Figure  5-10a,c,  Figure  
5-13a,b),  consistent  with  the  heterogeneous  nature  of  this  cell  population  36,164,180.  This  
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heterogeneity  manifested  in  two  ways:  in  both  the  intensity  of  the  labeled  matrix  proteins,  
and  the  pattern  of  matrix  protein  distribution.  Select  MSCs  produced  labeled  fibrous  
proteins  by  day  9,  but  these  molecules  were  often  found  far  away  from  the  cell,  
suggesting  that  MSCs  may  be  less  able  than  chondrocytes  to  sequester  ECM  within  the  
pericellular  space,  or  may  have  a  higher  level  of  matrix  degradation  and  turnover.  MSCs  
also  sometimes  distributed  extracellular  proteins  asymmetrically  around  the  cell  body  
(45%  symmetric,  42%  asymmetric,  13%  without  matrix  at  Day  9;;  Figure  5-13a).  In  
contrast,  the  organization  of  continuously  labeled  matrix  protein  was  very  similar  
between  chondrocytes,  and  was  symmetric  around  individual  cells  (Figure  5-11).  
Consistent  with  continuous  labeling,  MSCs  that  were  pulse  labeled  between  days  7-9  
showed  high  cell-to-cell  variability  in  matrix  accumulation  patterns  (Figure  5-10b,d,  
Figure  5-13b).  Intriguingly,  nascent  matrix  proteins  in  pulse  labeled  chondrocytes  were  
also  markedly  heterogeneous  (Figure  5-10b,d,  Figure  5-11b)  during  this  time  point.  
These  data  indicate  that,  as  the  timescale  considered  shortens,  apparent  heterogeneity  
in  matrix  protein  production  and  organization  increases.  Taken  together,  these  
observations  suggest  that  continuous  and  pulsed  HPG  labeling  can  capture  metabolic  
and  phenotypic  differences  that  may  be  of  biological  significance  in  the  assembly  of  the  
cellular  microenvironment  at  the  single  cell  level.    

Discussion	
  
In  this  work,  noncanonical  amino  acid  tagging  revealed  cell-,  time-  and  
microenvironment-dependent  patterns  in  extracellular  matrix  assembly  and  organization.  
Specifically,  we  considered  the  role  of  these  factors  in  a  chondrogenic  context,  with  a  
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Figure  5-10  (previous  page):  Apparent  heterogeneity  in  matrix  accumulation  is  cell  type  and  
timescale  dependent.    (a,b)  Representative  chondrocytes  and  MSCs  labeled  with  HPG  continuously  (a;;  
blue)  or  between  days  7-9  (b;;  orange).  Pulse  labeled  samples  were  imaged  with  higher  gain  settings  than  
continuously  labelled  samples,  given  that  the  shorter  labeling  period  results  in  much  lower  overall  intensity  
(see  Fig  S7  for  direct  comparison).  (c,d)  Quantified  matrix  distribution  of  individual  cells,  represented  as  the  
cumulative  fraction  of  total  intensity  versus  distance  from  the  cell.  Median  is  shown  in  black;;  representative  
cells  from  (a)  and  (b)  are  shown  in  dashed  blue  and  orange  lines.  Other  individual  cells  are  represented  in  
grey  (n  =  20  cells/group).  

  
focus  on  how  native  chondrocytes  and  differentiating  MSCs  establish  and  respond  to  the  
cellular  niche.  Visualization  of  detailed  matrix  structures  highlighted  the  differing  nature  
of  the  proteinaceous  ECM  produced  by  these  two  cell  types.  Chondrocytes  produced  a  
well-organized,  mechanically-robust  matrix  proteins  that  formed  a  physical  barrier  and  
ultimately  restricted  molecular  mobility  within  the  extracellular  space.    Interestingly,  pulse  
labeling  revealed  persistent  heterogeneity  in  the  active  remodeling  of  this  network,  which  
summated  to  a  consistent  profile  of  matrix  protein  distribution.  In  contrast,  MSCs  
produced  matrix  proteins  that  were  loosely  organized,  poorly  retained  and  often  
asymmetrically  distributed  around  individual  cells.  Similarly,  on  an  individual  cell  basis,  
MSCs’  nascent  matrix  proteins  remained  heterogeneous  in  both  amount  and  distribution.  
Such  differences  in  matrix  protein  organization  likely  impact  not  only  the  bulk  mechanics  
that  develop  over  time  within  the  construct,  but  also,  and  perhaps  more  importantly,  the  
biochemical  and  biophysical  environment  perceived  by  individual  cells  at  a  given  time  
point.  ECM  organization  modulates  microscale  transport  properties,  including  the  
mobility  and  availability  of  soluble  molecules  such  as  growth  factors  227.  Furthermore,  
matrix  organization  and  connectivity  influence  how  forces  are  transduced  to  the  cell  79.    
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Figure  5-11  (previous  page):  Cell-to-cell  heterogeneity  in  HPG-labeled  nascent  matrix  formed  by  
chondrocytes.  (a)  A  panel  of  representative  chondrocytes  cultured  in  agarose  and  labeled  with  HPG  for  up  
to  9  days.  Colormap  and  scale  bar  are  consistent  across  all  images.  (b)  Radial  intensity  profiles  for  20  
individual  chondrocytes  cultured  and  labeled  for  9  days.  

  

  
Figure  5-12:  Exposure  to  BAPN  increases  nascent  matrix  synthesis.  (a)  Continuous  and  pulse  labeling  
(final  2  days)  of  chondrocytes  cultured  in  the  presence  and  absence  of  BAPN,  a  collagen  cross-linking  
enzyme  inhibitor.  Pulse  labeled  cells  are  the  same  cells  shown  in  Figure  5,  visualized  here  using  the  same  
imaging  settings  as  the  continuously  labeled  groups.  (b)  Radial  intensity  profiles  of  chondrocytes  
continuously  labeled  with  HPG  for  9  days  in  the  presence  and  absence  of  BAPN.    Lines  represent  median  
th
th
intensity  profile,  shaded  areas  represent  25   to  75   percentiles  (n  =  20  cells/group).  
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Figure  5-13  (previous  page):  Cell-to-cell  heterogeneity  in  HPG-labeled  nascent  matrix  formed  by  
mesenchymal  stem  cells  (MSCs).  (a)  A  panel  of  representative  MSCs  cultured  in  agarose  and  labeled  with  
HPG  continuously  for  9  days.  (b)  Radial  intensity  profiles  for  20  individual  MSCs  cultured  and  labeled  for  9  
days.  

	
  
Thus,  the  collective  organization  of  matrix  proteins  is  both  a  key  product  and  determinant  
of  cell  phenotype,  and  is  uniquely  visualized  by  FUNCAT  labeling.  
Both  construct  maturity  and  biomaterial  density  regulated  the  distribution  of  nascent  
matrix  proteins  in  the  extracellular  space.  As  the  permissivity  of  the  microenvironment  
decreased,  nascent  proteins  were  retained  more  closely  to  the  cell.  That  is,  the  more  
permissive  the  microenvironment,  the  more  readily  newly-formed  matrix  could  disperse  
throughout  the  construct.  This  finding  may  explain,  in  part,  why  the  intentional  removal  of  
proteoglycans  from  developing  cartilage  constructs  hastens  subsequent  construct  
growth  158.    Perhaps  by  decreasing  the  density  of  the  pericellular  microenvironment,  mild  
digestion  creates  space  for  increased  collagen  deposition.  Similarly,  microenvironmental  
permissivity  may  play  a  role  in  matrix  biosynthesis  following  injury  and  during  
degeneration.  In  the  degenerative  condition  of  osteoarthritis,  the  density  of  the  
extracellular  matrix  is  decreases,  weakening  its  mechanical  integrity,  particularly  in  the  
pericellular  space  228.  At  the  same  time,  osteoarthritic  cartilage  has  higher  matrix  
synthesis  activity  than  healthy  tissue  127.    Thus,  not  only  will  osteoarthritic  cells  produce  
more  nascent  matrix,  but  this  matrix  will  have  greater  mobility  in  less  dense,  
degenerating  tissue  (consistent  with  observations  of  expanded  pericellular  matrix  in  
degenerative  cartilage  228).    
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The  utility  of  FUNCAT  labeling  also  extends  to  the  examination  of  how  chemical  and  
biological  perturbations  influence  matrix  assembly  and  organization.  Previously,  BAPN  
treatment  of  cartilage  explants  and  alginate  hydrogels  indicated  a  reduction  in  the  stable  
incorporation  of  nascent  collagen  into  the  tissue  ECM  or  gel  microenvironment  11,145.  
Here,  our  results  build  on  these  existing  bulk  analyses  and  show  that  this  defect  in  
crosslinking  manifests  organizationally,  with  a  buildup  of  matrix  proteins  in  the  immediate  
pericellular  space,  and  a  decrease  in  protein  content  further  removed  from  the  cell.  It  is  
possible  that,  upon  BAPN  washout,  this  pool  of  unincorporated  collagen  becomes  
available  for  rapid  cross-linking  and  network  assembly,  potentially  explaining  why  BAPN  
pre-treatment  can  improve  integration  strength  between  two  pieces  of  cartilage  145.  
Strikingly,  fibrous  matrix  proteins  organized  perpendicularly  to  the  cell  membrane  in  both  
control  and  treated  conditions.  In  tendon  cells,  the  secretion  of  aligned  matrix  is  a  force-
dependent  process,  requiring  cellular  contractility  and  a  competent  cytoskeleton  24.  Our  
finding  that  BAPN  localized  matrix  proteins,  but  inhibited  their  wider  distribution,  
suggests  that  collagen  crosslinking  is  required  to  establish  a  functional  framework  
against  which  newly  formed  matrix  molecules  are  ‘pushed’  progressively  further  from  the  
cell.    
Modulation  of  cartilage  cross-linking  is  only  one  of  many  possible  matrix  assembly  
perturbations.  A  similar  labeling  strategy  could  be  used  to  finely  assess  the  role  of  
specific  matrix  components;;  for  example,  how  does  knockdown  or  knockout  of  individual  
proteoglycans  or  structural  matrix  proteins  influence  the  organization  and  timing  of  
matrix  assembly?  Notably,  a  FUNCAT-based  approach  would  also  be  able  to  identify  
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contexts  in  which  turnover  is  altered,  but  where  total  matrix  protein  content  remains  
unchanged  –  a  situation  that  traditional  staining  procedures  would  be  unable  to  detect.  
This  investigation  of  the  biosynthetic  response  to  injury,  disease,  or  altered  genetic  
program  could  be  performed  either  in  vitro  (as  we  assessed  tissue  engineered  construct  
formation  here)  or  in  vivo.    Previous  studies  have  examined  protein  synthesis  in  
drosophila  and  zebrafish  systems  and  mice  22,55,83;;  scaling  FUNCAT  to  mammalian  
systems  with  in  vivo  models  of  cartilage  degeneration  (e.g.  meniscus  destabilization)  or  
joint  development  could  lend  insight  into  how  matrix  proteins  form  and  reorganize  during  
these  processes.  Recent  studies  indicate  that  HPG  and  AHA  can  incorporate  into  
developing  murine  embryos  22,  supporting  the  potential  scalability  of  FUNCAT  analysis    
to  such  model  systems.    
An  important  limitation  of  the  FUNCAT  procedure  is  that  labeling  is  restricted  to  
methionine-containing  proteins.  The  vast  majority  of  ECM  proteins  contain  methionine:  
across  a  set  of  361  standard  ECM  proteins,  85%  contain  >1%  methionine,  and  30%  
contain  >2%  methionine  (Fig  1a  and  Table  SX).  Comparatively,  the  proteins  most  
commonly  found  in  the  cartilage-like  matrix  (i.e.  collagen  II  and  aggrecan)  are  
methionine-poor.  Given  that  we  were  able  to  visualize,  with  high  fidelity,  ECM  
predominantly  composed  of  these  two  molecules,  FUNCAT  should  also  be  amenable  to  
the  examination  of  the  ECM  in  other  tissues,  including  those  rich  in  fibronectin  (1.1%  
Met),  laminins  (0.9-2.4%  Met),  and  other  collagens  (0.6-3.1%  Met).  Indeed,  proteomic  
analysis  has  indicated  successful  in  vivo  incorporation  of  AHA  and  HPG  across  tissues  
including  heart,  lung,  brain,  muscle,  and  kidney22.  A  notable  exception  is  the  protein  
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elastin,  which  contains  only  a  single  methionine  residue;;  such  low  methionine  content  
suggests  that  AHA-  or  HPG-based  FUNCAT  would  be  unable  to  fully  detail  matrix  
protein  dynamics  in  elastin-rich  tissues  (e.g.  arteries)2.  Similarly,  FUNCAT  is  also  unable  
to  directly  capture  the  dynamics  of  non-proteinaceous  ECM  components,  including  
glycosaminoglycans.  Such  components  may  be  amenable  to  assessment  through  
similar  metabolic  labeling  strategies  that  incorporate  azide-modified  sugars  to  monitor  
nascent  glycan  synthesis  9,119,120,235.  
A  second  limitation  of  the  FUNCAT  procedure  described  herein  is  its  reliance  on  copper  
to  catalyze  the  azide-alkyne  reaction.  Copper-catalyzed  reactions  are  well-suited  to  fixed  
samples,  such  as  those  examined  here,  but  have  more  limited  utility  in  live-cell  imaging  
applications,  where  metal  toxicity  impairs  cell  viability  92.  A  cell-compatible  alternative,  
copper-free  click  chemistry,  relies  on  strain-promoted  cycloaddition  between  a  
biomolecule  containing  azide  (e.g.  AHA)  and  cyclooctynes  conjugated  to  fluorophores  or  
affinity  tags.  Direct  comparisons  of  copper-  and  copper-free  click  chemistries  in  
proteomic  applications  suggest  that  the  copper-free  chemistry  has  decreased  sensitivity  
and  increased  non-specific  labeling  in  comparison  to  copper-catalyzed  reactions  14,125.  
Alternatively,  the  modification  of  copper-catalyzed  click  reactions  to  include  ligand  
acceleration14,84  or  copper  chelation220  has  recently  improved  cytocompatability  to  levels  
comparable  with  the  copper-free  chemistry,  albeit  with  modified  or  additional  reagents.  
Thus,  the  choice  of  specific  cycloaddition  chemistry  will  require  one  to  establish    an  
application-specific  balance  between  desired  biocompatibility,  sensitivity,  and  reaction  
complexity.      
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In  conclusion,  our  findings  highlight  that  the  spatial  organization  of  extracellular  proteins  
is  a  sensitive  readout  modulated  by  diverse  stimuli.  While  our  work  focuses  on  
chondrogenesis,  the  metabolic  labeling  approach  used  here  offers  the  ability  to  query  
extracellular  matrix  formation  by  different  cell  types,  in  many  different  contexts,  including  
tissue  degeneration,  wound  healing,  fibrosis,  and  other  pathologic  changes  in  tissue  
phenotype.    Most  importantly,  given  the  fidelity  and  localization  of  this  labeling,  these  
alterations  in  normal  tissue  homeostasis  can  be  examined  at  the  single  cell  level,  where  
such  global  changes  in  tissue  structure  and  function  first  originate.  Future  applications  of  
this  technique  will  elucidate  the  spatiotemporal  aspects  of  proteinaceous  matrix  
assembly  and  remodeling,  and  contribute  to  our  understanding  of  how  dynamic  cell-
matrix  interactions  regulate  tissue  formation,  degeneration,  and  repair.      

Methods	
  
Quantifying protein methionine content
Using  the  UniProtKB/Swiss-Prot  database219,  human  proteins  of  interest  were  identified  
using  the  gene  ontology  terms  ‘extracellular  matrix  structural  constituents’  (GO:0005201)  
and  ‘proteinaceous  extracellular  matrix’  (GO:0005578).  Methionine  content  was  
calculated  by  counting  the  number  of  methionine  residues  relative  to  the  number  of  total  
amino  acids  in  each  protein  sequence.    

Construct fabrication
MSCs  and  chondrocytes  were  isolated  from  juvenile  bovine  knees  (Research  87,  
Boylston  MA)  and  passaged  once  before  encapsulation  in  3D  gels.  For  all  conditions,  
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cells  were  encapsulated  at  a  density  of  1.5  -  2x106  cells/mL.  To  obtain  1%,  2%  and  3%  
(w/v)  agarose  gels,  molten  4%  agarose  was  combined  with  a  warm  cell  suspension  and  
solidified  into  thin  sheets  (~400  µm  thick)  underneath  coverslips  36.  4mm  x  5mm  µ-gels  
were  cut  from  the  sheets  and  cultured  individually  in  48  well  plates.  

Functional, noncanonical amino acid labeling
Samples  were  cultured  in  a  chemically  defined  media:  high  glucose  DMEM  without  
glutamine,  methionine,  or  cystine  (Life  Technologies  21013024)  supplemented  with  
either  0.1  mM  L-methionine  (Sigma  M5308;;  control  media)  or  0.1  mM  L-
homopropargylglycine  (Molecular  Probes  C10186;;  labeling  media),  10  ng/  ml  TGFβ-3,  
0.1  µM  dexamethasone,  4  mM  L-glutamine,  0.201  mM  cystine  (Sigma  C7602),  100  
µg/mL  sodium  pyruvate,  1.25  mg/mL  bovine  serum  albumin,  0.1%  ITS  premix,  50  µg/mL  
ascorbate  2-phosphate,  40  µg/mL  proline,  and  1%  penicillin-streptomycin-amphotericin.  
Medium  was  replenished  every  2-3  days,  and  finally  fixed  in  4%  phosphate-buffered  
paraformaldehyde  for  15  minutes  before  storage  in  PBS  at  4oC.  Cartilage  plugs  (4  mm  
diameter)  were  cultured  in  labeling  media  for  3  days,  and  fixed  in  4%  PFA  overnight.    
HPG  incorporated  into  fixed  samples  was  covalently  tagged  with  Alexa  Fluor  488.  
Samples  collected  up  to  day  9  were  stained  and  imaged  as  intact  gels.  To  enhance  
imaging,  cartilage  and  gels  collected  at  21  and  42  days  were  cryosectioned  to  yield  40  
µm  thick  cross-sections.  Both  intact  gels  and  cryosections  were  first  stained  with  a  
1:1000  dilution  of  a  plasma  membrane  stain  (Molecular  Probes  C10046)  in  PBS  for  30  
minutes  at  room  temperature.  Next,  samples  were  rinsed  twice  with  PBS,  and  incubated  
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in  a  click  reaction  labeling  solution  (prepared  from  Molecular  Probes  C10428  according  
to  product  instructions,  and  including  Alexa  Fluor  488  azide)  for  40  minutes  at  room  
temperature.  Samples  were  washed  in  reaction  rinse  buffer  (Molecular  Probes  C10428,  
5  minutes  at  room  temperature),  and  then  once  with  PBS.  Nuclei  were  labeled  with  
Hoechst  in  PBS  for  15  minutes  at  room  temperature,  and  samples  were  washed  twice  
with  PBS  before  imaging.  The  same  labeling  procedure  was  followed  for  AHA  samples,  
with  Alexa  Fluor  594  alkyne  (Molecular  Probes  C10102  and  A10275).  

FUNCAT Imaging and Image Quantification
Samples  were  mounted  in  PBS  and  imaged  using  a  Nikon  A1  confocal  microscope.  To  
acquire  large  fields  of  view  (Figure  5-2),  confocal  slices  were  captured  at  40X.  To  
visualize  staining  near  individual  cells,  cells  within  100  µm  of  the  gel  surface  were  
identified  via  nuclear  staining,  and  100X  confocal  sections  were  taken  through  the  cell  
midplane.  To  quantify  the  staining  associated  with  each  cell,  20  radial  intensity  profiles  
emanating  from  the  cell  center  were  mapped,  truncated  to  include  only  the  extracellular  
domain  (demarcated  by  membrane  staining),  and  averaged  over  each  cell.  Any  
encroaching  matrix  from  nearby  cells  was  manually  excluded  from  this  quantification.  
For  easier  visualization,  post-processing  was  used  to  enhance  the  contrast;;  all  images  in  
a  subfigure  figure  were  imaged  and  post-processed  identically.  Quantified  HPG  intensity  
values  shown  in  graphs  were  not  transformed  and  are  comparable  between  Figure  5-7  
and  Figure  5-9A.  Sample  size  was  selected  based  on  a  bootstrap  resampling  of  a  
dataset  of  n=40  cells;;  samples  sizes  of  n=5,  10,  20,  30  and  40  cells  were  simulated  over  
100  bootstrap  replicates.  Aggregate  metrics  were  near-identical  between  n=20,  30,  and  
111  
  

40  cells,  suggesting  that  a  sample  size  of  n=20  cells  per  condition  balanced  sufficient  
statistical  coverage  with  experimental  efficiency.  
To  determine  matrix  radius,  background  signal  levels  were  determined  for  each  profile.  
Radius  was  considered  as  the  first  distance  where  intensity  dipped  below  110%  of  the  
background  signal  level.  Profiles  were  averaged  to  determine  the  matrix  radius  of  each  
cell;;  values  reported  are  the  mean  ±  standard  error  of  20  cells.    

Alcian Blue Staining & Immunofluorescence
Histological  sections  or  intact  µ-gels  were  stained  with  Alcian  blue  pH  1.0  (Rowley  
Biochemical)  to  identify  sulfated  proteoglycans  36.  Immunofluorescence  staining  was  
performed  following  the  cell  membrane,  HPG  and  nuclear  staining  described  above.  µ-
gels  were  stained  for  aggrecan  (1°:  Abcam  ab3778,  1:50  in  PBS  overnight  at  4°C;;  2°:  
ThermoFisher  AlexaFluor  546  goat  anti-mouse,  1:200  in  5%  BSA  for  1  hr  at  room  
temperature).  Additional  µ-gels  were  stained  for  collagen  II  (1°:  DSHB  ii-ii6b3,  10  µg/mL  
in  PBS  overnight  at  4°C;;  2°:  ThermoFisher  AlexaFluor  546  goat  anti-mouse,  1:200  in  5%  
BSA  for  1  hr  at  room  temperature).  Collagen  II  staining  was  performed  with  and  without  
hyaluronidase  digestion  (300  µg/ml,  2.5  hours  at  room  temperature).  

Matrix Digestion & Perturbation
Following  9  days  of  continuous  culture  in  labeling  media,  agarose  µ-gels  were  digested  
with  a  panel  of  enzymes.  Highly  purified  collagenase  (Worthington  CLSPA)  was  
suspended  at  300  U/mL  in  PBS.  Chondrotinase  ABC  (Sigma  C2905)  was  suspended  at  
0.4U/mL  in  50  mM  Tris,  60  mM  sodium  acetate,  0.02%  BSA,  pH  8.0.    Hyaluronidase  
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(Type  IV-S  from  bovine  testes,  Sigma  H3884)  was  suspended  at  300  µg/mL  in  PBS.  
Digestion  was  performed  at  37°C  for  either  1  or  18  hours.    To  assess  the  impact  of  a  
decrease  in  collagen  crosslinking,  β-aminopropionitrile  (BAPN,  Sigma  A3134)  was  
added  to  labeling  media  at  300  µM  151.    BAPN  was  applied  for  varying  time  periods  as  
indicated  in  the  results  and  figure  legends.    

Microcompression
Agarose  gels  seeded  with  2x106  chondrocytes/mL  were  cast  between  two  glass  plates  
and  cut  to  yield  cylindrical  samples  measuring  4  mm  in  diameter  and  2  mm  thick.  
Constructs  were  cultured  in  either  control  media  (native  methionine)  or  labeling  media  
(HPG)  for  up  to  9  days.  Unfixed  samples  were  halved  through  the  mid-sagittal  plane  and  
stained  with  calcein  AM  and  Hoechst  to  mark  cell  bodies  and  nuclei.    Using  a  confocal-
mounted  device  60,  samples  were  compressed  to  30%  strain  in  increments  of  5%.  Before  
each  compressive  step,  3D  stacks  depicting  a  region  of  interest  were  imaged.  Following  
each  compressive  step,  the  sample  was  allowed  to  equilibrate  for  5  minutes.  Individual  
cells  depicted  in  stack  maximum  Z  projections  were  computationally  segmented  and  
manually  tracked  through  multiple  strain  levels.  For  identified  cells,  the  cell  aspect  ratio  
was  calculated  as  the  ratio  of  the  long  axis  to  the  short  axis.  Data  are  presented  as  the  
ratio  of  strained  to  unstrained  cell  aspect  ratio,  calculated  on  a  single  cell  basis.  
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Introduction	
  
Ensemble  measurements  of  genome-wide  mRNA  and  protein  abundance  suggest  that  
mRNA  and  protein  expression  generally  correlate,  with  gene-to-gene  differences  in  
mRNA  levels  explaining  approximately  40-80%  of  the  variation  in  protein  content.38,223  
However,  amongst  individual  cells  and  for  a  single  gene,  mRNA  abundance  only  weakly  
corresponds  with  protein  quantity.  For  example,  in  eukaryotes,  a  screen  of  >120  genes  
compared  single  cell  mRNA  abundance  with  the  signal  of  corresponding  fluorescent  
reporter  proteins;;  this  analysis  showed  that,  at  the  single  cell  level,  mRNA  and  protein  
were  uncorrelated.212    Discordance  between  mRNA  and  protein  has  also  been  
demonstrated  in  mammalian  cells1,  but  single  cell  mRNA-protein  relationships  may  also  
be  cell-type  and  gene  dependent.162  Within  the  specific  context  of  chondrogenesis,  we  
have  previously  noted  that,  at  the  single  cell  level,  the  transcriptional  abundance  of  
extracellular  matrix  genes  does  not  correlate  with  the  amount  of  matrix  protein  
accumulated  by  individual  cells  undergoing  differentiation.36  
A  possible  explanation  for  the  apparent  disconnect  between  mRNA  and  protein  
abundance  is  that  these  molecules  often  differ  in  their  temporal  dynamics.  For  example,  
extracellular  matrix  proteins  tend  to  accumulate  with  time,  but  gene  expression  is  a  
stochastic  process  that  occurs  in  rapid  bursts  separated  by  periods  of  transcriptional  
silence.  Generally,  the  half-lives  of  corresponding  mRNAs  and  proteins  are  
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uncorrelated190,  and  this  mismatch  is  particularly  exacerbated  for  matrix  components.    
For  instance,  the  half-life  of  many  matrix  proteins  can  range  from  months  to  years,  while  
typical  mRNA  half-lives  range  from  1  hour  to  2  days  (median  =  9  hours).190,201    While  it  
may  be  possible  for  mRNA  and  protein  molecules  with  similar  longevities  to  correlate,  or  
for  quantities  of  a  stable  mRNA  and  unstable  protein  to  correspond,  it  is  difficult  to  
imagine  how  an  unstable  mRNA  and  highly  stable  protein  could  do  so.  Indeed,  previous  
studies  exploring  the  influence  of  protein  half-life  on  the  mRNA-to-protein  relationship  
suggest  that  when  a  protein  does  not  rapidly  turn  over,  the  correlation  between  mRNA  
and  protein  quantity  weakens.177  
To  explicate  this  discordance  between  message  and  output,  this  study  employs  a  
computational  model  to  examine  the  interplay  between  temporal  dynamics  to  message  
and  output  in  the  mRNA-protein  relationship.  We  experimentally  quantify  the  
transcriptional  dynamics  of  five  chondrogenic  matrix  components,  and  use  this  data  to  
parameterize  stochastic  simulations  of  gene  and  protein  expression  in  single  cells.  Using  
these  simulations,  we  temporally  sample  the  molecular  abundance  of  mRNA  and  protein  
in  individual  ‘cells’  and  explore  how  sampling  window  influences  the  observed  correlation  
between  mRNA  and  protein  expression  of  chondrogenic  matrix  genes.  Specifically,  we  
consider  the  relationship  between  instantaneous  mRNA  expression,  nascent  protein  
expression,  and  total  protein  deposition  over  the  course  of  early  tissue  development  in  
engineered  constructs.    
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Experimental	
  Results	
  
Transcriptional dynamics differ between chondrogenic marker genes
To  establish  a  biologically  relevant  parameter  space,  we  experimentally  quantified  single  
cell  transcription  of  five  chondrogenic  marker  genes:  ACAN,  COL6a1,  COL9a1,  
COL11a1,  and  HSPG2.  The  corresponding  proteins  are  integral  components  of  the  
chondrocyte  extracellular  matrix:  aggrecan,  collagen  VI  and  perlecan  are  found  in  the  
pericellular  matrix,  while  collagens  IX  and  XI  integrate  into  forming  fibrous  network.  As  
expected,  each  gene  was  expressed  in  chondrocytes  cultured  in  agarose  for  7  days  in  
the  presence  of  TGFβ  (Figure  6-1A).  ACAN,  COL6  and  COL11  had  high  median  
abundance  (340-560  mRNA),  while  COL9  and  HSPG2  had  low  median  abundance  (70-
110  mRNA).  For  each  gene,  there  was  substantial  cell-to-cell  variation  in  mRNA  
abundance,  with  copy  number  ranging  over  multiple  orders  of  magnitude  (101  –  103).  
To  more  fully  understand  how  mRNA  levels  may  change  within  a  single  cell  over  time,  
we  measured  two  additional  parameters:  the  mRNA  half-life  and  the  fraction  of  cells  with  
active  transcription  sites.  To  measure  RNA  half-life,  we  compared  mRNA  abundance  
before  and  after  transcriptional  inhibition.  mRNA  half-life  varied  widely  amongst  these  
genes,  ranging  from  approximately  3  hours  (COL6,  COL11)  to  >24  hours  (COL9).  ACAN  
and  HSPG2  showed  an  intermediate  mRNA  stability,  with  half-lives  on  the  order  of  6-9  
hours  (Figure  6-1B).  We  note  that  mRNA  half-life  is  cell-type  and  context-
dependent,49,182  and  that  while  our  measurement  of  ACAN  half-life  was  similar  to  other  
reports,  the  half-lives  of  the  collagens  and  HSPG2  differed  from  values  measured  in  
monolayer  cultures.196,213  
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Figure  6-1:  Transcriptional  differences  in  expression  of  chondrogenic  marker  genes.  A)  Distribution  of  
mRNA  copy  number  amongst  individual  chondrocytes  cultured  in  agarose  for  7  days  (n  =  85-154  
cells/group).  B)  mRNA  halflife  of  chondrogenic  marker  genes  (n  =  84-234  /  group,  mean  ±  bootstrapped  95%  
confidence  interval).  C)  Maximum  projection  of  a  COL6  RNA  FISH  image  (white:  COL6,  magenta:    DAPI).  
The  white  foci  in  the  nucleus  of  the  lower  left  cell  indicate  that  it  was  actively  transcribing  COL6.  D)  Fraction  
of  cells  that  were  actively  transcribing  chondrogenic  marker  genes  (n  =  104  –  160  cells  /  group,  measured  
fraction  ±  bootstrapped  95%  confidence  interval).      

  
To  establish  transcriptional  activity,  we  considered  a  cell  as  being  in  an  actively  
transcribing  state  if  bright  FISH  foci  were  visible  within  the  nucleus.    Such  spots  
represent  the  co-localization  of  many  nascent  mRNA  at  a  transcription  locus  (Figure  
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6-1C).    Sporadic  transcription  site  activity  suggests  that  each  of  the  five  genes  was  
expressed  in  bursts.  The  relative  fraction  of  cells  bursting  was  highly  gene  dependent  
(Figure  6-1D,  p  =  1.024e-10,  n  =  104  –  160  cells/group).  Notably,  while  select  gene  
pairs  exhibited  similar  mRNA  distributions,  mRNA  half-lives,  or  bursting  fractions,  the  
combination  of  these  three  metrics  yielded  a  distinct  transcriptional  signature  for  each  
gene  considered.      

A	
  stochastic	
  model	
  of	
  chondrocyte	
  gene	
  expression	
  and	
  matrix	
  
production	
  
Establishing and parameterizing a stochastic model
To  model  the  stochasticity  inherent  to  gene  and  protein  expression  in  chondocytes,  we  
considered  a  random  telegraph  model  of  transcription  and  translation.70,177,214  The  model  
describes  transcription  from  two  copies  of  a  single  gene  (Figure  6-2).  Each  gene  copy  
independently  switches  between  an  inactive  and  active  state  (respectively  denoted  I  and  

A).  Transcription  from  the  active  gene  yields  individual  mRNA  molecules  (M).  mRNAs  
are  translated  to  create  proteins  (P),  and  are  also  allowed  to  decay  over  time.    

  
Figure  6-2:  Schematic  of  the  reactions  included  in  the  stochastic  simulations.  
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These  chemical  processes  are  described  by  the  equations:        
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where  λ  is  the  rate  of  gene  activation,  γ  is  the  rate  of  gene  inactivation,  μ  is  the  
transcription  rate  from  an  active  gene,  μp  is  the  rate  of  protein  translaation,  and  δ  is  rate  
of  mRNA  decay.    This  model  incorporates  the  assumption  that  all  translated  protein  is  
retained  by  the  cell  indefinitely;;  this  assumption  is  consistent  with  experimental  data  
showing  that  broad-spectrum  inhibition  of  matrix  degradation  during  the  first  nine  days  of  
culture  had  minimal  impact  on  matrix  quantity  and  organization  (Figure  6-3),  as  well  as  
measurements  of  matrix  turnover  in  native  cartilage  tissue.  That  is  not  to  say  that  formed  
matrix  is  not  lost  to  the  medium  (some  proteins  do  not  assemble  into  the  network  but  
instead  diffuse  out  of  the  construct),  but  rather  indicates  that  this  process  is  not  
governed  by  protein  degradation  per  se,  and  is  instead  determined  by  the  ability  of  the  
formed  protein  to  couple  into  the  network.  
  

119  
  

  
Figure  6-3:  Comparison  of  chondrocyte  extracellular  matrix  production  in  the  presence  and  absence  
of  MMP  inhibitors.  Constructs  were  cultured  for  9  days  in  media  containing  the  methionine  analog  HPG,  
which  was  fluorescently  tagged  to  label  proteins  following  sample  fixation.  

  
Having  established  the  model,  we  next  estimated  the  transcriptional  parameters  λ,  γ,  
and  μ  by  fitting  experimentally  measured  mRNA  distributions  with  the  steady-state  
solution  to  the  master  equation  using  the  maximum  likelihood  method.177  The  translation  
rate  μp  was  coarsely  estimated  from  the  number  of  aggrecan  molecules  capable  of  
packing  into  a  the  pericellular  matrix  of  a  chondrocyte;;  our  estimate    fell  within  the  range  
of  translation  rates  observed  in  mammalian  cells.190  Details  regarding  parameter  
estimation  are  discussed  in  the  methods  section,  and  the  identified  parameters  are  
summarized  in  Table  6-1.  Notably,  after  accounting  for  the  fraction  of  cells  that  were  
actively  transcribing,  transcription  rates  (μ)  were  consistent  with  measured  transcription  
rates  in  populations  of  mammalian  cells  (100  –  102  mRNA/cell/hour).190  Furthermore,  
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even  though  the  fraction  of  cells  with  active  transcription  sites  was  not  used  as  a  model  
input,  the  steady  state  bursting  ratios  λ/(λ  +  γ)  output  from  the  model  were  consistent  
with  the  experimental  measurements  of  transcriptional  activity  (Table  6-1,  Figure  6-1D).    
Collectively,  these  model  outputs  suggested  that    the  fitting  procedure  for  data  from  
chondrocytes  in  3D  culture  faithfully  recapitulated  biological  behavior  in  mammalian  
cells.  
Table  6-1:  Parameters  used  to  model  expression  of  chondrogenic  
markers.    
  
δ  (s-1)  
μ  (s-1)  
𝜆  (s-1)  
𝛾  (s-1)  
ACAN  
COL6  
COL9  
COL11  
HSPG2  

1.10  x  10-4  
2.65  x  10-4  
7.87  x  10-6  
2.06  x  10-4  
6.09  x  10-5  

6.16  x  10-4  
6.14  x  10-4  
1.66  x  10-4  
5.02  x  10-4  
3.25  x  10-4  

2.04  x  10-5  
5.66  x  10-5  
8.02  x  10-6  
7.13  x  10-5  
3.21  x  10-5  

3.71  x  10-2  
5.41  x  10-2  
9.58  x  10-3  
4.51  x  10-2  
1.26  x  10-2  

  
𝜆
  
𝜆+𝛾
.15  
.30  
.045  
.29  
.15  

Intrinsic heterogeneity emerges in single cell simulations using realistic
model parameters
Having  obtained  biologically-informed  parameter  sets,  we  next  used  a  Gillespie  Monte-
Carlo  method  to  simulate  the  dynamics  of  many  individual  cells.70  At  the  simulation  
endpoint  (t  =  216  hours  =  9  days),  the  stochastic  model  reproduced  the  mRNA  
distributions  observed  experimentally  (Figure  6-4B),  and  also  showed  cell-to-cell  
variation  in  final  protein  content  (Figure  6-4C).  Over  time,  individual  cells  randomized  
away  from  the  initial  condition  of  zero  mRNA,  and  the  simulated  population  achieved  a  
steady  state  mRNA  distribution  after  approximately  2  days.  Individual  cell  traces  
demonstrated  large  fluctuations  with  time  (e.g.  transcriptional  burstiness,  Figure  6-4C).  
Protein  content  increased  near-linearly  with  time,  with  variation  in  the  slopes  of  individual  
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cell  traces  (Figure  6-4D).  Consistent  with  our  previous  experimental  results,36  
instantaneous  measures  of  mRNA  abundance  correlated  poorly  with  simultaneous  
protein  quantities.  This  lack  of  correlation  held  across  the  multiple  genes  considered  in  
the  simulations  (Figure  6-4E).  

  
Figure  6-4:  Cell-to-cell  variation  arises  in  simulations  of  single  cell  gene  and  protein  expression.  A)  
Distribution  of  ACAN  mRNA  at  the  final  simulation  time  point,  t  =  216  hours  (9  days).    Grey  bars  indicate  
histogram  of  observations;;  line  indicates  estimate  of  the  associated  continuous  distribution.  B)  Distribution  of  
aggrecan  protein  at  the  final  simulation  time  point,  t  =  216  hours.  C)  Simulated  single  cell  ACAN  mRNA  over  
time.  D)  Simulated  single  cell  ACAN  protein  over  time.  The  same  example  cells  are  shown  in  C  and  D,  
dotted  line  indicates  mean  response  and  grey  region  indicates  standard  deviation.  E)  Scatterplots  and  
associated  Spearman  correlations  relating  instantaneous  mRNA  and  protein  counts  at  t  =  216  hours  for  
ACAN,  COL6,  COL9,  COL11  and  HSPG2.  For  clarity,  plots  represent  300  points  randomly  sampled  from  
1000  simulations/condition.      
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Figure  6-5  (previous  page):  In  silico  correlation  between  nascent  protein  and  final  mRNA  count  is  
time-  and  half-life  dependent.  A)  Scatterplots  of  temporally  labeled  nascent  protein  and  final  instantaneous  
mRNA  counts.  (n=  1000  simulated  cells,  with  300  randomly  selected  cells  plotted.)  B)  Simulated  correlation  
between  nascent  protein  and  final  mRNA  for  chondrogenic  marker  genes,  as  a  function  of  the  labeling  start  
time.  C)  Simulated  correlation  between  nascent  protein  and  final  mRNA  for  ACAN,  as  a  function  of  time  and  
the  mRNA  half  life  parameter.  D-E)  Labeling  start  times  corresponding  to  rs  =  0.90,  0.75  and  0.50  for  altered  
values  of  mRNA  half-life  (D)  and  additional  model  parameters  (E).  For  B-E,  n=  1000  simulations/  condition;;  
values  shown  are  mean  ±  bootstrapped  95%  confidence  intervals.  

In silico correlation between temporal protein fraction and instantaneous
gene expression
Next,  we  considered  how  the  correlation  of  final  mRNA  expression  with  nascent  protein  
expression  might  differ  from  the  correlation  between  final  mRNA  expression  and  total  
protein  content.  Nascent  protein  fractions  were  identified  as  those  produced  in  specific  
temporal  windows,  similar  to  how  proteins  might  be  tagged  in  a  pulse  labeling  
experiment.  For  long  sampling  windows,  mRNA  and  protein  were  only  weakly  correlated.  
However,  as  the  sampling  window  shorted,  the  correlation  between  instantaneous  
mRNA  and  nascent  protein  increased  (Figure  6-5A,B).  The  relationship  between  
window  duration  and  correlation  was  gene-dependent;;  ACAN  and  COL9  demonstrated  
the  most  persistent  relationships,  while  COLXI  mRNA  and  protein  quickly  lost  correlation  
(Figure  6-5B).  mRNA  half-life  strongly  influenced  correlation  persistence  when  all  other  
parameters  were  held  constant  (Figure  6-5C,D).  Increasing  or  decreasing  mRNA  half-
life  by  four-fold  altered  the  time  at  which  mRNA  and  protein  exhibited  a  correlation  of  
0.50  by  >1  day  (Figure  6-5D).  Independent  perturbation  of  other  model  parameters  had  
minimal  effect,  suggesting  that  mRNA  half-life  was  the  dominant  determinant  of  mRNA-
protein  correlation  in  this  system  (Figure  6-5E).    
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Correlations between nascent and total protein fractions: model and
experiment
These  simulations  also  allowed  us  to  consider  how  apparent  heterogeneity  in  protein  
expression  may  change  with  time.  Using  metabolic  labeling  of  nascent  protein,  we  
previously  noted  that  nascent  protein  fractions  exhibited  greater  cell-to-cell  variability  
than  measurements  of  total  protein  per  cell.146  This  observation  was  replicated  by  the  
simulated  populations,  which  further  demonstrated  the  strong  dependence  of  single-cell  
protein  variation  on  the  temporal  window  considered  (Figure  6-6A).  In  vitro,  nascent  
protein  expression  moderately  correlated  with  total  protein  expressed  by  the  same  cell.  
Notably,  the  nascent-total  protein  correlation  observed  in  vitro  was  greater  than  that  
predicted  by  the  simulations  (Figure  6-6B,C).    This  difference  is  likely  attributable  to  the  
role  of  extrinsic  noise  sources,  which  were  not  incorporated  into  the  model  described  
here.  

Discussion	
  
In  this  study,  quantitative  single  cell  analysis  was  combined  with  stochastic  simulations  
to  illustrate  the  conditions  under  which  instantaneous  mRNA  levels  correlate  with  
nascent  protein  fractions  more  strongly  than  with  total  protein.  In  simulations,  this  
mRNA-nascent  protein  correlation  was  markedly  gene-dependent  and  highly  sensitive  to  
changes  in  the  mRNA  half-life.  Intuitively,  long  or  short  mRNA  half-lives  may  smooth  or  
exacerbate  the  impact  of  stochastic  gene  (in)activation,  and  resultant  transcriptional  
burstiness.  This  finding  complements  previous  work  demonstrating  that  for  a  given  
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Figure  6-6:  Variability  of  and  correlation  between  nascent  and  total  protein  fractions.  A)  Coefficient  of  
variation  describing  labeled  protein  levels,  as  a  function  of  labeling  start  time.  B)  Experimental  
measurements  of  nascent  protein  metabolically  labeled  with  HPG  and  total  protein  stained  with  DTAF.  (n  =  
40-42  cells/condition.)  C)  Correlation  between  nascent  and  total  protein  measurements  in  single  cells.  
Experimental  data  is  shown  in  green  and  simulation  data  is  shown  in  black.  

  
mRNA  half-life,  protein  half-life  is  a  strong  determinant  of  the  mRNA-protein  
correlation.177  
Across  the  transcriptome,  mRNA  half-lives  range  over  multiple  orders  of  magnitude  (<1  
hour  to  years).  mRNA  stability  is  influenced  by  multiple  determinants,  including  the  
126  
  

mRNA’s  inherent  nucleotide  sequence  and  a  host  of  external  factors.  Collectively,  these  
regulatory  mechanisms  allow  the  stability  of  a  given  mRNA  to  vary  across  different  
environments  and  conditions.  For  example,  one  genetically  encoded  determinant  of  
stability  is  the  ‘optimality’  of  a  mRNA’s  codons  (essentially  how  efficiently  the  mRNA  can  
be  translated).169,182  As  tRNA  abundance  changes,  so  too  may  codon  optimality,  and  
thus  mRNA  stability.169  Dynamic  external  regulators  of  mRNA  stability  include  cytokines  
and  mRNA  binding  proteins.182  Two  particularly  relevant  to  chondrogenesis  are  TGFβ  
and  IL-1.  TGFβ  treatment  upregulates  the  expression  of  RNA  binding  proteins  that  
enhance  mRNA  stability,  while  IL-1  stabilizes  mRNA  associated  with  some  inflammatory  
genes.182  Indeed,  for  many  genes,  including  those  encoding  key  components  of  the  
extracellular  matrix,  mRNA  stability  is  reduced  in  osteoarthritis.213  Thus,  while  we  
identified  aggrecan  and  collagen  IX  as  having  the  most  temporally  persistent  mRNA  –  
protein  relationships,  this  finding  may  be  highly  context  dependent.  In  other  situations,  
the  perceived  mRNA-to-protein  correlation  may  differ.    
While  we  found  weak  correlations  between  mRNA  and  protein  levels  for  all  but  the  
shortest  of  labeling  windows,  we  acknowledge  the  importance  of  the  dynamic  range  of  
molecular  count  in  these  calculations.  For  example,  if  a  similar  assay  were  performed  on  
a  mixture  of  two  cell  populations  which  differed  substantially  in  their  average  expression  
(e.g.  one  highly  expressing,  and  one  non-expressing),  the  correlation  measurement  
would  be  dominated  by  the  difference  between  the  two  subpopulations  instead  of  
differences  between  individual  cells.  In  contrast,  isolated  consideration  of  either  
subpopulation  would  likely  suggest  a  weak  correlation  (similar  to  the  conditions  
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described  here).  This  notion  is  consistent  with  the  well  established  experimental  strategy  
of  overexpressing  a  gene  to  bolster  protein  expression.  
One  limitation  of  the  model  presented  here  is  that  it  considered  only  intrinsic  variation,  
and  assumed  that  each  gene-copy,  and  indeed  each  cell,  were  subject  to  identical  
regulation.  Even  for  isogenic  populations  of  relatively  homogenous  cells  (e.g.  
chondrocytes),  extrinsic  noise  arising  from  factors  including  an  individual  cell’s  specific  
lineage,  microenvironment,  and  cell  cycle  stage  also  regulates  mRNA  abundance.  
Extrinsic  noise  is  likely  of  even  greater  importance  for  cell  types  with  significant  cell-to-
cell  variation  in  phenotype  (e.g.  MSCs).  For  example,  the  epigenetic  and  metabolic  
differences  observed  amongst  MSC  populations  represent  an  additional  layer  of  noise  
not  accounted  for  by  this  model.  Existing  frameworks  to  identify  and  model  the  relative  
contributions  of  intrinsic  and  extrinsic  noise  utilize  either  instantaneous  measurements  of  
dual  fluorescent  reporter  expression,  or  time-series  measurements  of  a  single  
reporter.53,63  Such  experiments  in  naïve,  differentiating,  and  committed  cell  types  might  
help  to  elucidate  the  relative  importance  of  extrinsic  noise  in  the  initiation  and  
maintenance  of  chondrogenesis.  Multilayered  models  might  even  shed  light  on  how  
intrinsic  noise  helps  to  establish  sources  of  extrinsic  noise  that  emerge  within  an  initially  
identical  population,  potentially  leading  to  the  predisposition  of  individual  cells  towards  
specific  phenotypic  states.    
In  summary,  this  model  provides  support  to  the  notion  of  a  temporal  influence  on  the  
correlation  between  gene  and  protein  expression  for  matrix  molecules.  Experimental  
evidence  of  such  a  relationship  might  be  demonstrated  by  studies  combining  single  cell  
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quantitation  of  mRNA  abundance  (e.g.  RNA  FISH)  with  measurement  of  nascent  protein  
fractions  (e.g.  FUNCAT).  Progress  towards  these  experiments,  and  other  future  
directions,  will  be  discussed  in  the  next  chapter.  

Methods	
  
Cell isolation & culture
Passage  1  chondrocytes  isolated  from  the  bovine  calve  knee  joints  (Research  87)  were  
encapsulated  in  thin  2%  agarose  microgels  (μgels)  and  cultured  in  chemically  defined  
media  supplemented  with  TGFβ  for  up  to  7  days  as  previously  described  in  Refs.  36,146.  
MMP-mediated  matrix  degradation  was  inhibited  through  the  addition  of  an  MMP  
inhibitor  (Sigma  GM6001,  10  μM)  for  the  duration  of  culture.  
Nascent  protein  was  labeled  during  synthesis  through  the  incorporation  of  a  non-
canonical  methionine  analog  (azidohomoalanine  or  homopropargylglycine),  and  was  
tagged  following  fixation  via  a  click  reaction.146  Total  protein  was  detected  by  staining  
samples  with  200  μM  DTAF  for  1  hour  at  room  temperature.  Proteins  were  imaged  using  
a  Nikon  confocal  microscope  at  100x  magnification.  

RNA Fluorescence In-Situ Hybridization, Imaging, and Quantification
To  measure  single  cell  gene  expression,  single  molecule  RNA  FISH  was  performed  as  
previously  described.36,179  Briefly,  day  7  μgels  were  fixed  in  4%  PFA  and  stored  in  70%  
ethanol  prior  to  in  situ  hybridization.  Samples  were  stained  with  oligonucleotide  probes  
targeting  aggrecan,  collagen  IX,  collagen  XI,  and  perlecan  (Stellaris  oligonucleotides,  
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Biosearch  Technologies)  and  DAPI.  Probes  were  conjugated  with  either  Alexa  594  or  
Atto  647N,  and  their  sequences  are  listed  in  Appendix  1.  For  imaging,  gels  were  
compressed  and  mounted  in  2x  saline  sodium  citrate  buffer.  Image  stacks  
encompassing  the  full  cell  height  were  collected  using  a  Leica  DMI600B  equipped  with  a  
100x  Plan  Apo  objective.  To  quantify  single  cell  gene  expression,  cells  were  manually  
segmented  and  individual  mRNA  spots  were  counted  with  a  custom  MATLAB  script.  The  
transcriptional  state  (active  vs.  inactive)  of  individual  cells  was  assessed  by  manually  
examining  images  for  bright  probe  foci  located  within  the  nucleus,  indicative  of  multiple  
mRNA  that  have  not  yet  diffused  away  from  an  active  transcriptional  site.177  Relative  
fractions  of  actively  transcribing  cells  were  compared  via  chi-squared  test  for  equality  of  
proportions.  
RNA  decay  was  measured  by  inhibiting  transcription  in  living  agarose-encapsulated  
chondrocytes.  Samples  (Day  7  μgels)  were  fixed  after  either  0  or  4  hours  of  treatment  
with  1  μg/ml  actinomycin  D  (Sigma  A1410).  RNA  FISH  was  used  to  quantify  the  
expression  of  ACAN,  COL6a1,  COL9a1,  COL11a1,  and  HSPG2  at  both  timepoints;;  n  >  
84  cells  were  measured  per  condition.  Decay  was  assumed  to  be  exponential,  and  RNA  
half  life  (𝑡Q/S )  was  estimated  as:  
𝑡Q/S =

𝑡
log S (𝑁W − 𝑁X )

  

where  𝑁W     and  𝑁X   are  the  mean  mRNA  copy  number  measured  after  0  and  4  hours  
respectively.    
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For  both  mRNA  half-life  and  transcriptional  state  measurements,  95%  confidence  
intervals  were  constructed  through  bootstrapping  (500  bootstrap  samples/condition).  

Fitting transcriptional parameters to experimental data
The  transcriptional  parameters  λ,  γ,  and  μ  by  were  obtained  by  fitting  experimentally  
measured  mRNA  distributions  with  the  steady-state  solution  to  the  master  equation  
using  the  maximum  likelihood  method  as  described  in  the  supplement  of  Ref.  177.  The  
translation  rate  μp  was  estimated  by  coarsely  calculating  the  number  of  aggrecan  
molecules  capable  of  packing  into  a  chondrocyte’s  pericellular  matrix.  To  do  so,  
aggrecan  molecules  were  considered  as  cylinders  400  nm  long  and  80  nm  in  
diameter,154  and  were  estimated  to  occupy  the  pericellular  matrix  volume  with  50%  
packing  efficiency.  The  pericellular  volume  was  considered  as  a  spherical  shell  with  an  
inner  radius  of  15  μm  and  an  outer  radius  of  22.5  μm  (dimensions  corresponding  to  
chondrocytes  cultured  in  agarose  for  9  days).146  Under  these  conditions,  approximately  3  
million  aggrecan  molecules  could  pack  into  the  periceullar  volume.  The  accumulation  of  
these  molecules  over  9  days  approximately  corresponded  to  𝜇Z   =  0.5  min-1.  Changing  
this  estimate  by  an  order  of  magnitude  had  minimal  impact  on  the  correlation-labeling  
window  relationship,  and  thus  this  estimate  was  deemed  sufficient  (Figure  6-5E).  

Computational simulations
To  model  stochastic  gene  expression,  we  used  the  Gillespie  algorithm  to  govern  the  
evolution  of  mRNA  and  protein  counts  over  time.70  At  each  simulation  step,  the  algorithm  
randomly  selected  which  of  the  five  possible  reactions  (Eq.  6-1)  would  occur  next,  taking  
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into  account  weights  based  on  the  reactions’  relative  propensities  (the  reactant  
concentration  multiplied  by  the  reaction  rate  constant).    Next,  the  algorithm  identified  the  
time  until  the  next  reaction  would  occur  by  selecting  randomly  from  an  exponential  
probability  distribution  function.    Finally,  the  algorithm  executed  the  chosen  reaction  by  
changing  the  number  of  molecules  in  the  system  and  advancing  the  simulation  time.  For  
each  condition  described,  gene  and  protein  expression  of  1,000  cells  was  simulated  over  
9  days  of  simulation  time  using  custom  C  code.177    Simulation  data  was  recorded  at  10  
minute  intervals  for  subsequent  analysis.  
  
  
    

  

132  
  

  Summary	
  and	
  Future	
  Directions	
  
Summary	
  
Mesenchymal  stem  cells  display  substantial  cell-to-cell  variation.  Their  heterogeneity  
manifests  across  many  aspects  of  cell  phenotype,  including  differentiation  capacity,  
molecular  signature,  and  cellular  biophysics.  Such  pervasive  variability  complicates  the  
use  of  MSCs  in  regenerative  applications  and  potentially  limits  their  therapeutic  
efficacy.86  As  a  result,  strategies  to  leverage  or  otherwise  mitigate  this  variability  could  
ultimately  improve  the  clinical  performance  of  MSC-based  therapies.  However,  most  
conventional  assays  measure  MSC  properties  in  bulk  and,  as  a  consequence,  mask  this  
cell-to-cell  variation.  To  better  understand  the  nature  of  MSC  heterogeneity  and  its  
underlying  mechanisms,  we  have  quantitatively  assessed  MSC  phenotype  at  the  clonal  
and  single  cell  level.  We  conducted  this  investigation  within  the  context  of  
chondrogenesis,  and  have  contrasted  MSC  heterogeneity  against  the  single  cell  
behavior  of  chondrocytes,  the  relatively  homogenous  cells  found  in  native  cartilage.    
In  Chapter  3,  we  observed  that  MSC  heterogeneity  extends  to  include  aspects  of  cellular  
mechanotransduction.  Clonal  MSC  populations  differed  morphologically  and  also  varied  
in  their  contractility,  ability  to  transmit  extracellular  strain  the  nucleus,  and  capacity  to  
form  mechanically  competent  cartilage-like  matrix.  Clones  also  differed  in  their  
transcriptional  signature,  but  variability  within  a  clone  was  similar  to  the  variation  
observed  between  clones  (Chapter  4).    
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In  Chapter  4,  we  used  single  molecule  RNA  FISH  to  query  the  mRNA  expression  levels  
of  conventional  differentiation  markers  (aggrecan,  cartilage  oligomeric  matrix  protein,  
Sox9,  osteopontin,  and  lipoprotein  lipase)  at  the  single  cell  level,  and  found  that  both  
primary  chondrocytes  and  chondrogenically-induced  MSCs  showed  substantial  mRNA  
expression  heterogeneity.  Even  small  MSC  colonies  and  sister  cell  pairs  showed  high  
cell-to-cell  variation  in  transcript  abundance,  suggesting  that  marker  mRNA  expression  
was  not  heritable  through  cell  division.  Surprisingly,  this  variation  in  marker  transcript  
levels  only  weakly  associated  with  cartilage-like  matrix  production  at  the  single  cell  level.  
Furthermore,  transcriptome-wide  analysis  of  single  cell  derived  clones  suggested  that  
other  markers,  either  alone  or  in  linear  combination,  did  not  correlate  with  functional  
potential.  This  RNA-protein  disconnect  was  also  apparent  in  fully  differentiated  cells:  as  
primary  chondrocytes  dedifferentiated  with  monolayer  expansion,  mRNA  expression  of  
the  cartilage  marker  aggrecan  did  not  correlate  with  the  extent  of  cartilage-like  matrix  
accumulation.  Together,  these  quantitative  analyses  suggested  that  efforts  to  sort  
chondrogenically  “superior”  MSC  subpopulations  based  on  these  markers  would  only  
marginally  enrich  the  progenitor  population.  Our  results  also  suggested  that,  although  
canonical  markers  have  very  clear  functional  roles  in  differentiation  and  matrix  formation,  
their  instantaneous  mRNA  abundance  is  only  tenuously  linked  to  the  chondrogenic  
phenotype  and  matrix  accumulation  at  the  single  cell  level.    
One  possible  explanation  for  the  apparent  disconnect  between  gene  and  protein  
expression  is  that  mRNA  and  protein  exhibit  different  temporal  dynamics.  Chiefly,  in  
comparison  to  mRNA,  extracellular  matrix  proteins  are    stable  over  much  longer  time  
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frames  and  tend  to  accumulate  in  developing  tissue  engineered  constructs.  As  a  result,  
the  assessment  of  mRNA  and  protein  abundance  over  time  might  provide  insight  into  
what  governs  their  correlation.  However,  quantifying  the  spatiotemporal  organization  of  
matrix  proteins  is  challenging  using  standard  techniques.  In  Chapter  5  we  addressed  
these  challenges  by  using  noncanonical  amino  acid  tagging  to  fluorescently  label  
extracellular  matrix  synthesized  in  the  presence  of  bio-orthogonal  methionine  analogs.  
This  strategy  labeled  matrix  proteins  with  high  resolution,  without  compromising  their  
distribution  or  mechanical  function.  We  demonstrated  that  the  organization  and  temporal  
dynamics  of  the  proteinaceous  matrix  depended  on  the  biophysical  features  of  the  
microenvironment,  including  the  biomaterial  scaffold  and  the  niche  constructed  by  cells  
themselves.  Pulse  labeling  experiments  revealed  that,  in  immature  constructs,  nascent  
matrix  was  highly  fibrous  and  interdigitated  with  pre-existing  matrix,  while  in  more  
developed  constructs,  nascent  matrix  lacked  fibrous  organization  and  was  retained  in  
the  immediate  pericellular  matrix.  Inhibition  of  collagen  crosslinking  increased  matrix  
synthesis,  but  compromised  matrix  organization.  Finally,  these  data  demonstrated  
marked  cell-to-cell  heterogeneity  in  nascent  matrix  production  amongst  both  
chondrocytes  and  mesenchymal  stem  cells  undergoing  chondrogenesis.    Collectively,  
these  results  introduced  fluorescent  noncanonical  amino  acid  tagging  as  a  strategy  to  
investigate  spatiotemporal  matrix  organization,  and  demonstrated  its  ability  to  identify  
differences  in  phenotype,  microenvironment,  and  matrix  assembly  at  the  single  cell  level.  
We  then  united  these  notions  of  transcriptional  stochasticity  and  temporal  matrix  
dynamics  in  Chapter  6,  where  we  assessed  the  impact  of  mRNA  kinetics  (production  
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and  degradation)  on  the  correlation  between  mRNA  and  protein,  and  defined  its  
dependence  on  the  observational  window  utilized.    To  do  so,  we  computationally  
simulated  stochastic  gene  and  protein  expression  at  the  single  cell  level  for  five  matrix  
genes:  aggrecan,  collagen  IV,  collagen  IX,  collagen  XI,  and  perlecan.  For  each  gene,  
simulation  parameters  reflecting  transcriptional  dynamics  were  identified  through  
experimental  measurement  of  single  cell  gene  expression.  These  experimentally  derived  
parameters  yielded  simulations  that  demonstrated  both  transcriptional  bursting  and  a  
lack  of  correlation  between  instantaneous  mRNA  and  total  protein  levels  –  results  that  
were  consistent  with  our  experimental  observations  in  Chapter  4.    Intriguingly,  
shortening  the  window  of  protein  considered  (analogous  to  how  nascent  protein  labeling  
would  tag  a  temporal  fraction  of  the  proteinaceous  matrix)  increased  the  correlation  
between  mRNA  and  protein  abundance.    This  model  further  illustrated  how  mRNA  
stability  was  a  crucial  determinant  of  the  timescale  over  which  any  such  correlation  
persists.    

Future	
  directions	
  
Defining the role of observation window on mRNA-protein correlations
A  logical  extension  of  the  work  presented  here  would  be  to  experimentally  test  the  
hypotheses  put  forth  by  the  model  described  in  Chapter  6  first,  that  timing  and  
observational  window  strongly  influence  the  correlation  between  mRNA  and  protein  at  
the  single  gene/single  cell  level,  and  second,  that  mRNA  abundance  will  correlate  
strongly  with  nascent  matrix  deposition,  but  only  weakly  with  total  matrix  deposition.  One  
strategy  to  experimentally  test  this  hypothesis  is  to  combine  FUNCAT  and  RNA  FISH,  
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thus  enabling  the  simultaneous  measurement  of  nascent  protein  and  instantaneous  
mRNA  abundance.  Towards  this  end,  we  have  obtained  preliminary  data  suggesting  that  
the  RNA  FISH  and  FUNCAT  techniques  are  compatible.  The  combination  of  FUNCAT  
and  RNA  FISH  techniques  minimally  impacted  the  signal  of  each.  Our  early  data  show  
that  mRNA  abundance  was  unaltered  by  exposure  to  the  FUNCAT  reaction  mixture  in  
samples  cultured  with  native  methionine  (Figure  7-1A).  FUNCAT  intensity  was  similarly  
unaffected  (Figure  7-1B).  Furthermore,  while  all  of  the  FUNCAT  imaging  presented  in  
Chapter  5  was  performed  on  a  confocal  microscope,  labeled  nascent  matrix  can  also  be  
imaged  on  fluorescent  microscopes  optimized  for  FISH  imaging  (Figure  7-1C-E).  
Indeed,  cell-by-cell  comparisons  of  detected  signal  demonstrate  strong  correlation  
between  the  two  microscope  types,  with  the  exception  of  situations  with  high  out-of-
plane  fluorescence  due  to  vertically  stacked  cells  (Figure  7-1E).  Thus,  we  are  poised  to  
experimentally  query  the  relationship  between  instantaneous  mRNA  expression,  and  
nascent  and  total  protein  expression.    These  studies  are  ongoing.  
An  alternative  strategy  to  test  these  hypotheses  would  be  to  combine  continuous  
measurements  of  RNA  abundance  with  assays  for  either  nascent  or  total  protein  levels.  
For  example,  temporal  averages  of  mRNA  over  time  in  individual  cells  could  be  reported  
through  the  use  of  molecular  beacons  or  genetically  engineered  reporter  proteins.  
Following  a  period  of  live  cell  imaging,  these  time-averaged  mRNA  measurements  could  
be  compared  with  nascent  protein  labeled  during  the  same  window,  or  final  total  protein  
levels.    
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Figure  7-1:  Preliminary  controls  related  to  the  combination  of  FUNCAT  and  RNA  FISH.  A)  Histograms  
and  smoothed  PDFs  of  single  cell  GAPDH  mRNA  abundance,  with  and  without  the  FUNCAT  reaction.  B)  
th
th
FUNCAT  intensity  with  and  without  RNA  FISH  hybridization.  Lines  represent  median  intensity  ±  25   and  75   
percentiles.  C-D)  Images  of  the  same  FUNCAT-labeled  cell,  taken  on  an  inverted  fluorescence  microscope  
optimized  for  FISH  (C)  and  a  confocal  microscope  (D).  E)  Comparison  of  mean  FUNCAT  pixel  intensity  
detected  using  an  inverted  fluorescence  microscope  and  a  confocal  microscope.  The  same  cells  were  
imaged  using  each  microscope;;  the  pink  points  indicated  locations  where  there  was  substantial  out-of-plane  
fluorescent  intensity.    These  points  were  included  in  the  calculation  of  linear  fit  (black  line  ±  grey  confidence  
interval)  and  the  correlation.  n  =  19  cells.  

Leveraging heterogeneity to improve outcomes in cartilage tissue
engineering
A  second  possible  avenue  of  future  study  is  the  application  of  our  understanding  of  
heterogeneity  to  develop  more  robust  tissue  engineered  cartilage  replacements.  The  
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path  towards  this  goal  is  less  well  defined,  but  may  include  implementing  cell  sorting  
prior  to  construct  fabrication,  or  using  transcriptome-wide  screens  to  identify  novel  
predictive  markers  of  chondrogenesis  whose  mRNA  fluctuations  are  less  stochastic  in  
nature.  
We  initially  hypothesized  that  highly  chondrogenic  MSCs  could  be  prospectively  
identified  based  on  their  aggrecan  mRNA  levels.  However,  perhaps  the  most  striking  
finding  of  this  work  is  that,  at  the  single  cell  level,  instantaneous  aggrecan  mRNA  
abundance  was  a  poor  predictor  of  the  amount  of  aggrecan  protein  content  accumulated  
during  chondrogenic  culture.  Computational  simulations  of  how  sorting  might  perform  
suggested  that  selecting  cells  based  on  instantaneous  aggrecan  expression  would  only  
slightly  enrich  the  fraction  of  highly  chondrogenic  cells.  At  the  same  time,  the  number  of  
cells  would  be  greatly  reduced  due  to  the  exclusion  of  cells  with  high  chondrogenic  
capacity.    
However,  this  is  not  to  say  that  efforts  to  sort  MSCs  should  be  abandoned.  While  our  
findings  are  consistent  with  a  growing  body  of  evidence  that  finds  discordance  between  
mRNA  and  protein  abundance  at  the  single  cell  level,  they  contrast  with  the  success  of  
recent  efforts  using  live-cell  mRNA  measurements  to  identify  the  most  osteogenic  
MSCs.  Both  molecular  beacons  (targeting  alkaline  phosphatase)  and  SmartFlares  
(targeting  Sox9  and  Runx2)  have  been  used  to  isolate  highly  osteogenic  MSC  
subpopulations.123,138  This  raises  the  question:  why  does  mRNA-based  sorting  appear  to  
be  effective  for  osteogenic  progenitors?  These  mRNA  do  not  appear  to  have  
extraordinary  stability  (alkaline  phosphotase:  t1/2  =  21  hrs,  Sox9:  1.7  hrs,  Runx2:  6.1  hrs,  
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in  embryonic  stem  cells),  so  their  performance  is  not  attributable  to  mRNA  dynamics.196  
One  possibility  is  that  the  markers  used  to  query  osteogenic  potential  are  simply  better  
suited  to  this  type  of  application  than  the  chondrogenic  markers  we  considered.  For  
example,  the  osteogenic  markers  may  exhibit  greater  differential  expression  between  
high-  and  low-potential  cells,  and  perhaps  these  differences  would  be  detectable  despite  
temporal  fluctuations  in  mRNA  abundance.    
If  this  were  the  case,  one  way  to  improve  cell  selection  for  chondrogenesis  would  be  to  
identify  more  predictive  markers.  In  Chapter  4,  we  noted  that  the  poor  performance  of  
our  in  silico  sort  did  not  seem  to  be  due  to  our  choice  of  marker:  other  chondrogenic  
markers,  markers  of  alternative  fates,  and  combinations  thereof  were  similarly  unable  to  
predict  single  cell  matrix  accumulation,  either  alone  or  in  combination.    Additionally,  we  
performed  paired  RNA  sequencing  and  proteoglycan  assays,  and  found  that  at  the  
ensemble  level,  aggrecan  was  one  of  the  best  predictors  of  extracellular  matrix  
accumulation.  However,  one  limitation  of  this  RNA  sequencing  study  is  that  it  compared  
gene  expression  in  naïve  MSCs  with  their  ultimate  matrix  deposition.  The  osteogenic  
selection  studies  have  identified  the  need  for  an  osteogenic  priming  period  prior  to  cell  
sorting.  This  priming  period  appears  necessary  to  elevate  gene  expression  in  the  
responsive  cells.  It  is  possible  that  a  similar  transcriptomic  screen  following  priming  
exposure  to  chondrogenic  stimuli  could  identify  non-canonical  markers  of  
chondrogenesis.    
The  disparity  between  the  osteogeneic  sorting  experiments  and  our  projections  of  
chondrogenic  sorting  may  also  be  due  to  measurement  technique.  Here,  we  performed  
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RNA  FISH  in  intact,  fixed  cells  and  obtained  measurements  of  the  exact  mRNA  copy  
number.  The  live  cell  techniques  instead  yield  more  approximate  measurements  and  
may  smooth  temporal  fluctuations  in  mRNA  abundance.  For  example,  perhaps  oligo-
mRNA  binding  and  any  re-conjugation  between  SmartFlare’s  fluorophore  and  quencher  
are  slightly  delayed  following  changes  in  mRNA  abundance.  Indeed,  molecular  beacons  
targeting  the  adipogenesis  marker  PPARG  take  approximately  25  minutes  to  fully  detect  
control  cDNA  in  a  microplate  assay.115  Depending  on  the  specific  kinetics  of  an  mRNA  
and  its  corresponding  probe,  a  temporal  lag  could  allow  fluorescent  intensity  to  reflect  
some  quasi-average  of  mRNA  abundance  over  time.  If  so,  it  is  possible  that  a  
temporally-averaged  measurement  would  be  more  predictive  of  cell  propensity  than  truly  
instantaneous  measures.  Thus,  despite  our  RNA-FISH  findings,  it  may  be  worthwhile  to  
assess  chondrogenic  potential  in  experimentally  sorted  populations.  
Even  given  an  mRNA  target  and  measurement  technique  capable  of  identifying  high  
potential  cells,  there  are  additional  challenges  associated  with  the  practical  
implementation  of  a  cell  sorting  strategy.  If  cells  must  be  primed  to  assess  their  
chondrogenic  potential,  it  would  be  necessary  to  culture  MSC  monolayers  in  pro-
chondrogenic  media.  However,  traditional  chondrogenic  media  induces  high  cellular  
contractility  and  often  causes  MSCs  to  detach  from  the  culture  surface  after  ~  3-5  days  –  
a  duration  shorter  than  the  priming  windows  used  for  osteogenic  sorting.123,138  Thus,  to  
avoid  cell  detachment,  it  would  be  necessary  to  determine  if  shorter  priming  durations  
would  be  sufficient  to  elevate  target  mRNA  expression,  or  if  priming  could  occur  without  
the  upregulation  of  contractility.  Additionally,  the  use  of  molecular  beacons  requires  
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cellular  permeabilization,  and  while  SmartFlares  can  be  endocytosed,  there  are  
concerns  about  the  mechanisms  and  kinetics  of  their  uptake.35    
If  mRNA  expression  is  not  the  ideal  metric  to  predict  chondrogeneis,  it  is  possible  that  
other  assays  may  prove  more  effective.  We  observed  correlation  between  nascent  and  
total  protein  at  the  single  cell  level,  suggesting  that  there  is  indeed  temporally  persistent  
cell-to-cell  heterogeneity  in  matrix  production.  Intuitively  then,  something  must  determine  
a  cell’s  chondrogenic  potential.  As  discussed  in  Chapter  2,  there  are  many  other  
dimensions  of  MSC  heterogeneity,  and  they  may  hold  the  key  to  successful  
chondrogenic  enrichment.  For  example,  biophysical  sorting  of  MSCs  could  be  smoothly  
integrated  into  isolation  and  expansion  procedures122,  and  it  may  be  possible  to  identify  
a  biophysical  chondrogenic  signature.  

Modulating	
  MSC	
  heterogeneity	
  
In  Chapter  5,  our  data  hinted  at  the  notion  that  matrix  heterogeneity  may  be  influenced  
by  the  encapsulating  biomaterial  construct.  At  high  concentrations  of  agarose  (4%  w/v),  
the  accumulation  of  extracellular  matrix  proteins  was  restricted  to  a  tight  band  around  
the  cells.  Conversely,  in  low  concentration  gels  (2%  w/v),  the  matrix  diffused  throughout  
the  construct,  and  effectively  homogenized  the  environment.  At  an  intermediate  
concentration  (3%),  the  matrix  remained  associated  with  individual  cells,  but  extended  
sufficiently  from  the  cells  to  exhibit  substantial  cell-to-cell  variation.  While  it  is  not  yet  
clear  if  gel  density  modulated  cell-to-cell  variation  in  matrix  quantity  (vs.  modulating  
variation  in  spatial  distribution),  these  data  raise  the  question  of  if  the  choice  of  
biomaterial  platform  governs  MSC  heterogeneity.    
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Figure  7-2:  Schematic  of  possible  distributions  underlying  population-level  improvement  in  
differentiation  potential  (μ1  →  μ2).  i)  Example  distribution  of  baseline  performance.  The  choice  of  bimodal  
behavior  is  for  illustrative  purposes  only,  and  may  not  reflect  the  true  distribution  of  chondrogenic  
differentiation  capacity.  ii  –  iv)  Possible  distributions  exhibiting  improved  mean  behavior.  ii)  Uniform  
improvement.  iii)  Improvement  amongst  high  performing  cells  only.  iv)  Improvement  amongst  low  performing  
cells  only.  

  
Numerous  biomaterial  systems  have  been  shown  to  enhance  MSC  chondrogenesis.  Is  
this  accomplished  by  improving  the  performance  of  the  entire  MSC  population  (i.e.  
shifting  the  entire  distribution,  Figure  7-2i,ii)?  Alternatively,  do  sub-populations  
differentially  respond  to  these  microenvironmental  stimuli?  For  example,  the  most  
chondrogenic  cells  could  become  even  more  chondrogenic,  while  the  least  chondrogenic  
cells  remain  unaffected  (Figure  7-2iii).  Alternatively,  an  environmental  stimulus  could  
improve  the  performance  of  the  least  chondrogenic  cells,  while  having  minimal  effect  on  
the  most  chondrogenic  subpopulations  (Figure  7-2iv).    
It  would  be  of  particular  interest  to  examine  how  biologically  active  biomaterials  regulate  
such  cell-to-cell  variability  (e.g.  hyaluronic  acid  ±  N-cadherin  moieties).  Additional  stimuli  
of  interest  include  hypertrophic  conditions,  co-culture  between  MSCs  and  chondrocytes,  
and  the  use  of  active  mechanical  loading  to  induce  chondrogenesis.  It  is  tempting  to  
speculate  that  if  two  pro-chondrogenic  stimuli  shift  the  distribution  in  different  ways,  they  
might  combine  synergistically.  Additionally,  improved  understanding  of  the  biological  
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pathways  underlying  MSC  heterogeneity  may  reveal  opportunities  to  modify  poorly  
performing  cells  and  enhance  their  chondrogenic  capacity,  or  to  identify  them  early  in  the  
process,  and  remove  them  from  the  population.  

Conclusion	
  
To  conclude,  tissue  engineering  with  adult  mesenchymal  stem  cells  is  a  promising  
avenue  of  research  in  regenerative  medicine.  However,  not  all  MSCs  have  the  same  
functional  potential,  and  individual  MSCs  differ  in  their  responses  to  the  same  
differentiation  cues.  Here,  we  have  begun  to  understand  MSC  heterogeneity  as  it  applies  
to  cartilage  tissue  engineering,  with  the  ultimate  goal  of  developing  strategies  to  identify  
MSC  subpopulations  best  suited  for  cartilage  tissue  engineering.  These  studies  create  a  
foundation  for  future  tissue  engineering  work  wherein  heterogeneity  is  minimized  to  
“synchronize”  MSCs  or  prospectively  isolate  only  those  MSCs  most  likely  to  robustly  
undergo  chondrogenesis,  potentially  improving  therapeutic  outcomes.  
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Appendix	
  1:	
  RNA	
  FISH	
  probe	
  sequences	
  
Oligonucleotide  probe  sequences  used  to  quantify  mRNA  abundance.    
  
Target  
Aggrecan  
Collagen  VI  alpha  1  
Collagen  IX  alpha  1  
    
ACAN  
COL6A1  
COL9A1  
#  probes:   32  probes  
32  probes  
32  probes  
Probe  1  
gtccttgtctccatagcaac  
cagcacaaagaacaggtcca   acgcttgacagtcactgatg  
Probe  2  
acacgtcataggtttcgttg  
tggtgaaggacttgaccttg  
aatcatcttgtccaatcctg  
Probe  3  
cttggaaggtgaacttctcc  
tgtcgttcaggttgtcaatg  
ctggatgctgctttatctat  
Probe  4  
tttctgggatgtccacaaag  
acttcgtcgctatagtgcag  
ctgtaaggcagttgatccaa  
Probe  5  
cccttacttcagggacaaac  
ctttccgaagtacttgacgg  
ggttggaatcctgaagtcta  
Probe  6  
actgatgtcctctactccag  
ccacaaccaagtacttgttc  
cttccagtcatccgaaaagt  
Probe  7  
gcagagatttctggaccttc  
acggagaagactttgatgcc  
ctgaggaatcctgaatctgc  
Probe  8  
actgatgtcctctactccag  
atggtctggctgatgacttc  
gtttggccattaatcttcac  
Probe  9  
aaggtcctctactccagaag  
tgatcatgtcggtgatggtg  
aaaggctgcagtttggagac  
Probe  10   agaaggaagtccactaaggt  
cacacttgctccacattatt  
ggaatcgaacaaggagggca  
Probe  11   agtctgctgagatcctctac  
tccttggataccatcgaatc  
cgccaatcatgatcttatgc  
Probe  12   tctactccagaagcagagac  
gcaatgtcattattgtcctc  
cgaaaagagtcgcactgctc  
Probe  13   actgatgtcctctactccag  
tccaaaatctcgcattcgtc  
taaggactcaatcctgttgc  
Probe  14   caccagaaggaagaacactg  
actcacagcaagagcacatt  
tttgacctcttggctttata  
Probe  15   actgatgtcctctactccag  
gcacgaagaggatgtcgatg   tcagcatccattgaagttca  
Probe  16   actgatgtcctctactccag  
gcgatctcgaagttctgtag  
accaggaattcctggagaac  
Probe  17   cctccagaaggaagtctact  
ggtcaatgaccttgacgatg  
aatcctatatctccgagttc  
Probe  18   agaaggaagtccactaaggt  
ctcaaacttgaccagctcat  
atgcaaacctgcttgatgtg  
Probe  19   gaaggtattctgccaaggtc  
atctggttgtggctgtactg  
catctgagcaaagtgctctt  
Probe  20   gtccactgaaatcaggaagg  
caatgcggttgttcggagtg  
aacctgatggtcagatcgac  
Probe  21   caaagagtccagaggtttcc  
caagccaaagacatccttga  
ttgctgaatagcaccattgt  
Probe  22   ccactaatgtcaggaaaccc  
caggagatgacgttgagctg  
caaaaggaggggtgttgtct  
Probe  23   gtcacgccagatatttctcc  
gttttccttgaccaatgaga  
agaacacgcgctcactacaa  
Probe  24   gatttctggttgtccagagg  
gcagtgatgttcttcaggaa  
aaatccttgcagagctggaa  
Probe  25   caattgctccagaagacagt  
ggacatttcttgtctatgca  
gggctgcttcttaactaatc  
Probe  26   aagttccagaatgcctgaag  
caggaggatggtgatgtcgg  
agcaccaattctcttgacag  
Probe  27   ccaaagatcccaaatggtct  
gcgtttggtgatgtcaaagt  
agcagaaaggcaagctgacg  
Probe  28   accactggattcaaaaagct  
gtgtagttctgcaggaactg  
gggtttggatacagtacagt  
Probe  29   tgggactgatgacacttcta  
gagttgccatccgagaagag   tggacgagcccaaaatacga  
Probe  30   cagatcagcttcatggaagg  
cgaagaccacgtcatactca  
acttcttttcattgaaccca  
Probe  31   ggattcgatttctagacgcg  
taactgggcacgcggaacag   acacaggcctacagaaatgc  
Probe  32   attgatctcgtatcggtcct  
gacaccgtctggtagaagac  
ggagcagaaagggcttttta  
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Cartilage  Oligomeric  Matrix  
Protein  
    
COL11A1  
COMP  
#  probes:   32  probes  
32  probes  
Probe  1  
aaatcgcgattgcagaccta   gtaatctccttgacctgctg  
Probe  2  
cgcactcacaactgtgaact   catcaccgtgtttttcagga  
Probe  3  
gttgttatggtgaaatccca  
gttggctgtctcggtacaag  
Probe  4  
gttgtttttgatattccctc  
ctggtattgatgcagcgaac  
Probe  5  
gtgtggtcttcatacaggaa  
cgtacaaacctgcttgttgg  
Probe  6  
ttccattggtgtcaacgatt  
cggtctcacactcgttaatg  
Probe  7  
cccctcaaaaacttcttcat  
attgacgcatacagagttgg  
Probe  8  
tggactgtaatgctcacagt  
gaaagccgtctaagtctgtg  
Probe  9  
tgatccagatacactcctag  
cagttgtcctttctgcactg  
Probe  10   ttcttcaactggatttggct  
gcagttgtccttctcattga  
Probe  11   cataatcctctccagttaga  
cttgtcgccatccgtatttc  
Probe  12   attagtgggacttgttggtt  
cattctggtcgtcgttcttc  
Probe  13   atctgtttctgctggaacac  
ctttctgatctgagttgggc  
Probe  14   ttcaataagcatgccaggtt  
ttgtcacaggcatctcctac  
Probe  15   actaacatggtaccaggagg   gtctgcgttgctcttctgag  
Probe  16   gaagtccatcaaatcctcga   gtcttggtcgctgtcacaa  
Probe  17   gaatccaactggaccttgag   cagttgtccttcgagtcctg  
Probe  18   accaactggaccttgaagac   ccatcattgtcgtcatcgtc  
Probe  19   accaggatctccaggaaaac   ctagacggcagttgtcccta  
Probe  20   ggaaccaaatatttcctcca  
accttgtccgcatcaaagtc  
Probe  21   acttcatatgctcgatgtct  
ggacacacatcgatcttgtc  
Probe  22   gttgcagatctttgcaagtt  
acccagttagggtctatctg  
Probe  23   tcctttggccatgatgaaat  
atctccataccctggttgag  
Probe  24   gaaattttgccgagcagagg   gtcgctgttcatcgtctgta  
Probe  25   tgatcccaagaaccgaagtg   tggaacgtgccttcgaaatc  
Probe  26   tgtcctaatcttagccaaga  
ggtagccaaagatgaaacca  
Probe  27   aaatgggttggtggtaccaa   catgaccacatagaagctgg  
Probe  28   acatccttgatggatgggaa  
cagtacgtctgctccatctg  
Probe  29   ggaattcagagacacgtgca   taggatgtcttgtccttcca  
Probe  30   ccaaaagtcttccaggtttt  
cctcgtagaatcgcactcta  
Probe  31   gaagagttgctcggtatgtg  
catggtcgtatccaggatca  
Probe  32   ttctcatacacgttttcctg  
atgatgttctcctgggagaa  
  
  
Target  

Collagen  XI  alpha  1  
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GAPDH  
GAPDH  
20  probes  
agaattaaaagcagccctgg  
tcattgatggcgacgatgtc  
agaccatgtagtgaaggtca  
ttgactgtgccgttgaactt  
ctttccattgatgacgagct  
gatctcgctcctggaagatg  
tctccatggtagtgaagacc  
agagatgatgaccctcttgg  
ttgttatacttctcgtggtt  
gaggcattgctgacaatctt  
ccaaagtggtcatggatgac  
aagcagggatgatattctgg  
ttgagctcagggatgacctt  
gtcagatccacaacagacac  
catacttggcaggtttctcc  
gtcctcagtgtagcctagaa  
tgagtgtcgctgttgaagtc  
aatgagcttgacaaagtggt  
ttgctgtagccgaattcatt  
tactccttggaggccatgtg  
  
  
  
  
  
  
  
  
  
  
  
  

Target  
    
#  probes:  
Probe  1  
Probe  2  
Probe  3  
Probe  4  
Probe  5  
Probe  6  
Probe  7  
Probe  8  
Probe  9  
Probe  10  
Probe  11  
Probe  12  
Probe  13  
Probe  14  
Probe  15  
Probe  16  
Probe  17  
Probe  18  
Probe  19  
Probe  20  
Probe  21  
Probe  22  
Probe  23  
Probe  24  
Probe  25  
Probe  26  
Probe  27  
Probe  28  
Probe  29  
Probe  30  
Probe  31  
Probe  32  

Perlecan  
HSPG2  
32  probes  
gaaatttaccagtgctcgga  
ctcacaatcgagctcatcag  
agtctccagttgatgatagg  
cacaggacaagccggaatag  
tctgtgtccagaaagcaagt  
ccaatggcatggaggagaat  
atcttcacgagaccagtaga  
atgatggagattccgacagg  
gtacattgcgaatggtcagg  
ccatggcgaacatattggag  
cacacagaggtaaaagccgg  
aaggacgaccacttgaatcc  
gtggaggacagagacgatga  
gaagatgtacaagcgggagc  
ttggtgactgtgactgtgat  
acagagtctacaggctcaat  
tgtgaggaggatgactcgat  
tactgacatggcacacgtac  
ctggatggtgacgatgagtg  
tgggaagacgacgactcgat  
cgggtcaatggagatcacag  
catggacgaggcacttgaag  
tgaggttcacaacactctgg  
tctgacggtttagctgatga  
tctacaatcacttccactcg  
gatgagtacggatggcagag  
catgcaagggaagacagctg  
aaggagatgaagtcgggctg  
tgaggtcgtggaagacgatc  
acacagacactggaactcgt  
ggaagccgttgtcatagaag  
ttaatggggtcttcggagac  

Lipoprotein  Lipase  
LPL  
32  probes  
ggagtcctgagagcaaattt  
caggaatgaggtggcaagtg  
tgctgtggttgaagtgacag  
caactctcatacattcctgt  
gacactggataatgctgctg  
ataaacttggccacatcctg  
agttaaattcatccgccatc  
atcccaagagatgcacattg  
ttcttattggtcagacttcc  
catactcgaagttaggtcca  
caggagaaaggcgacttgga  
ccctggtgaatgtgtgtaaa  
ttctggattccgatacttcg  
cgttagggtaaatgtccaca  
caatgttacatcctggttgg  
ctctgcaatcacacggagag  
taggccttacttggattttc  
ggcagagacctttctcaaag  
tgaccttgttgatctcgtag  
tacatcttgctgcttctttt  
gcatctgagaacgagtcttc  
cctggttggtgtatgtatta  
cagtgccatacagagagatc  
aaaagggatgttctcgctct  
ttgtggaaacttcaggcagg  
aatatccacctccgtgtaaa  
ggaccagctgaagtaggaat  
cacctttttttgagtctctc  
gataagacattttctcccgg  
tatcacaggtgactttcctt  
acttgtcatggcatttcaca  
cagccagactttctattcag  
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Osteopontin  
OPN  
24  probes  
cccaagaggcagaagcaaat  
gtttaactggaagggcggag  
tacagcatctgggtatttgt  
aagtctgcttctgagatggg  
gacacagaattctgtggtgc  
gggtattttgtttgttgtca  
ggctttcattggacttactt  
gtcatctagatcgtctgttt  
cgtcggagtcattagagttg  
aatggtcagggtcatcagtg  
tcagaatggtgagactcgtc  
gcgattgttggaatatcagt  
ccgtagggataaacggagtg  
tcttgacttcagtccgtaag  
ttagatcggcggaacttctt  
tgtggcatctggactctgaa  
ctgactcgtcttcttaggtg  
tggcgtgagttctttggaaa  
gaatgcttgttcttatcctt  
tttcctgactctcaatcaga  
aattcttggctgagtttgga  
atgatctaggtctagcttgt  
tttcaggtgtttgtcttctt  
attgacctcagaagaggcac  
  
  
  
  
  
  
  
  

Target  
    
#  probes:  
Probe  1  
Probe  2  
Probe  3  
Probe  4  
Probe  5  
Probe  6  
Probe  7  

Sox9  
SOX9  
7  probes  
aaggggtccaggagattcat  
ctgctcgtcggtcatcttca  
cttggggaacgtgttctcct  
gacggcctcgcggatgcaca  
cgtagcccttgagcacctgg  
ggcatgggcaccagcgtcca  
Ttgttcttgctcgagccgtt  
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Appendix	
  2:	
  Supplementary	
  statistical	
  analysis	
  related	
  to	
  Chapter	
  
4  
Supplementary  Table  1  
Comparison  

Adjusted  P-
value  

-TGFB  vs  +TGFB,  Day  01   0.3572  
-TGFB  vs  +TGFB,  Day  04   0.0827  
-TGFB  vs  +TGFB,  Day  07   0.0361  
-TGFB  vs  +TGFB,  Day  14   0.9479  
-TGFB  vs  +TGFB,  Day  21   0.9980  
+TGFB,  Day  1  vs  Day  4  

0.0022  

+TGFB,  Day  1  vs  Day  7  

0.4637  

+TGFB,  Day  1  vs  Day  14  

<.0001  

+TGFB,  Day  1  vs  Day  21  

0.0002  

+TGFB,  Day  4  vs  Day  7  

0.0019  

+TGFB,  Day  4  vs  Day  14  

0.0002  

+TGFB,  Day  4  vs  Day  21  

0.0009  

+TGFB,  Day  7  vs  Day  14  

<.0001  

+TGFB,  Day  7  vs  Day  21  

0.0002  

+TGFB,  Day  14  vs  Day  21   0.0016  
Supplementary  Table  1:  Additional  statistical  information  related  to  GAPDH  RNA  abundance  
differentiating  MSCs.  Companion  table  to  Supplementary  Figure  4-1b.  P-values  indicated  for  all  planned  
contrasts  between  –TGFβ  and  +TGFβ  groups  over  21  days  of  culture.  GAPDH  RNA  count  means  compared  
by  t-tests  with  Satterthwaite  approximation  and  simulated  adjustment  for  multiple  comparisons.  
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Supplementary  Table  2  
Timepoint/Gene  Pair  

r2  

Pearson’s  correlation  coefficient   p-value  

Day  1  aggrecan  -  osteopontin  

0.24  

0.49  

1.0e-07  

.34  

.0019  

Day  21  aggrecan  -  osteopontin   .11  
Day  1  aggrecan-LPL  

7.5e-5   .0087  

.92  

Day  21  aggrecan-LPL  

.0022  

.67  

Day  1  osteopontin-LPL  

1.9e-5   .0044  

.96  

Day  21  osteopontin-LPL  

.04  

.059  

.047  

.21  

Supplementary  Table  2:  Correlation  of  marker  gene  RNA  abundance  in  individual  differentiating  
2
MSCs.  r   and  Pearson’s  correlation  coefficient  between  abundance  of  aggrecan,  osteopontin,  and  LPL  in  
MSCs  cultured  with  TGFβ  in  agarose  for  either  1  or  21  days.  Test  for  the  significance  of  the  Pearson  
correlation  coefficient  was  conducted  with  103  degrees  of  freedom  for  Day  1  comparisons,  and  and  77  
degrees  of  freedom  for  Day  21  comparisons.  n=  105  cells  at  Day  1  and  79  cells  at  Day  21.  

  

Supplementary  Table  3  
  
Colony  A  
Aggrecan  CV  
1.71  
GAPDH  CV  
0.32  

Colony  B  
1.34  
0.35  

Colony  C  
1.07  
0.31  

Colony  D  
0.91  
0.20  

Supplementary  Table  3:  Coefficient  of  variation  (CV)  of  single  cell  RNA  count  in  small  MSC  colonies.  
GAPDH  RNA  abundance  was  less  variable  in  small  colonies  than  aggrecan  RNA  abundance.  (n  =  75  cells  in  
colony  A,  7  cells  in  colony  B,  6  cells  in  colony  C,  8  cells  in  colony  D).  
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Supplementary  Table  4  
Comparison  

Adjusted  P-value  

-TGFB  vs  +TGFB,  Day  01  

0.0067  

-TGFB  vs  +TGFB,  Day  04  

0.0043  

-TGFB  vs  +TGFB,  Day  07  

0.0020  

-TGFB  vs  +TGFB,  Day  14  

0.0017  

-TGFB  vs  +TGFB,  Day  21  

0.0031  

+TGFB,  Day  1  vs  Day  4  

0.0006  

+TGFB,  Day  1  vs  Day  7  

0.0002  

+TGFB,  Day  1  vs  Day  14  

0.0047  

+TGFB,  Day  1  vs  Day  21  

0.0002  

+TGFB,  Day  4  vs  Day  7  

0.0004  

+TGFB,  Day  4  vs  Day  14  

0.0021  

+TGFB,  Day  4  vs  Day  21  

0.0002  

+TGFB,  Day  7  vs  Day  14  

0.0002  

+TGFB,  Day  7  vs  Day  21  

<.0001  

+TGFB,  Day  14  vs  Day  21  

0.0002  

       

  

Supplementary  Table  4:  Additional  statistical  information  related  to  aggrecan  RNA  abundance  
differentiating  MSCs.  Companion  table  to  Figure  4-1e.  P-values  indicated  for  all  planned  contrasts  
between  –TGFβ  and  +TGFβ  groups  over  21  days  of  culture.  Aggrecan  RNA  count  means  compared  by  t-
tests  with  Satterthwaite  approximation  and  simulated  adjustment  for  multiple  comparisons.  
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Supplementary  Table  5  
Comparison  

Adjusted  
P-value    

<  12  hrs  

[12-23  hrs]   <.0001  

<  12  hrs  

[24-35  hrs]   <.0001  

<  12  hrs  

[36-47  hrs]   <.0001  

<  12  hrs  

>  47  hrs  

  

  

<.0001  

[12-23  hrs]   [24-35  hrs]   0.8759  
[12-23  hrs]   [36-47  hrs]   0.7564  
[12-23  hrs]   >  47  hrs  

0.9997  

[24-35  hrs]   [36-47  hrs]   <.0001  
[24-35  hrs]   >  47  hrs  

<.0001  

[36-47  hrs]   >  47  hrs  

<.0001  

  

Supplementary  Table  5:  Additional  statistical  information  related  to  divergence  in  aggrecan  RNA  
abundance  between  sister  cells.  Companion  table  to  Figure  4-6f.  Means  compared  by  t-tests  with  
Satterthwaite  approximation  and  simulated  adjustment  for  multiple  comparisons,  n  =  81  sister  cell  pairs.  
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Supplementary  Table  6  
Comparison  

Adjusted  
P-value  

  <  12  hrs  

[12-23  hrs]   0.1649  

<  12  hrs  

[24-35  hrs]   0.6435  

<  12  hrs  

[36-47  hrs]   <.0001  

<  12  hrs  

>  47  hrs  

<.0001  

[12-23  hrs]   [24-35  hrs]   0.0173  
[12-23  hrs]   [36-47  hrs]   <.0001  
[12-23  hrs]   >  47  hrs  

<.0001  

[24-35  hrs]   [36-47  hrs]   <.0001  
[24-35  hrs]   >  47  hrs  

<.0001  

[36-47  hrs]   >  47  hrs  

<.0001  

Supplementary  Table  6:  Additional  statistical  information  related  to  divergence  in  GAPDH  RNA  
abundance  between  sister  cells.  Companion  table  to  Figure  4-7b.  Means  compared  by  t-tests  with  
Satterthwaite  approximation  and  simulated  adjustment  for  multiple  comparisons,  n  =  81  sister  cell  pairs.  
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Supplementary  Table7  
Passage  
Compariso
n  

Aggrecan/GAPDH  
(Pooled  
Population)  
Adjusted  P-value  

Aggrecan  per  Cell   GAPDH  per  Cell  
Adjusted  P-value   Adjusted  P-value  

0  

1  

0.0079  

0.2108  

0.0006  

0  

3  

0.0004  

0.9342  

0.0006  

0  

5  

0.0002  

0.9999  

0.0008  

0  

7  

0.0002  

1.0000  

0.0008  

0  

9  

0.0011  

0.9984  

0.0025  

1  

3  

0.7036  

0.6621  

1.0000  

1  

5  

0.5040  

0.2891  

0.9945  

1  

7  

0.4593  

0.1658  

0.9929  

1  

9  

0.9377  

0.3623  

0.7026  

3  

5  

0.9993  

0.9783  

0.9981  

3  

7  

0.9982  

0.8850  

0.9972  

3  

9  

0.9944  

0.9934  

0.7784  

5  

7  

1.0000  

0.9988  

1.0000  

5  

9  

0.9510  

0.9999  

0.9343  

7  

9  

0.9309  

0.9941  

0.9431  

Supplementary  Table  7:  Additional  statistical  information  related  to  RNA  abundance  in  chondrocytes  
during  passage-induced  de-differentiation.  Companion  table  to  Figure  4-8b-d.  P-values  indicated  for  all  
planned  contrasts  between  chondrocytes  at  different  passages  (passages  0-9).  Pooled  aggrecan/GAPDH  
levels  compared  via  one-way  ANOVA  with  Tukey’s  post-hoc  test.  Single  cell  RNA  count  means  compared  
by  t-tests  with  Satterthwaite  approximation  and  simulated  adjustment  for  multiple  comparisons.  
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Supplementary  Table  8  

Comparison  

Aggrecan  per  
Cell  
Adjusted  P-
value  

GAPDH  per  Cell   Aggrecan/GAPDH    
Adjusted  P-
per  Cell  
value  
Adjusted  P-value  

Day  1,  P0  vs  P5   0.0016  

0.0406  

0.9983  

P0,  Day  1  vs  14   0.0897  

0.0006  

0.0176  

Day  14,  P0  vs  
P5  

0.0002  

0.6714  

0.0588  

P5,  Day  1  vs  14   <.0001  

<.0001  

0.1982  

Supplementary  Table  8:  Additional  statistical  information  related  to  RNA  abundance  in  chondrocytes  
during  re-differentiation  in  agarose.  Companion  table  to  Figure  4-8h-j.  P-values  indicated  for  all  planned  
contrasts  between  chondrocytes  at  different  passages  (passages  0  and  5)  and  culture  time  points  (days  1  
and  14).  Pooled  aggrecan/GAPDH  levels  compared  via  one-way  ANOVA  with  Tukey’s  post-hoc  test.  Single  
cell  RNA  count  means  compared  by  t-tests  with  Satterthwaite  approximation  and  simulated  adjustment  for  
multiple  comparisons.  
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Appendix	
  3:	
  Methionine	
  Content	
  of	
  Extracellular	
  Matrix	
  Proteins	
  
Methionine  content  of  extracellular  matrix  structural  constituents  (GO:0005201)  &  
proteinaceous  extracellular  matrix  (GO:0005578).    
Retrieved  from  UniProtKB/Swiss-Prot  October2016,  and  filtered  for  human  proteins.  
#  Met   #  Amino  %  Met  
UniProt  
Protein  Name  
Gene  
Acids  
ID  
P08253  
72  kDa  type  IV  collagenase    
MMP2    
12  
660   1.82%  
Q9UHI8  

A  disintegrin  and  metalloproteinase  
with  thrombospondin  motifs  1    
Q9H324   A  disintegrin  and  metalloproteinase  
with  thrombospondin  motifs  10    
P58397  
A  disintegrin  and  metalloproteinase  
with  thrombospondin  motifs  12    
Q76LX8   A  disintegrin  and  metalloproteinase  
with  thrombospondin  motifs  13    
Q8WXS8   A  disintegrin  and  metalloproteinase  
with  thrombospondin  motifs  14    
Q8TE58   A  disintegrin  and  metalloproteinase  
with  thrombospondin  motifs  15    
Q8TE57   A  disintegrin  and  metalloproteinase  
with  thrombospondin  motifs  16    
Q8TE56   A  disintegrin  and  metalloproteinase  
with  thrombospondin  motifs  17    
Q8TE60   A  disintegrin  and  metalloproteinase  
with  thrombospondin  motifs  18    
Q8TE59   A  disintegrin  and  metalloproteinase  
with  thrombospondin  motifs  19    
O95450  
A  disintegrin  and  metalloproteinase  
with  thrombospondin  motifs  2    
P59510  
A  disintegrin  and  metalloproteinase  
with  thrombospondin  motifs  20    
O15072  
A  disintegrin  and  metalloproteinase  
with  thrombospondin  motifs  3    
O75173  
A  disintegrin  and  metalloproteinase  
with  thrombospondin  motifs  4    
Q9UNA0   A  disintegrin  and  metalloproteinase  
with  thrombospondin  motifs  5    
Q9UKP5   A  disintegrin  and  metalloproteinase  
with  thrombospondin  motifs  6    
Q9UKP4   A  disintegrin  and  metalloproteinase  
with  thrombospondin  motifs  7    
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ADAMTS1    

15  

967   1.55%  

ADAMTS10    

12  

1103   1.09%  

ADAMTS12    

30  

1594   1.88%  

ADAMTS13    

24  

1427   1.68%  

ADAMTS14    

17  

1223   1.39%  

ADAMTS15    

11  

950   1.16%  

ADAMTS16    

26  

1224   2.12%  

ADAMTS17    

16  

1095   1.46%  

ADAMTS18    

15  

1221   1.23%  

ADAMTS19    

28  

1207   2.32%  

ADAMTS2    

26  

1211   2.15%  

ADAMTS20    

35  

1910   1.83%  

ADAMTS3    

27  

1205   2.24%  

ADAMTS4    

14  

837   1.67%  

ADAMTS5    

10  

930   1.08%  

ADAMTS6    

17  

1117   1.52%  

ADAMTS7    

15  

1686   0.89%  

Q9UP79  

A  disintegrin  and  metalloproteinase  
with  thrombospondin  motifs  8    
A  disintegrin  and  metalloproteinase  
with  thrombospondin  motifs  9    
Acetylcholinesterase    

ADAMTS8    

11  

889   1.24%  

ADAMTS9    

26  

1935   1.34%  

ACHE    

9  

614   1.47%  

COLQ    

14  

455   3.08%  

Q8N6G6  

Acetylcholinesterase  collagenic  tail  
peptide    
ADAMTS-like  protein  1    

ADAMTSL1    

17  

1762   0.96%  

Q86TH1  

ADAMTS-like  protein  2    

ADAMTSL2    

14  

951   1.47%  

P82987  

ADAMTS-like  protein  3    

ADAMTSL3    

30  

1691   1.77%  

Q6UY14  

ADAMTS-like  protein  4    

ADAMTSL4    

7  

1074   0.65%  

Q6ZMM2   ADAMTS-like  protein  5    

ADAMTSL5    

4  

481   0.83%  

P16112  

Aggrecan  core  protein    

ACAN    

13  

2415   0.54%  

O00468  

Agrin    

AGRN    

13  

2067   0.63%  

P05186  

ALPL    

15  

524   2.86%  

P01009  

Alkaline  phosphatase,  tissue-
nonspecific  isozyme    
Alpha-1-antitrypsin    

SERPINA1    

10  

418   2.39%  

P37840  

Alpha-synuclein    

SNCA    

4  

140   2.86%  

O75443  

Alpha-tectorin    

TECTA    

21  

2155   0.97%  

Q9NP70  

Ameloblastin    

AMBN    

25  

447   5.59%  

Q99217  

Amelogenin,  X  isoform    

AMELX    

11  

191   5.76%  

Q99218  

Amelogenin,  Y  isoform    

AMELY    

9  

206   4.37%  

Q6UX39  

Amelotin    

AMTN    

3  

209   1.44%  

P51693  

Amyloid-like  protein  1    

APLP1    

16  

650   2.46%  

P03950  

Angiogenin    

ANG    

3  

147   2.04%  

Q9BY76  

Angiopoietin-related  protein  4    

ANGPTL4    

7  

406   1.72%  

P07355  

Annexin  A2    

ANXA2    

9  

339   2.65%  

P23352  

Anosmin-1    

ANOS1    

5  

680   0.74%  

Q9BXN1  

Asporin    

ASPN    

12  

380   3.16%  

P98160  

43  

4391   0.98%  

Q96PL2  

Basement  membrane-specific  heparan   HSPG2    
sulfate  proteoglycan  core  protein    
Beta-tectorin    
TECTB    

5  

329   1.52%  

P21810  

Biglycan    

BGN    

8  

368   2.17%  

P13497  

Bone  morphogenetic  protein  1    

BMP1    

10  

986   1.01%  

P12644  

Bone  morphogenetic  protein  4    

BMP4    

8  

408   1.96%  

BCAN    

8  

911   0.88%  

Q9P2N4  
P22303  
Q9Y215  

Q96GW7   Brevican  core  protein    
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Q2TAL6  

Brorin    

VWC2    

5  

325   1.54%  

P27797  

Calreticulin    

CALR    

5  

417   1.20%  

Q8N4T0  

Carboxypeptidase  A6    

CPA6    

12  

437   2.75%  

Q66K79  

Carboxypeptidase  Z    

CPZ    

16  

652   2.45%  

Q9NQ79  

Cartilage  acidic  protein  1    

CRTAC1    

13  

661   1.97%  

O75339  

Cartilage  intermediate  layer  protein  1     CILP    

26  

1184   2.20%  

Q8IUL8  

Cartilage  intermediate  layer  protein  2     CILP2    

14  

1156   1.21%  

P21941  

Cartilage  matrix  protein    

MATN1    

8  

496   1.61%  

P49747  

Cartilage  oligomeric  matrix  protein    

COMP    

8  

757   1.06%  

O75718  

Cartilage-associated  protein    

CRTAP    

9  

401   2.24%  

P48509  

CD151  antigen    

CD151    

5  

253   1.98%  

P36222  

Chitinase-3-like  protein  1    

CHI3L1    

7  

383   1.83%  

O15335  

Chondroadherin    

CHAD    

3  

359   0.84%  

Q6NUI6  

Chondroadherin-like  protein    

CHADL    

2  

762   0.26%  

O43405  

Cochlin    

COCH    

10  

550   1.82%  

Q76M96  

29  

950   3.05%  

P02452  

Coiled-coil  domain-containing  protein   CCDC80    
80    
Collagen  alpha-1(I)  chain    
COL1A1    

13  

1464   0.89%  

P08123  

Collagen  alpha-2(I)  chain    

COL1A2    

10  

1366   0.73%  

P02458  

Collagen  alpha-1(II)  chain    

COL2A1    

16  

1487   1.08%  

P02461  

Collagen  alpha-1(III)  chain    

COL3A1    

17  

1466   1.16%  

P02462  

Collagen  alpha-1(IV)  chain    

COL4A1    

31  

1669   1.86%  

P08572  

Collagen  alpha-2(IV)  chain    

COL4A2    

25  

1712   1.46%  

Q01955  

Collagen  alpha-3(IV)  chain    

COL4A3    

29  

1670   1.74%  

P53420  

Collagen  alpha-4(IV)  chain    

COL4A4    

24  

1690   1.42%  

P29400  

Collagen  alpha-5(IV)  chain    

COL4A5    

26  

1685   1.54%  

Q14031  

Collagen  alpha-6(IV)  chain    

COL4A6    

25  

1691   1.48%  

P20908  

Collagen  alpha-1(V)  chain    

COL5A1    

23  

1838   1.25%  

P05997  

Collagen  alpha-2(V)  chain    

COL5A2    

24  

1499   1.60%  

P25940  

Collagen  alpha-3(V)  chain    

COL5A3    

12  

1745   0.69%  

P12109  

Collagen  alpha-1(VI)  chain    

COL6A1    

11  

1028   1.07%  

P12110  

Collagen  alpha-2(VI)  chain    

COL6A2    

13  

1019   1.28%  

P12111  

Collagen  alpha-3(VI)  chain    

COL6A3    

37  

3177   1.16%  

A8TX70  

Collagen  alpha-5(VI)  chain    

COL6A5    

55  

2615   2.10%  
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A6NMZ7  

Collagen  alpha-6(VI)  chain    

COL6A6    

47  

2263   2.08%  

Q02388  

Collagen  alpha-1(VII)  chain    

COL7A1    

18  

2944   0.61%  

P27658  

Collagen  alpha-1(VIII)  chain    

COL8A1    

23  

744   3.09%  

P25067  

Collagen  alpha-2(VIII)  chain    

COL8A2    

9  

703   1.28%  

P20849  

Collagen  alpha-1(IX)  chain    

COL9A1    

12  

921   1.30%  

Q14055  

Collagen  alpha-2(IX)  chain    

COL9A2    

11  

689   1.60%  

Q14050  

Collagen  alpha-3(IX)  chain    

COL9A3    

6  

684   0.88%  

Q03692  

Collagen  alpha-1(X)  chain    

COL10A1    

11  

680   1.62%  

P12107  

Collagen  alpha-1(XI)  chain    

COL11A1    

24  

1806   1.33%  

P13942  

Collagen  alpha-2(XI)  chain    

COL11A2    

16  

1736   0.92%  

Q99715  

Collagen  alpha-1(XII)  chain    

COL12A1    

45  

3063   1.47%  

Q05707  

Collagen  alpha-1(XIV)  chain    

COL14A1    

33  

1796   1.84%  

P39059  

Collagen  alpha-1(XV)  chain    

COL15A1    

30  

1388   2.16%  

Q07092  

Collagen  alpha-1(XVI)  chain    

COL16A1    

26  

1604   1.62%  

Q9UMD9   Collagen  alpha-1(XVII)  chain    

COL17A1    

33  

1497   2.20%  

P39060  

Collagen  alpha-1(XVIII)  chain    

COL18A1    

15  

1754   0.86%  

Q14993  

Collagen  alpha-1(XIX)  chain    

COL19A1    

18  

1142   1.58%  

Q96P44  

Collagen  alpha-1(XXI)  chain    

COL21A1    

12  

957   1.25%  

Q8NFW1   Collagen  alpha-1(XXII)  chain    

COL22A1    

20  

1626   1.23%  

Q17RW2   Collagen  alpha-1(XXIV)  chain    

COL24A1    

24  

1714   1.40%  

Q96A83  

Collagen  alpha-1(XXVI)  chain    

COL26A1    

6  

441   1.36%  

Q8IZC6  

Collagen  alpha-1(XXVII)  chain    

COL27A1    

38  

1860   2.04%  

Q6UXH8  

8  

406   1.97%  

4  

243   1.65%  

P45452  

Collagen  and  calcium-binding  EGF  
CCBE1    
domain-containing  protein  1    
Collagen  triple  helix  repeat-containing   CTHRC1    
protein  1    
Collagenase  3    
MMP13    

12  

471   2.55%  

P29279  

Connective  tissue  growth  factor    

CTGF    

13  

349   3.72%  

P54108  

Cysteine-rich  secretory  protein  3    

CRISP3    

5  

245   2.04%  

Q9H0B8  

12  

497   2.41%  

P07585  

Cysteine-rich  secretory  protein  LCCL   CRISPLD2    
domain-containing  2    
Decorin    
DCN    

5  

359   1.39%  

Q13316  

Dentin  matrix  acidic  phosphoprotein  1     DMP1    

6  

513   1.17%  

Q96CG8  

Q9NZW4   Dentin  sialophosphoprotein    

DSPP    

4  

1301   0.31%  

Q07507  

DPT    

8  

201   3.98%  

Dermatopontin    
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Q12959  

Disks  large  homolog  1    

DLG1    

13  

904   1.44%  

Q03001  

Dystonin    

DST    

158  

7570   2.09%  

Q14118  

Dystroglycan    

DAG1    

19  

895   2.12%  

Q9Y5L3  

9  

495   1.82%  

11  

493   2.23%  

8  

443   1.81%  

P19957  

Ectonucleoside  triphosphate  
ENTPD2    
diphosphohydrolase  2    
EGF-containing  fibulin-like  extracellular  EFEMP1    
matrix  protein  1    
EGF-containing  fibulin-like  extracellular  EFEMP2    
matrix  protein  2    
Elafin    
PI3    

3  

117   2.56%  

P15502  

Elastin    

ELN    

1  

786   0.13%  

Q96A84  

EMI  domain-containing  protein  1    

EMID1    

12  

441   2.72%  

Q9Y6C2  

EMILIN-1    

EMILIN1    

7  

1016   0.69%  

Q9BXX0  

EMILIN-2    

EMILIN2    

18  

1053   1.71%  

Q9NT22  

EMILIN-3    

EMILIN3    

6  

766   0.78%  

Q9NRM1   Enamelin    

ENAM    

21  

1142   1.84%  

Q9HCU0  

Endosialin    

CD248    

8  

757   1.06%  

Q8IUX8  

Epidermal  growth  factor-like  protein  6     EGFL6    

9  

553   1.63%  

Q99645  

Epiphycan    

EPYC    

5  

322   1.55%  

Q96RT1  

Erbin    

ERBIN    

31  

1412   2.20%  

P43003  

Excitatory  amino  acid  transporter  1    

SLC1A3    

26  

542   4.80%  

Q16610  

Extracellular  matrix  protein  1    

ECM1    

5  

540   0.93%  

O94769  

Extracellular  matrix  protein  2    

ECM2    

13  

699   1.86%  

Q86XX4  

Extracellular  matrix  protein  FRAS1    

FRAS1    

61  

4008   1.52%  

P35555  

Fibrillin-1    

FBN1    

52  

2871   1.81%  

P35556  

Fibrillin-2    

FBN2    

59  

2912   2.03%  

Q75N90  

Fibrillin-3    

FBN3    

38  

2809   1.35%  

P05230  

Fibroblast  growth  factor  1    

FGF1    

2  

155   1.29%  

P31371  

Fibroblast  growth  factor  9    

FGF9    

2  

208   0.96%  

Q06828  

Fibromodulin    

FMOD    

7  

376   1.86%  

P02751  

Fibronectin    

FN1    

27  

2386   1.13%  

P23142  

Fibulin-1    

FBLN1    

8  

703   1.14%  

P98095  

Fibulin-2    

FBLN2    

12  

1184   1.01%  

Q9UBX5  

Fibulin-5    

FBLN5    

11  

448   2.46%  

Q53RD9  

Fibulin-7    

FBLN7    

7  

439   1.59%  

Q12805  
O95967  
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Q5H8C1  

FREM1    

39  

2179   1.79%  

FREM2    

66  

3169   2.08%  

FREM3    

34  

2139   1.59%  

P09382  

FRAS1-related  extracellular  matrix  
protein  1    
FRAS1-related  extracellular  matrix  
protein  2    
FRAS1-related  extracellular  matrix  
protein  3    
Galectin-1    

LGALS1    

2  

135   1.48%  

Q08380  

Galectin-3-binding  protein    

LGALS3BP    

9  

585   1.54%  

Q6ZMI3  

Gliomedin    

GLDN    

15  

551   2.72%  

Q3B7J2  

GFOD2    

17  

385   4.42%  

P78417  

Glucose-fructose  oxidoreductase  
domain-containing  protein  2    
Glutathione  S-transferase  omega-1    

GSTO1    

7  

241   2.90%  

P35052  

Glypican-1    

GPC1    

11  

558   1.97%  

Q8N158  

Glypican-2    

GPC2    

10  

579   1.73%  

P51654  

Glypican-3    

GPC3    

23  

580   3.97%  

O75487  

Glypican-4    

GPC4    

18  

556   3.24%  

P78333  

Glypican-5    

GPC5    

18  

572   3.15%  

Q9Y625  

Glypican-6    

GPC6    

19  

555   3.42%  

Q92896  

Golgi  apparatus  protein  1    

GLG1    

38  

1179   3.22%  

Q96RW7   Hemicentin-1    

HMCN1    

73  

5635   1.30%  

Q8NDA2  

Hemicentin-2    

HMCN2    

42  

5059   0.83%  

Q9Y251  

Heparanase    

HPSE    

9  

543   1.66%  

Hyaluronan  and  proteoglycan  link  
protein  1    
Q9GZV7   Hyaluronan  and  proteoglycan  link  
protein  2    
Q96S86   Hyaluronan  and  proteoglycan  link  
protein  3    
Q86UW8   Hyaluronan  and  proteoglycan  link  
protein  4    
Q8WWQ2   Inactive  heparanase-2    

HAPLN1    

2  

354   0.56%  

HAPLN2    

3  

340   0.88%  

HAPLN3    

2  

360   0.56%  

HAPLN4    

2  

402   0.50%  

HPSE2    

10  

592   1.69%  

P05019  

Insulin-like  growth  factor  I    

IGF1    

5  

195   2.56%  

P23229  

Integrin  alpha-6    

ITGA6    

15  

1130   1.33%  

P05556  

Integrin  beta-1    

ITGB1    

15  

798   1.88%  

Q01638  

Interleukin-1  receptor-like  1    

IL1RL1    

12  

556   2.16%  

Q17R60  

Interphotoreceptor  matrix  proteoglycan   IMPG1    
1    

18  

797   2.26%  

Q5SZK8  
P0C091  

P10915  

161  
  

Q9BZV3  

Interphotoreceptor  matrix  proteoglycan   IMPG2    
2    
Interstitial  collagenase    
MMP1    

23  

1241   1.85%  

10  

469   2.13%  

KAZALD1    

3  

304   0.99%  

O60938  

Kazal-type  serine  protease  inhibitor  
domain-containing  protein  1    
Keratocan    

KERA    

10  

352   2.84%  

O00515  

Ladinin-1    

LAD1    

6  

517   1.16%  

P25391  

Laminin  subunit  alpha-1    

LAMA1    

40  

3075   1.30%  

P24043  

Laminin  subunit  alpha-2    

LAMA2    

46  

3122   1.47%  

Q16787  

Laminin  subunit  alpha-3    

LAMA3    

44  

3333   1.32%  

Q16363  

Laminin  subunit  alpha-4    

LAMA4    

32  

1823   1.76%  

O15230  

Laminin  subunit  alpha-5    

LAMA5    

41  

3695   1.11%  

P07942  

Laminin  subunit  beta-1    

LAMB1    

32  

1786   1.79%  

P55268  

Laminin  subunit  beta-2    

LAMB2    

16  

1798   0.89%  

Q13751  

Laminin  subunit  beta-3    

LAMB3    

28  

1172   2.39%  

A4D0S4  

Laminin  subunit  beta-4    

LAMB4    

18  

1761   1.02%  

P11047  

Laminin  subunit  gamma-1    

LAMC1    

22  

1609   1.37%  

Q13753  

Laminin  subunit  gamma-2    

LAMC2    

22  

1193   1.84%  

Q9Y6N6  

Laminin  subunit  gamma-3    

LAMC3    

14  

1575   0.89%  

Q14766  

LTBP1    

19  

1721   1.10%  

LTBP2    

16  

1821   0.88%  

LTBP4    

10  

1624   0.62%  

FLRT1    

12  

646   1.86%  

FLRT2    

13  

660   1.97%  

FLRT3    

12  

649   1.85%  

O75829  

Latent-transforming  growth  factor  beta-
binding  protein  1    
Latent-transforming  growth  factor  beta-
binding  protein  2    
Latent-transforming  growth  factor  beta-
binding  protein  4    
Leucine-rich  repeat  transmembrane  
protein  FLRT1    
Leucine-rich  repeat  transmembrane  
protein  FLRT2    
Leucine-rich  repeat  transmembrane  
protein  FLRT3    
Leukocyte  cell-derived  chemotaxin  1    

LECT1    

8  

334   2.40%  

P16150  

Leukosialin    

SPN    

10  

400   2.50%  

P51884  

Lumican    

LUM    

4  

338   1.18%  

Q08397  

Lysyl  oxidase  homolog  1    

LOXL1    

3  

574   0.52%  

Q9Y4K0  

Lysyl  oxidase  homolog  2    

LOXL2    

20  

774   2.58%  

P39900  

Macrophage  metalloelastase    

MMP12    

12  

470   2.55%  

P03956  
Q96I82  

Q14767  
Q8N2S1  
Q9NZU1  
O43155  
Q9NZU0  

162  
  

Q7Z304  

MAM  domain-containing  protein  2    

MAMDC2    

15  

686   2.19%  

O00339  

Matrilin-2    

MATN2    

19  

956   1.99%  

O15232  

Matrilin-3    

MATN3    

6  

486   1.23%  

P09237  

Matrilysin    

MMP7    

9  

267   3.37%  

Q9NQ76  

ME  

8  

525   1.52%  

P08493  

Matrix  extracellular  
phosphoglycoprotein    
Matrix  Gla  protein    

MGP    

3  

103   2.91%  

P51512  

Matrix  metalloproteinase-16    

MMP16    

15  

607   2.47%  

Q9ULZ9  

Matrix  metalloproteinase-17    

MMP17    

10  

603   1.66%  

Q99542  

Matrix  metalloproteinase-19    

MMP19    

10  

508   1.97%  

O60882  

Matrix  metalloproteinase-20    

MMP20    

14  

483   2.90%  

O75900  

Matrix  metalloproteinase-23    

MMP23A    

5  

390   1.28%  

Q9Y5R2  

Matrix  metalloproteinase-24    

MMP24    

10  

645   1.55%  

Q9NPA2  

Matrix  metalloproteinase-25    

MMP25    

9  

562   1.60%  

Q9NRE1  

Matrix  metalloproteinase-26    

MMP26    

5  

261   1.92%  

Q9H239  

Matrix  metalloproteinase-28    

MMP28    

5  

520   0.96%  

P14780  

Matrix  metalloproteinase-9    

MMP9    

9  

707   1.27%  

P01033  

Metalloproteinase  inhibitor  1    

TIMP1    

4  

207   1.93%  

P16035  

Metalloproteinase  inhibitor  2    

TIMP2    

6  

220   2.73%  

P35625  

Metalloproteinase  inhibitor  3    

TIMP3    

6  

211   2.84%  

Q99727  

Metalloproteinase  inhibitor  4    

TIMP4    

4  

224   1.79%  

P55083  

Microfibril-associated  glycoprotein  4    

MFAP4    

4  

255   1.57%  

P55081  

Microfibrillar-associated  protein  1    

MFAP1    

14  

439   3.19%  

P55001  

Microfibrillar-associated  protein  2    

MFAP2    

2  

183   1.09%  

Q13361  

Microfibrillar-associated  protein  5    

MFAP5    

4  

173   2.31%  

P20774  

Mimecan    

OGN    

2  

298   0.67%  

Q02505  

Mucin-3A    

MUC3A    

74  

3323   2.23%  

Q99102  

Mucin-4    

MUC4    

34  

2169   1.57%  

P98088  

Mucin-5AC    

MUC5AC    

45  

5654   0.80%  

Q6W4X9  

Mucin-6    

MUC6    

31  

2439   1.27%  

Q9H8L6  

Multimerin-2    

MMRN2    

15  

949   1.58%  

Q9H1U4  

MEGF9    

4  

602   0.66%  

Q99972  

Multiple  epidermal  growth  factor-like  
domains  protein  9    
Myocilin    

MYOC    

8  

504   1.59%  

Q2UY09  

NA  

COL28A1    

14  

1125   1.24%  

163  
  

Q15063  

NA  

POSTN    

17  

836   2.03%  

Q9BQB4  

NA  

SOST    

2  

213   0.94%  

Q6UXI9  

Nephronectin    

NPNT    

8  

565   1.42%  

O95631  

Netrin-1    

NTN1    

10  

604   1.66%  

O00634  

Netrin-3    

NTN3    

4  

580   0.69%  

Q9HB63  

Netrin-4    

NTN4    

11  

628   1.75%  

O00533  

15  

1208   1.24%  

O14594  

Neural  cell  adhesion  molecule  L1-like   CHL1    
protein    
Neurocan  core  protein    
NCAN    

24  

1321   1.82%  

Q8IVL1  

Neuron  navigator  2    

NAV2    

53  

2488   2.13%  

P22894  

Neutrophil  collagenase    

MMP8    

8  

467   1.71%  

P14543  

Nidogen-1    

NID1    

8  

1247   0.64%  

Q14112  

Nidogen-2    

NID2    

8  

1375   0.58%  

Q9GZU5  

Nyctalopin    

NYX    

4  

481   0.83%  

A1E959  

Odontogenic  ameloblast-associated  
protein    
Olfactomedin-like  protein  2A    

ODAM    

8  

279   2.87%  

OLFML2A    

11  

652   1.69%  

Q9UBM4   Opticin    

OPTC    

5  

332   1.51%  

Q99983  

OMD    

12  

421   2.85%  

Q7RTW8   Otoancorin    

OTOA    

25  

1153   2.17%  

O95428  

Papilin    

PAPLN    

9  

1278   0.70%  

O14936  

Peripheral  plasma  membrane  protein   CASK    
CASK    
Peroxidasin  homolog    
PXDN    

23  

926   2.48%  

24  

1479   1.62%  
840   2.14%  

P36955  

Phosphatidylinositol-glycan-specific  
GPLD1    
18  
phospholipase  D    
Phosphoethanolamine/phosphocholine   PHOSPHO1     7  
phosphatase    
Pigment  epithelium-derived  factor    
SERPINF1    
6  

Q63HQ2  

Pikachurin    

EGFLAM    

21  

1017   2.06%  

P21246  

Pleiotrophin    

PTN    

3  

168   1.79%  

Q7Z5L7  

Podocan    

PODN    

4  

613   0.65%  

Q6PEZ8  

Podocan-like  protein  1    

PODNL1    

5  

512   0.98%  

Q5K4E3  

Polyserase-2    

PRSS36    

9  

855   1.05%  

P51888  

Prolargin    

PRELP    

6  

382   1.57%  

Q32P28  

Prolyl  3-hydroxylase  1    

P3H1    

16  

736   2.17%  

Q68BL7  

Q92626  
P80108  
Q8TCT1  

Osteomodulin    

164  
  

267   2.62%  
418   1.44%  

Q8IVL5  

Prolyl  3-hydroxylase  2    

P3H2    

14  

708   1.98%  

O00622  

Protein  CYR61    

CYR61    

6  

381   1.57%  

Q14129  

Protein  DGCR6    

DGCR6    

4  

220   1.82%  

Q8TB73  

Protein  NDNF    

NDNF    

6  

568   1.06%  

P48745  

Protein  NOV  homolog    

NOV    

6  

357   1.68%  

Q96JX3  

Protein  SERAC1    

SERAC1    

16  

654   2.45%  

Q9GZT5  

Protein  Wnt-10a    

WNT10A    

8  

417   1.92%  

O00744  

Protein  Wnt-10b    

WNT10B    

6  

389   1.54%  

O96014  

Protein  Wnt-11    

WNT11    

11  

354   3.11%  

Q9UBV4  

Protein  Wnt-16    

WNT16    

12  

365   3.29%  

P09544  

Protein  Wnt-2    

WNT2    

11  

360   3.06%  

Q93097  

Protein  Wnt-2b    

WNT2B    

6  

391   1.53%  

P56704  

Protein  Wnt-3a    

WNT3A    

6  

352   1.70%  

P56705  

Protein  Wnt-4    

WNT4    

6  

351   1.71%  

P41221  

Protein  Wnt-5a    

WNT5A    

12  

380   3.16%  

Q9H1J7  

Protein  Wnt-5b    

WNT5B    

9  

359   2.51%  

Q9Y6F9  

Protein  Wnt-6    

WNT6    

5  

365   1.37%  

O00755  

Protein  Wnt-7a    

WNT7A    

8  

349   2.29%  

P56706  

Protein  Wnt-7b    

WNT7B    

6  

349   1.72%  

Q9H1J5  

Protein  Wnt-8a    

WNT8A    

8  

351   2.28%  

Q93098  

Protein  Wnt-8b    

WNT8B    

5  

351   1.42%  

O14904  

Protein  Wnt-9a    

WNT9A    

4  

365   1.10%  

O14905  

Protein  Wnt-9b    

WNT9B    

4  

357   1.12%  

P28300  

Protein-lysine  6-oxidase    

LOX    

5  

417   1.20%  

P04628  

Proto-oncogene  Wnt-1    

WNT1    

5  

370   1.35%  

P56703  

Proto-oncogene  Wnt-3    

WNT3    

5  

355   1.41%  

Q8IWL2  

SFTPA1    

6  

248   2.42%  

SFTPA2    

5  

248   2.02%  

SFTPD    

8  

375   2.13%  

A6NMY6  

Pulmonary  surfactant-associated  
protein  A1    
Pulmonary  surfactant-associated  
protein  A2    
Pulmonary  surfactant-associated  
protein  D    
Putative  annexin  A2-like  protein    

ANXA2P2    

9  

339   2.65%  

Q16473  

Putative  tenascin-XA    

TNXA    

4  

311   1.29%  

P23471  

Receptor-type  tyrosine-protein  
phosphatase  zeta    

PTPRZ1    

42  

2315   1.81%  

Q8IWL1  
P35247  

165  
  

P78509  

Reelin    

RELN    

70  

3460   2.02%  

Q8NC24  

RELT-like  protein  2    

RELL2    

9  

303   2.97%  

Q6XPR3  

Repetin    

RPTN    

4  

784   0.51%  

P10745  

Retinol-binding  protein  3    

RBP3    

30  

1247   2.41%  

Q8N474  

Secreted  frizzled-related  protein  1    

SFRP1    

10  

314   3.18%  

P02768  

Serum  albumin    

ALB    

7  

609   1.15%  

O75093  

Slit  homolog  1  protein    

SLIT1    

20  

1534   1.30%  

O94813  

Slit  homolog  2  protein    

SLIT2    

16  

1529   1.05%  

O75094  

Slit  homolog  3  protein    

SLIT3    

16  

1523   1.05%  

Q8IVN8  

5  

264   1.89%  

Q15465  

Somatomedin-B  and  thrombospondin   SBSPON    
type-1  domain-containing  protein    
Sonic  hedgehog  protein    
SHH    

5  

462   1.08%  

P09486  

SPARC    

SPARC    

5  

303   1.65%  

Q14515  

SPARC-like  protein  1    

SPARCL1    

12  

664   1.81%  

Q9H4F8  

SMOC1    

7  

434   1.61%  

SMOC2    

3  

446   0.67%  

Q9HCB6  

SPARC-related  modular  calcium-
binding  protein  1    
SPARC-related  modular  calcium-
binding  protein  2    
Spondin-1    

SPON1    

27  

807   3.35%  

Q9BUD6  

Spondin-2    

SPON2    

3  

331   0.91%  

P08254  

Stromelysin-1    

MMP3    

7  

477   1.47%  

P09238  

Stromelysin-2    

MMP10    

10  

476   2.10%  

P24347  

Stromelysin-3    

MMP11    

5  

488   1.02%  

Q9UQE7  

SMC3    

35  

1217   2.88%  

P01730  

Structural  maintenance  of  
chromosomes  protein  3    
T-cell  surface  glycoprotein  CD4    

CD4    

7  

458   1.53%  

Q7Z7G0  

Target  of  Nesh-SH3    

ABI3BP    

6  

1075   0.56%  

P24821  

Tenascin    

TNC    

23  

2201   1.04%  

Q9UQP3  

Tenascin-N    

TNN    

21  

1299   1.62%  

Q92752  

Tenascin-R    

TNR    

22  

1358   1.62%  

P22105  

Tenascin-X    

TNXB    

55  

4242   1.30%  

Q08629  

Testican-1    

SPOCK1    

5  

439   1.14%  

Q92563  

Testican-2    

SPOCK2    

6  

424   1.42%  

Q9BQ16  

Testican-3    

SPOCK3    

6  

436   1.38%  

Q6ZMP0  

Thrombospondin  type-1  domain-
containing  protein  4    

THSD4    

19  

1018   1.87%  

Q9H3U7  

166  
  

P35442  

Thrombospondin-2    

THBS2    

12  

1172   1.02%  

P35443  

Thrombospondin-4    

THBS4    

9  

961   0.94%  

P48307  

Tissue  factor  pathway  inhibitor  2    

TFPI2    

4  

235   1.70%  

Q03167  

Transforming  growth  factor  beta  
receptor  type  3    
Transforming  growth  factor  beta-1    

TGFBR3    

20  

851   2.35%  

TGFB1    

7  

390   1.79%  

TGFBI    

14  

683   2.05%  

Q07654  

Transforming  growth  factor-beta-
induced  protein  ig-h3    
Trefoil  factor  3    

TFF3    

2  

80  

P0DKB5  

Trophoblast  glycoprotein-like    

TPBGL    

4  

382   1.05%  

Q9UJW2  

Tubulointerstitial  nephritis  antigen    

TINAG    

10  

476   2.10%  

Q9GZM7   Tubulointerstitial  nephritis  antigen-like     TINAGL1    

15  

467   3.21%  

Q9UBB9  

Tuftelin-interacting  protein  11    

TFIP11    

26  

837   3.11%  

O00300  

Tumor  necrosis  factor  receptor  
superfamily  member  11B    
Uncharacterized  protein  C6orf15    

TNFRSF11B    

5  

401   1.25%  

C6orf15    

5  

325   1.54%  

Q8WVF2   Unique  cartilage  matrix-associated  
protein    
O75445  
Usherin    

UCMA    

5  

138   3.62%  

USH2A    

78  

5202   1.50%  

P15692  

Vascular  endothelial  growth  factor  A    

VEGFA    

8  

232   3.45%  

P13611  

Versican  core  protein    

VCAN    

55  

3396   1.62%  

Q53GQ0  

HSD17B12    

10  

312   3.21%  

Q6UXI7  

Very-long-chain  3-oxoacyl-CoA  
reductase    
Vitrin    

VIT    

9  

678   1.33%  

P04004  

Vitronectin    

VTN    

7  

478   1.46%  

P04275  

von  Willebrand  factor    

VWF    

56  

2813   1.99%  

Q6PCB0  

5  

445   1.12%  

12  

755   1.59%  

5  

367   1.36%  

2  

250   0.80%  

6  

354   1.69%  

P60852  

von  Willebrand  factor  A  domain-
VWA1    
containing  protein  1    
von  Willebrand  factor  A  domain-
VWA2    
containing  protein  2    
WNT1-inducible-signaling  pathway  
WISP1    
protein  1    
WNT1-inducible-signaling  pathway  
WISP2    
protein  2    
WNT1-inducible-signaling  pathway  
WISP3    
protein  3    
Zona  pellucida  sperm-binding  protein  1    ZP1    

8  

638   1.25%  

Q05996  

Zona  pellucida  sperm-binding  protein  2    ZP2    

22  

745   2.95%  

P01137  
Q15582  

Q6UXA7  

Q5GFL6  
O95388  
O76076  
O95389  

167  
  

2.50%  

P21754  

Zona  pellucida  sperm-binding  protein  3    ZP3    

8  

424   1.89%  

Q12836  

Zona  pellucida  sperm-binding  protein  4    ZP4    

6  

540   1.11%  

O60844  

Zymogen  granule  membrane  protein  
16    

1  

167   0.60%  
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